data_2ltk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ltk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.376 0.132 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.481 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.408 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.709 0.29 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.534 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.807 -0.072 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.613 0.244 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.493 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.493 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.427 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 142' ' ' TRP . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . 0.409 ' H ' ' C ' ' A' ' 140' ' ' SER . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 120.706 0.289 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.406 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.406 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.046 -0.026 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.454 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.454 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.556 0.217 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.426 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.426 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.467 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.467 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.76 -0.162 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.409 0.147 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 121.036 0.446 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.463 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.463 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.438 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.438 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.435 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.984 0.421 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.56 57.17 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.8 ttp -81.46 124.9 29.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.909 1.284 . . . . 0.0 111.212 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.27 165.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.218 1.407 . . . . 0.0 111.104 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.481 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.481 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.408 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.408 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.391 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.83 149.13 26.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.174 0.989 . . . . 0.0 112.369 163.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.5 ttp -97.56 138.69 34.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 111.06 172.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.52 162.33 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.965 1.306 . . . . 0.0 111.07 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.03 115.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.065 2.546 . . . . 0.0 115.237 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 ttp -66.98 143.47 56.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.253 1.021 . . . . 0.0 110.243 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -121.41 159.32 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.879 1.272 . . . . 0.0 109.679 171.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.273 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.97 163.59 25.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.741 1.216 . . . . 0.0 113.787 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.1 ttm -92.4 147.47 22.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.578 166.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.94 155.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.484 1.114 . . . . 0.0 110.787 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.415 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.72 156.92 46.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.774 0.787 . . . . 0.0 112.86 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.2 ttp -88.02 131.35 34.67 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.568 1.147 . . . . 0.0 110.632 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m -108.65 162.94 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 110.778 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.534 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.534 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.92 158.8 43.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.837 1.255 . . . . 0.0 113.071 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 ttm -99.98 130.93 46.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.391 1.076 . . . . 0.0 110.421 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.94 164.07 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.894 1.278 . . . . 0.0 110.807 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.77 -168.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.344 1.458 . . . . 0.0 112.264 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 44.0 ttp -131.76 134.94 46.4 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.929 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -118.18 167.82 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.992 1.317 . . . . 0.0 111.523 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.493 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.493 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.427 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.58 152.35 30.8 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.2 ttm -66.0 147.58 53.14 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.278 1.431 . . . . 0.0 110.507 163.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.87 162.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.982 1.313 . . . . 0.0 111.547 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 142' ' ' TRP . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . 0.409 ' H ' ' C ' ' A' ' 140' ' ' SER . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.42 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.65 160.04 0.09 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.41 1.884 . . . . 0.0 115.531 -170.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.1 ttm -63.59 129.66 41.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.356 1.462 . . . . 0.0 110.276 166.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.14 164.9 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.556 1.142 . . . . 0.0 111.152 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.406 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.406 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.82 160.82 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -167.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 21.5 ttm -81.13 140.61 34.92 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 153.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.142 0.977 . . . . 0.0 110.547 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.4 158.25 43.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.173 0.986 . . . . 0.0 112.825 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.4 ttm -74.94 137.68 41.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.723 0.809 . . . . 0.0 110.954 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.66 161.05 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 110.935 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.454 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.454 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.86 11.56 4.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.3 1.44 . . . . 0.0 113.814 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.7 ttp 59.53 95.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.32 2.248 . . . . 0.0 113.468 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.69 169.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.205 1.402 . . . . 0.0 110.479 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.426 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.426 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.12 155.08 20.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.61 1.164 . . . . 0.0 113.516 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.2 ttm -72.62 137.05 45.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.824 0.849 . . . . 0.0 110.497 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.21 156.91 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.864 0.866 . . . . 0.0 110.14 167.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.467 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.467 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.044 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.6 150.29 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.637 0.775 . . . . 0.0 112.253 169.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 20.3 ttp -85.11 153.35 22.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 110.331 167.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.21 159.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.372 1.069 . . . . 0.0 110.823 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.25 154.57 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.466 2.306 . . . . 0.0 116.975 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 31.7 ttp -83.7 149.13 26.68 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.3 1.04 . . . . 0.0 110.119 164.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.15 159.46 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.044 1.338 . . . . 0.0 110.11 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.03 148.1 45.11 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.646 0.723 . . . . 0.0 112.133 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.7 ttm -73.27 135.57 44.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.722 0.809 . . . . 0.0 110.137 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.43 167.39 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.727 1.611 . . . . 0.0 109.505 164.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.69 149.13 24.88 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttm -58.71 145.22 40.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.011 0.925 . . . . 0.0 110.826 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -127.91 161.47 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.828 1.251 . . . . 0.0 110.794 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.77 152.76 43.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.179 0.991 . . . . 0.0 113.338 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.8 ttp -119.47 130.99 55.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.612 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.95 163.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.329 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.463 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.463 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.23 139.34 58.16 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 48.1 ttp -114.54 136.07 53.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.256 1.822 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -114.68 165.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.788 1.235 . . . . 0.0 111.379 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.438 ' HD1' ' HB ' ' A' ' 131' ' ' VAL . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.438 ' HB ' ' HD1' ' A' ' 129' ' ' HIS . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.435 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 141.58 28.33 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.79 1.236 . . . . 0.0 114.042 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 29.1 ttp -72.43 160.61 32.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.5 1.12 . . . . 0.0 110.707 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.93 155.6 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.866 0.866 . . . . 0.0 111.653 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.376 0.132 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 102' ' ' PRO . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 100' ' ' GLU . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 132' ' ' VAL . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 127' ' ' LEU . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 103' ' ' MET . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 82' ' ' ILE . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.709 0.29 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.807 -0.072 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.613 0.244 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.451 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 120.706 0.289 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB3' HD12 ' A' ' 179' ' ' ILE . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TRP . . . . . 0.401 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 90' ' ' ASP . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.046 -0.026 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.556 0.217 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 80' ' ' LYS . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' HD12 ' A' ' 179' ' ' ILE . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 90' ' ' ASP . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.76 -0.162 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.46 ' CE ' HD12 ' A' ' 127' ' ' LEU . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.46 HD12 ' CE ' ' A' ' 103' ' ' MET . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 127' ' ' LEU . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 103' ' ' MET . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.409 0.147 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 179' ' ' ILE . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 179' ' ' ILE . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.472 HD11 ' HE2' ' A' ' 151' ' ' LYS . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 121.036 0.446 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 148' ' ' LEU . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 148' ' ' LEU . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 148' ' ' LEU . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 110' ' ' MET . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' H ' HD13 ' A' ' 148' ' ' LEU . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.459 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.984 0.421 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.56 57.17 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.8 ttp -81.46 124.9 29.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.909 1.284 . . . . 0.0 111.212 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.27 165.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.218 1.407 . . . . 0.0 111.104 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 102' ' ' PRO . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 100' ' ' GLU . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.391 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.83 149.13 26.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.174 0.989 . . . . 0.0 112.369 163.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.5 ttp -97.56 138.69 34.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 111.06 172.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.52 162.33 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.965 1.306 . . . . 0.0 111.07 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.03 115.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.065 2.546 . . . . 0.0 115.237 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 ttp -66.98 143.47 56.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.253 1.021 . . . . 0.0 110.243 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -121.41 159.32 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.879 1.272 . . . . 0.0 109.679 171.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 132' ' ' VAL . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 127' ' ' LEU . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 103' ' ' MET . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 82' ' ' ILE . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.273 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.97 163.59 25.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.741 1.216 . . . . 0.0 113.787 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.1 ttm -92.4 147.47 22.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.578 166.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.94 155.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.484 1.114 . . . . 0.0 110.787 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.72 156.92 46.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.774 0.787 . . . . 0.0 112.86 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.2 ttp -88.02 131.35 34.67 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.568 1.147 . . . . 0.0 110.632 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m -108.65 162.94 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 110.778 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.92 158.8 43.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.837 1.255 . . . . 0.0 113.071 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 ttm -99.98 130.93 46.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.391 1.076 . . . . 0.0 110.421 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.94 164.07 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.894 1.278 . . . . 0.0 110.807 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.77 -168.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.344 1.458 . . . . 0.0 112.264 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 44.0 ttp -131.76 134.94 46.4 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.929 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -118.18 167.82 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.992 1.317 . . . . 0.0 111.523 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.451 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.58 152.35 30.8 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.2 ttm -66.0 147.58 53.14 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.278 1.431 . . . . 0.0 110.507 163.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.87 162.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.982 1.313 . . . . 0.0 111.547 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 19.3 t60 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.65 160.04 0.09 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.41 1.884 . . . . 0.0 115.531 -170.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.1 ttm -63.59 129.66 41.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.356 1.462 . . . . 0.0 110.276 166.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.14 164.9 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.556 1.142 . . . . 0.0 111.152 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.82 160.82 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -167.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 21.5 ttm -81.13 140.61 34.92 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 153.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.142 0.977 . . . . 0.0 110.547 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB3' HD12 ' A' ' 179' ' ' ILE . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TRP . . . . . 0.401 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 90' ' ' ASP . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.4 158.25 43.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.173 0.986 . . . . 0.0 112.825 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.4 ttm -74.94 137.68 41.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.723 0.809 . . . . 0.0 110.954 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.66 161.05 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 110.935 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.86 11.56 4.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.3 1.44 . . . . 0.0 113.814 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.7 ttp 59.53 95.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.32 2.248 . . . . 0.0 113.468 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.69 169.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.205 1.402 . . . . 0.0 110.479 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 80' ' ' LYS . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' HD12 ' A' ' 179' ' ' ILE . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 90' ' ' ASP . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.12 155.08 20.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.61 1.164 . . . . 0.0 113.516 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.2 ttm -72.62 137.05 45.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.824 0.849 . . . . 0.0 110.497 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.21 156.91 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.864 0.866 . . . . 0.0 110.14 167.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.044 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.6 150.29 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.637 0.775 . . . . 0.0 112.253 169.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 20.3 ttp -85.11 153.35 22.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 110.331 167.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.21 159.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.372 1.069 . . . . 0.0 110.823 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.46 ' CE ' HD12 ' A' ' 127' ' ' LEU . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.46 HD12 ' CE ' ' A' ' 103' ' ' MET . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.25 154.57 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.466 2.306 . . . . 0.0 116.975 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 31.7 ttp -83.7 149.13 26.68 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.3 1.04 . . . . 0.0 110.119 164.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.15 159.46 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.044 1.338 . . . . 0.0 110.11 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.03 148.1 45.11 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.646 0.723 . . . . 0.0 112.133 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.7 ttm -73.27 135.57 44.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.722 0.809 . . . . 0.0 110.137 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.43 167.39 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.727 1.611 . . . . 0.0 109.505 164.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 127' ' ' LEU . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 103' ' ' MET . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.69 149.13 24.88 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttm -58.71 145.22 40.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.011 0.925 . . . . 0.0 110.826 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -127.91 161.47 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.828 1.251 . . . . 0.0 110.794 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 179' ' ' ILE . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 179' ' ' ILE . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.472 HD11 ' HE2' ' A' ' 151' ' ' LYS . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.77 152.76 43.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.179 0.991 . . . . 0.0 113.338 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.8 ttp -119.47 130.99 55.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.612 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.95 163.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.329 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.23 139.34 58.16 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 48.1 ttp -114.54 136.07 53.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.256 1.822 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -114.68 165.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.788 1.235 . . . . 0.0 111.379 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 148' ' ' LEU . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 148' ' ' LEU . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 148' ' ' LEU . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 110' ' ' MET . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' H ' HD13 ' A' ' 148' ' ' LEU . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.459 ' N ' ' HE3' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 141.58 28.33 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.79 1.236 . . . . 0.0 114.042 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 29.1 ttp -72.43 160.61 32.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.5 1.12 . . . . 0.0 110.707 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.93 155.6 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.866 0.866 . . . . 0.0 111.653 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m . . . . . 0 N--CA 1.476 0.874 0 CA-C-O 120.376 0.132 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 102' ' ' PRO . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 100' ' ' GLU . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.927 -0.082 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 132' ' ' VAL . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 127' ' ' LEU . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 103' ' ' MET . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 82' ' ' ILE . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.479 0.995 0 CA-C-O 119.929 -0.081 . . . . 0.0 110.787 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m . . . . . 0 N--CA 1.476 0.869 0 CA-C-O 120.709 0.29 . . . . 0.0 110.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.807 -0.072 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.475 0.824 0 CA-C-O 120.613 0.244 . . . . 0.0 111.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.476 0.825 0 CA-C-O 120.706 0.289 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 110.547 -0.168 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB3' HD12 ' A' ' 179' ' ' ILE . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . 0.401 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 90' ' ' ASP . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.046 -0.026 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.475 0.797 0 CA-C-O 120.556 0.217 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 80' ' ' LYS . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' HD12 ' A' ' 179' ' ' ILE . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 90' ' ' ASP . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 119.76 -0.162 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.46 ' CE ' HD12 ' A' ' 127' ' ' LEU . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.46 HD12 ' CE ' ' A' ' 103' ' ' MET . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 127' ' ' LEU . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 103' ' ' MET . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.474 0.742 0 CA-C-O 120.409 0.147 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 179' ' ' ILE . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 179' ' ' ILE . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.472 HD11 ' HE2' ' A' ' 151' ' ' LYS . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 121.036 0.446 . . . . 0.0 111.329 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.379 0.14 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 148' ' ' LEU . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 148' ' ' LEU . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 148' ' ' LEU . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 110' ' ' MET . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.423 ' H ' HD13 ' A' ' 148' ' ' LEU . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.459 ' HE3' ' N ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.984 0.421 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.991 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.78 144.56 57.17 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.8 ttp -81.46 124.9 29.84 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.909 1.284 . . . . 0.0 111.212 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.7 m -104.27 165.48 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.218 1.407 . . . . 0.0 111.104 173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.2 -31.94 71.7 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.339 -1.476 . . . . 0.0 112.325 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -62.87 -25.97 68.55 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.121 1.368 . . . . 0.0 114.065 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.92 -32.88 65.61 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.326 -1.484 . . . . 0.0 111.98 174.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.7 mt -68.43 -43.37 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.412 0.551 . . . . 0.0 109.988 170.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -64.23 -42.25 96.63 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.31 -33.55 69.79 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.464 1.106 . . . . 0.0 112.048 174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.4 m -65.4 -40.23 93.19 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.646 0.778 . . . . 0.0 112.014 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 41.2 mt -62.36 -31.44 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 119.433 1.015 . . . . 0.0 111.668 173.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -77.17 -20.7 55.09 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.609 1.564 . . . . 0.0 114.508 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.8 t -91.31 -42.29 10.45 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.036 1.734 . . . . 0.0 114.351 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -93.47 156.99 16.44 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.06 1.744 . . . . 0.0 111.979 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -91.69 -26.87 18.42 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.568 -0.707 . . . . 0.0 111.26 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 36.2 t -133.7 128.34 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 C-N-CA 126.212 1.805 . . . . 0.0 109.468 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 70.7 t -133.02 147.98 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.938 0.895 . . . . 0.0 110.234 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -142.56 151.08 41.21 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.566 -0.709 . . . . 0.0 112.605 174.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -115.15 116.97 29.25 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.732 1.613 . . . . 0.0 109.035 174.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.7 pt -132.84 161.9 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 122.318 1.056 . . . . 0.0 113.83 -172.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -88.55 72.73 8.75 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.739 1.216 . . . . 0.0 109.605 172.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 102' ' ' PRO . . . 145.83 -178.94 23.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.69 1.138 . . . . 0.0 112.43 166.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.69 152.3 82.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.885 -1.362 . . . . 0.0 111.045 159.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.91 -20.0 26.33 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.537 2.825 . . . . 0.0 111.707 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 100' ' ' GLU . 11.8 pt-20 -91.53 -21.0 21.11 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.52 1.928 . . . . 0.0 114.624 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.11 65.77 8.25 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.068 0.947 . . . . 0.0 110.98 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' HA ' ' HA3' ' A' ' 97' ' ' GLY . 46.5 Cg_endo -67.98 153.9 74.08 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.395 2.063 . . . . 0.0 112.695 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.6 mtm -99.69 17.21 21.16 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.642 1.977 . . . . 0.0 111.602 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 10.9 t -155.83 139.74 16.27 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 127.06 2.144 . . . . 0.0 110.609 -177.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -66.32 -42.06 88.78 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.194 -0.941 . . . . 0.0 112.869 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -63.82 -27.24 69.04 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.145 -0.972 . . . . 0.0 112.157 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.4 m -70.99 -43.19 68.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.687 -0.633 . . . . 0.0 111.9 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.5 -47.84 69.5 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.899 0.88 . . . . 0.0 111.074 166.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -67.51 -34.75 77.75 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.39 1.076 . . . . 0.0 113.305 -175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 20.0 ttm -68.31 -45.16 73.75 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 119.17 0.896 . . . . 0.0 111.818 173.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.14 -35.39 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 122.91 0.484 . . . . 0.0 111.196 175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.95 -27.57 68.93 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 174.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.79 -43.03 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.58 -1.325 . . . . 0.0 110.205 169.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.6 -37.25 62.92 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.115 1.366 . . . . 0.0 112.409 -175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.73 -42.52 33.99 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.965 1.306 . . . . 0.0 112.906 173.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.16 -25.07 61.55 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.593 1.088 . . . . 0.0 113.251 -172.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 84.0 mt -88.71 -4.85 58.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.777 1.231 . . . . 0.0 113.325 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.58 43.71 67.18 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 119.118 0.872 . . . . 0.0 114.512 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 13.2 mt -89.87 170.07 10.71 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.569 1.185 . . . . 0.0 112.143 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -112.49 128.53 56.36 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.194 1.798 . . . . 0.0 111.205 164.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -148.82 161.63 41.43 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.439 1.095 . . . . 0.0 112.494 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m -111.39 125.12 53.53 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.483 1.113 . . . . 0.0 108.987 165.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.5 t -109.37 121.33 44.95 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.74 1.216 . . . . 0.0 110.998 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.59 127.89 50.94 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.824 1.25 . . . . 0.0 111.589 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.52 120.32 35.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.076 0.951 . . . . 0.0 110.748 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.1 m -71.27 -30.86 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.91 -21.67 47.01 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.62 -11.6 36.65 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -157.7 122.48 2.3 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-N 119.599 1.09 . . . . 0.0 111.38 -174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -62.02 -31.73 83.92 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.498 2.798 . . . . 0.0 112.826 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.27 -37.18 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 121.167 -0.958 . . . . 0.0 112.179 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.1 t -71.02 -49.49 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 O-C-N 121.518 -0.739 . . . . 0.0 110.556 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 12.2 ptt180 -66.27 -25.91 67.1 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 118.398 -0.811 . . . . 0.0 112.453 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.6 t -72.51 -41.77 65.55 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.858 1.263 . . . . 0.0 112.755 172.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -57.11 -45.18 83.66 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.354 -0.841 . . . . 0.0 110.774 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 89.8 t -62.07 -36.85 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 121.697 -0.627 . . . . 0.0 112.069 176.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.3 tmtt? -66.32 -54.73 21.21 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.995 0.918 . . . . 0.0 110.959 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -89.79 -31.63 17.31 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -169.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -114.86 -41.33 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.694 0.798 . . . . 0.0 112.568 -166.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -86.52 58.48 5.08 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.201 1.0 . . . . 0.0 111.407 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -65.15 0.73 1.22 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 116.468 2.025 . . . . 0.0 116.468 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.425 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 64.3 t-105 -67.9 145.0 97.69 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.3 1.04 . . . . 0.0 111.849 170.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.425 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 39.8 Cg_endo -68.54 -45.5 2.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.164 2.576 . . . . 0.0 115.075 -175.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.6 m -63.82 145.85 55.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.06 1.344 . . . . 0.0 113.66 -171.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -131.94 138.39 32.33 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.398 1.879 . . . . 0.0 108.947 167.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.35 171.18 67.56 Favored 'Cis proline' 0 CA--C 1.539 0.772 0 CA-C-N 120.099 1.071 . . . . 0.0 114.105 -0.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -126.11 149.09 49.18 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.811 1.244 . . . . 0.0 113.406 -175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.03 137.98 51.0 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 126.035 1.734 . . . . 0.0 111.178 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -127.19 135.74 51.08 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.525 1.93 . . . . 0.0 110.474 174.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.9 mm -125.18 131.33 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.381 1.472 . . . . 0.0 108.37 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 44.41 52.91 7.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.33 1.452 . . . . 0.0 113.833 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 64.91 18.78 11.64 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 117.122 2.267 . . . . 0.0 117.122 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -126.7 143.19 51.31 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.78 -1.2 . . . . 0.0 113.081 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -76.43 134.4 39.59 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 121.778 -0.576 . . . . 0.0 111.291 174.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.05 -50.29 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.646 1.179 . . . . 0.0 112.285 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 172.64 174.08 39.63 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 123.26 0.457 . . . . 0.0 114.087 -175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.72 -178.95 52.72 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 124.993 1.282 . . . . 0.0 113.585 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.22 -37.31 82.57 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 121.888 -0.772 . . . . 0.0 112.07 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -50.81 -37.46 42.88 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.161 0.985 . . . . 0.0 113.203 175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 38.4 mm -91.8 -36.96 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 126.005 1.722 . . . . 0.0 114.688 -171.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m -59.72 -32.5 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.869 -1.144 . . . . 0.0 112.965 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 43.8 p -62.44 -36.98 84.13 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.243 1.017 . . . . 0.0 112.73 173.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -68.06 -40.59 82.74 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 120.823 -1.173 . . . . 0.0 111.5 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 46.8 mtp -63.13 -37.72 88.34 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 169.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -63.4 -53.73 47.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.235 1.014 . . . . 0.0 110.005 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -52.78 -52.46 56.61 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.918 1.687 . . . . 0.0 112.471 174.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -69.41 -16.85 63.59 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.198 1.185 . . . . 0.0 114.198 -176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.65 73.81 Favored Glycine 0 CA--C 1.538 1.484 0 O-C-N 120.878 -1.139 . . . . 0.0 114.46 -171.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -65.68 -24.69 67.07 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 121.04 -1.27 . . . . 0.0 113.619 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.15 -52.48 16.47 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.207 -0.933 . . . . 0.0 110.382 177.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -59.41 -32.57 70.3 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.255 1.022 . . . . 0.0 112.074 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -62.16 -46.84 87.18 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 117.945 -1.026 . . . . 0.0 112.549 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.25 -44.64 83.12 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 119.757 1.162 . . . . 0.0 112.511 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.9 mt -58.05 -48.73 79.21 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.797 0.439 . . . . 0.0 110.35 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -65.46 -35.68 81.64 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.591 0.959 . . . . 0.0 113.591 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.73 -36.44 78.42 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -86.29 -14.77 42.71 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.242 1.017 . . . . 0.0 113.07 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.26 35.43 29.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 123.554 0.597 . . . . 0.0 113.727 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 78.0 mt -93.06 145.63 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.034 1.333 . . . . 0.0 109.203 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.7 t -65.61 127.08 30.44 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.072 0.949 . . . . 0.0 111.795 -176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.7 p -159.34 168.78 25.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.451 1.1 . . . . 0.0 113.476 168.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 83.5 mtt180 -60.41 162.79 5.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 126.709 2.003 . . . . 0.0 113.827 171.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -47.37 116.94 1.57 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.751 2.82 . . . . 0.0 113.487 -162.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--O 1.258 1.504 0 C-N-CA 127.107 2.163 . . . . 0.0 114.278 -166.504 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.391 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -154.83 149.13 26.09 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.174 0.989 . . . . 0.0 112.369 163.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.5 ttp -97.56 138.69 34.59 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.858 1.263 . . . . 0.0 111.06 172.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.2 m -113.52 162.33 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 124.965 1.306 . . . . 0.0 111.07 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -54.46 -37.58 65.38 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 120.996 -1.065 . . . . 0.0 112.558 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -57.99 -30.22 65.89 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.96 -33.37 75.88 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.565 1.075 . . . . 0.0 111.956 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.8 mt -74.75 -41.91 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 123.756 0.822 . . . . 0.0 110.085 176.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.59 -45.94 81.11 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.331 1.052 . . . . 0.0 111.31 175.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -74.33 -33.02 63.04 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.37 1.468 . . . . 0.0 112.962 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.0 m -71.0 -39.21 72.56 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.626 0.77 . . . . 0.0 111.269 176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.1 mt -62.67 -31.77 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-N 119.892 1.224 . . . . 0.0 111.908 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 24.3 mmtt -75.75 -21.6 57.31 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.201 1.4 . . . . 0.0 114.252 171.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.8 t -93.34 -33.67 13.8 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.536 1.934 . . . . 0.0 114.222 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -94.43 157.31 16.07 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.191 1.397 . . . . 0.0 112.642 -173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.69 -26.0 20.91 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 121.125 -0.985 . . . . 0.0 111.049 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 42.5 t -137.58 124.69 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.467 1.907 . . . . 0.0 109.775 -177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.0 t -136.24 139.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.536 0.734 . . . . 0.0 111.519 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.3 t -138.15 155.4 48.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.588 0.755 . . . . 0.0 113.035 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -123.21 122.63 38.87 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.109 1.764 . . . . 0.0 109.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.1 pt -137.55 155.2 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -174.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -66.65 79.31 0.11 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.908 1.283 . . . . 0.0 109.75 154.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 149.98 -174.39 29.44 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 126.133 1.825 . . . . 0.0 113.484 161.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.98 157.77 83.11 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.541 1.536 . . . . 0.0 110.993 149.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -81.96 -17.9 7.93 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.432 2.755 . . . . 0.0 112.424 -175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -83.18 -27.1 30.28 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.543 1.137 . . . . 0.0 113.756 171.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -142.14 59.83 9.75 Favored Pre-proline 0 CA--C 1.552 1.036 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -59.78 145.59 97.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.861 3.041 . . . . 0.0 113.344 -173.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.9 mtm -96.11 0.21 51.07 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.074 1.349 . . . . 0.0 112.944 -172.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 m -148.79 154.91 40.21 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.369 1.068 . . . . 0.0 112.348 -176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.99 -54.98 38.26 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.091 0.956 . . . . 0.0 113.063 -175.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -71.47 -24.95 62.1 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.273 -0.892 . . . . 0.0 112.212 -177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -55.5 34.2 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.885 0.874 . . . . 0.0 111.56 164.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.67 -42.03 74.55 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.488 1.515 . . . . 0.0 112.627 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.48 -35.31 70.78 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.43 1.492 . . . . 0.0 113.432 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 60.9 tpp -63.03 -49.91 72.74 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 119.313 0.96 . . . . 0.0 110.633 171.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.0 mm -60.33 -34.95 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.958 0.503 . . . . 0.0 111.297 177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -62.55 -36.98 84.38 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 173.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.75 -41.09 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 CA-C-N 120.178 1.354 . . . . 0.0 110.408 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -76.17 -37.66 57.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.887 1.275 . . . . 0.0 112.28 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -76.76 -41.17 45.82 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.768 1.227 . . . . 0.0 112.598 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.71 -20.56 61.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 119.268 0.94 . . . . 0.0 113.044 -175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -94.48 -4.94 47.26 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.58 1.152 . . . . 0.0 113.52 170.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.75 38.26 60.99 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.404 1.002 . . . . 0.0 114.715 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -88.1 176.24 7.38 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.696 1.198 . . . . 0.0 111.737 -175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.33 115.53 19.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.86 1.664 . . . . 0.0 111.441 176.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -135.28 172.14 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.124 1.37 . . . . 0.0 113.327 -166.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 55.7 m -121.88 132.74 54.73 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.646 1.178 . . . . 0.0 109.925 162.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.5 t -115.24 131.83 56.8 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.741 1.216 . . . . 0.0 111.485 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.68 142.33 44.15 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.236 1.414 . . . . 0.0 112.505 -177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -109.98 114.92 28.85 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.758 1.623 . . . . 0.0 113.681 -167.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.3 m -79.91 -29.76 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 120.853 -1.154 . . . . 0.0 113.973 -178.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 18.7 mt -83.0 -23.92 33.11 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.123 0.569 . . . . 0.0 112.051 -176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.63 -30.55 21.7 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -139.26 106.51 7.24 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -159.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -59.98 -33.39 95.59 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.208 1.939 . . . . 0.0 114.287 177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -57.02 -34.98 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 120.025 1.284 . . . . 0.0 112.514 170.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.5 t -69.09 -50.25 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 119.692 1.133 . . . . 0.0 110.979 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -69.39 -26.34 64.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 121.378 -0.826 . . . . 0.0 112.851 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 25.5 t -67.67 -40.43 84.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.147 1.379 . . . . 0.0 112.483 169.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -57.78 -41.32 81.82 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.2 -0.938 . . . . 0.0 111.235 171.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.18 -45.02 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 O-C-N 121.355 -0.841 . . . . 0.0 111.807 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.0 tmtt? -71.7 -32.4 67.79 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 119.444 1.02 . . . . 0.0 112.76 -177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 -106.1 -19.59 13.67 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 -170.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.2 -50.0 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 120.038 1.29 . . . . 0.0 112.258 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.0 m -90.19 54.17 2.71 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.781 1.232 . . . . 0.0 111.593 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -65.27 7.62 0.19 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 127.68 2.392 . . . . 0.0 116.2 -157.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -68.7 142.63 94.11 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 126.107 1.763 . . . . 0.0 110.835 167.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.12 -26.67 7.47 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.762 2.308 . . . . 0.0 115.187 -168.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 58.7 m -72.91 145.09 47.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.189 1.396 . . . . 0.0 113.039 -171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.7 mm -130.0 145.49 57.4 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 126.46 1.904 . . . . 0.0 109.159 164.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -71.07 170.02 65.99 Favored 'Cis proline' 0 C--N 1.35 0.611 0 CA-C-N 119.759 0.95 . . . . 0.0 113.354 -7.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 68.1 mt-30 -126.01 147.74 49.47 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.323 1.049 . . . . 0.0 111.737 176.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 46.9 tp -117.86 142.26 47.51 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.696 1.598 . . . . 0.0 111.075 169.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -124.12 139.45 53.92 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.212 2.205 . . . . 0.0 109.679 170.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.3 mm -128.07 126.98 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.844 1.257 . . . . 0.0 108.439 173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 50.6 mmtt 47.23 55.81 7.67 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.737 1.615 . . . . 0.0 112.645 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.25 . . 58.32 3.3 0.25 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 117.827 2.529 . . . . 0.0 117.827 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -104.62 140.8 37.5 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 119.945 1.248 . . . . 0.0 111.57 175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -71.09 135.1 47.52 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.539 0.736 . . . . 0.0 110.987 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.24 -32.52 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.345 1.458 . . . . 0.0 113.816 -171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 139.45 -173.59 22.7 Favored Glycine 0 CA--C 1.533 1.209 0 CA-C-N 119.275 0.943 . . . . 0.0 114.344 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.99 -172.1 44.81 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 125.102 1.334 . . . . 0.0 114.439 170.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.21 -36.55 81.92 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.503 -0.998 . . . . 0.0 112.75 -171.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -59.02 -42.08 89.32 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.913 -1.117 . . . . 0.0 112.688 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.2 -50.2 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.1 m -63.95 -37.37 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.379 0.536 . . . . 0.0 111.472 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.9 p -70.28 -37.25 74.8 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.747 0.419 . . . . 0.0 111.747 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.68 -45.55 91.76 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.214 -0.929 . . . . 0.0 112.757 168.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 88.0 mtp -61.34 -29.24 69.77 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.269 -0.895 . . . . 0.0 112.752 173.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.57 -47.59 63.12 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.476 1.51 . . . . 0.0 111.243 176.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.23 -38.62 77.18 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.402 -0.812 . . . . 0.0 112.321 170.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.3 m -80.23 -11.91 59.68 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 115.359 1.615 . . . . 0.0 115.359 -172.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.49 -6.59 29.97 Favored Glycine 0 CA--C 1.541 1.694 0 CA-C-N 119.31 0.959 . . . . 0.0 115.225 -172.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -73.69 -26.6 60.8 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.713 1.605 . . . . 0.0 114.25 -173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.0 -50.88 37.15 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.586 0.755 . . . . 0.0 109.679 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -60.94 -34.06 74.14 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.008 0.923 . . . . 0.0 112.389 173.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -61.96 -45.04 95.39 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 118.87 -0.586 . . . . 0.0 111.622 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -37.28 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 176.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 60.7 mt -63.83 -47.17 81.85 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.659 0.663 . . . . 0.0 111.482 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.2 ptt85 -66.97 -35.83 80.85 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -60.94 -39.51 89.73 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 175.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -92.45 -2.05 56.55 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.834 1.654 . . . . 0.0 114.686 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.52 40.06 40.1 Favored Glycine 0 CA--C 1.539 1.54 0 CA-C-N 119.512 1.051 . . . . 0.0 115.463 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 84.0 mt -107.1 141.49 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.969 1.308 . . . . 0.0 110.924 -175.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.0 t -59.16 129.67 43.25 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.445 1.098 . . . . 0.0 112.116 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 5.4 p -163.66 167.16 21.5 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.23 159.81 29.39 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.327 1.851 . . . . 0.0 113.073 172.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -46.73 119.85 2.68 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.952 2.501 . . . . 0.0 115.296 -157.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.256 1.412 0 C-N-CA 128.428 2.691 . . . . 0.0 115.297 -169.384 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.03 115.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 128.065 2.546 . . . . 0.0 115.237 -167.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 36.6 ttp -66.98 143.47 56.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 124.253 1.021 . . . . 0.0 110.243 170.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.5 m -121.41 159.32 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 124.879 1.272 . . . . 0.0 109.679 171.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -59.12 -31.57 69.06 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.064 -1.022 . . . . 0.0 112.903 -175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -51.82 -32.61 32.32 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.626 1.57 . . . . 0.0 114.367 169.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -71.23 -32.22 68.51 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.418 1.087 . . . . 0.0 112.586 176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 132' ' ' VAL . 16.6 mt -74.51 -41.49 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.467 -0.77 . . . . 0.0 109.653 174.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -58.85 -42.89 90.39 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.307 0.503 . . . . 0.0 111.096 171.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -67.02 -32.98 74.56 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.449 1.5 . . . . 0.0 113.199 178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.6 m -71.4 -45.83 61.79 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.544 0.738 . . . . 0.0 110.597 171.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.7 mt -62.75 -35.28 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 124.105 0.962 . . . . 0.0 112.152 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -77.65 -10.18 59.38 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 115.967 1.839 . . . . 0.0 115.967 174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.6 t -100.43 -52.86 3.25 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 126.432 1.893 . . . . 0.0 113.252 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -83.8 148.84 26.79 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.771 1.228 . . . . 0.0 112.344 -169.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -85.54 -27.33 25.64 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 123.215 0.606 . . . . 0.0 111.341 -167.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.49 127.62 42.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 C-N-CA 126.507 1.923 . . . . 0.0 109.28 176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.64 144.46 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.626 0.77 . . . . 0.0 110.795 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -138.48 149.61 45.59 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.514 0.726 . . . . 0.0 112.316 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.41 118.15 32.4 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.243 1.417 . . . . 0.0 108.708 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 pt -129.64 173.8 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.603 1.161 . . . . 0.0 113.344 -175.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -106.98 68.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.362 1.465 . . . . 0.0 109.808 -174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.02 -171.31 25.59 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 126.591 2.043 . . . . 0.0 110.939 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -68.8 163.25 57.34 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 120.872 -1.37 . . . . 0.0 113.78 162.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.88 -41.4 5.55 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.958 3.106 . . . . 0.0 112.129 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -83.11 -18.55 39.13 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.445 1.098 . . . . 0.0 113.912 175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -139.52 69.11 38.81 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 125.608 1.563 . . . . 0.0 112.582 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.02 150.03 37.47 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.01 1.807 . . . . 0.0 110.859 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.408 ' CE ' HD12 ' A' ' 127' ' ' LEU . 26.0 mtm -93.64 16.31 14.15 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.885 1.274 . . . . 0.0 111.465 178.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 8.1 t -160.42 147.1 15.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.54 1.136 . . . . 0.0 112.624 -173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.63 -54.73 43.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.437 1.095 . . . . 0.0 113.099 -178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -63.74 -24.59 67.83 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.498 -0.751 . . . . 0.0 112.452 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.5 m -72.1 -38.38 69.35 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.669 -0.644 . . . . 0.0 112.188 172.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -44.51 92.37 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.159 0.891 . . . . 0.0 110.455 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.26 -36.86 84.09 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.58 1.152 . . . . 0.0 113.66 -177.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -43.68 98.03 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.128 0.876 . . . . 0.0 111.543 173.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.7 mm -65.42 -37.55 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 123.124 0.57 . . . . 0.0 110.917 173.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.25 -39.13 91.85 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.331 175.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 77.3 t -58.89 -48.67 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-N 120.123 1.329 . . . . 0.0 110.028 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.6 mt -68.46 -35.73 77.98 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.565 1.146 . . . . 0.0 112.03 -176.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.4 mm-40 -82.7 -35.49 26.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.3 1.04 . . . . 0.0 113.177 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -72.33 -21.98 61.24 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.785 1.175 . . . . 0.0 112.424 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.9 -8.99 35.58 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.341 1.456 . . . . 0.0 113.364 169.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.89 31.22 44.57 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 124.83 1.205 . . . . 0.0 115.76 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.2 mt -84.43 165.77 17.88 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.035 1.417 . . . . 0.0 112.961 -173.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.26 120.11 40.06 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.757 2.423 . . . . 0.0 110.992 175.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -143.9 170.02 16.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.769 1.228 . . . . 0.0 113.704 -167.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 34.7 m -124.81 128.45 48.74 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.618 1.167 . . . . 0.0 109.117 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.6 t -108.01 138.84 43.57 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.404 1.482 . . . . 0.0 112.304 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -120.18 147.19 45.22 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.2 1.8 . . . . 0.0 112.252 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.28 120.91 40.43 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.434 1.094 . . . . 0.0 113.034 -177.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.2 m -73.02 -27.1 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 C-N-CA 124.867 1.267 . . . . 0.0 114.081 -175.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.408 HD12 ' CE ' ' A' ' 103' ' ' MET . 20.6 mt -82.31 -10.27 59.16 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -174.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -104.52 -14.15 15.78 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -158.11 123.05 2.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-N 119.418 1.008 . . . . 0.0 110.521 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -64.89 -24.65 60.65 Favored 'Trans proline' 0 CA--C 1.546 1.123 0 C-N-CA 123.038 2.492 . . . . 0.0 113.745 -176.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.2 t -51.01 -45.49 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 O-C-N 120.906 -1.121 . . . . 0.0 112.39 164.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.416 HG22 HD11 ' A' ' 82' ' ' ILE . 61.6 t -69.37 -43.08 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.367 -0.833 . . . . 0.0 110.526 -175.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -68.79 -26.0 64.98 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 175.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.3 t -74.66 -30.33 61.56 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.282 0.845 . . . . 0.0 113.282 174.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -57.21 -50.15 73.76 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 120.045 1.293 . . . . 0.0 111.53 178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 13.9 m -68.63 -25.55 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 O-C-N 120.896 -1.127 . . . . 0.0 113.579 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -74.82 -32.13 61.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.662 0.785 . . . . 0.0 112.293 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -107.02 -24.95 11.81 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 36.6 t -107.15 -57.16 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 CA-C-N 120.05 1.295 . . . . 0.0 113.008 -171.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 21.1 p -75.1 -27.33 59.83 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.116 -0.99 . . . . 0.0 111.307 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 60.41 38.67 19.23 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 127.102 2.161 . . . . 0.0 112.179 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -127.02 137.09 29.88 Favored Pre-proline 0 CA--C 1.547 0.833 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 -157.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -78.79 -34.82 1.18 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.897 3.065 . . . . 0.0 114.674 -174.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 15.1 m -61.13 140.19 57.94 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.606 1.162 . . . . 0.0 112.028 -172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 26.7 mm -133.76 141.18 38.98 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 124.523 1.129 . . . . 0.0 109.148 172.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.51 174.78 44.61 Favored 'Cis proline' 0 CA--C 1.544 1.014 0 CA-C-N 119.618 0.899 . . . . 0.0 114.071 -7.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -128.49 152.54 48.14 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.779 1.232 . . . . 0.0 113.43 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.47 140.02 53.22 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.233 1.813 . . . . 0.0 112.039 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -128.97 137.77 51.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.462 2.305 . . . . 0.0 109.955 173.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.9 mm -125.98 126.15 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.847 1.259 . . . . 0.0 109.345 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt 43.74 50.27 6.75 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.868 1.667 . . . . 0.0 112.205 -178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.302 . . 72.74 4.47 4.99 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 119.555 3.168 . . . . 0.0 119.555 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -117.36 147.33 42.73 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-N 120.523 1.511 . . . . 0.0 113.081 173.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -73.6 141.17 46.6 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.938 1.695 . . . . 0.0 113.793 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.05 -53.7 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 125.201 1.401 . . . . 0.0 112.177 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.94 -174.26 34.57 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.695 0.664 . . . . 0.0 114.378 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.45 -173.72 49.75 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 125.374 1.464 . . . . 0.0 115.4 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.05 -39.88 96.06 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.596 1.158 . . . . 0.0 113.121 -174.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -63.62 -37.37 87.07 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 110.722 175.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.2 mm -70.72 -49.09 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 123.752 0.821 . . . . 0.0 111.893 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.2 m -61.75 -35.75 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-N 119.786 1.175 . . . . 0.0 111.791 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 28.5 p -74.61 -37.93 62.72 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.951 0.9 . . . . 0.0 112.571 178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 -49.76 76.41 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.252 0.933 . . . . 0.0 111.474 168.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.5 mtp -61.92 -28.87 69.83 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.949 0.9 . . . . 0.0 113.189 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.55 -47.53 75.54 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.654 1.182 . . . . 0.0 111.646 171.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -66.61 -38.82 87.75 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.765 0.826 . . . . 0.0 113.078 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.8 p -77.2 -13.1 60.0 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.624 1.342 . . . . 0.0 114.624 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.32 -10.59 68.5 Favored Glycine 0 CA--C 1.537 1.45 0 C-N-CA 126.131 1.824 . . . . 0.0 114.894 -177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.97 -41.94 93.06 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.598 1.559 . . . . 0.0 113.396 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -66.08 -47.16 75.16 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.486 -0.759 . . . . 0.0 110.119 -175.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -64.22 -34.13 77.39 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.699 1.2 . . . . 0.0 111.79 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -62.98 -48.4 79.02 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.6 0.76 . . . . 0.0 111.361 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.78 84.36 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.505 1.048 . . . . 0.0 113.629 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 61.0 mt -64.61 -49.64 70.3 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.206 0.912 . . . . 0.0 112.016 177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -61.98 -37.46 84.88 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 175.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -63.75 -43.02 97.7 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.568 1.147 . . . . 0.0 113.089 177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.0 mptt -86.43 -9.27 56.62 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.615 1.166 . . . . 0.0 114.037 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.21 39.7 22.3 Favored Glycine 0 CA--C 1.533 1.216 0 CA-C-O 118.744 -1.031 . . . . 0.0 115.123 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 94.2 mt -100.55 141.92 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 118.711 1.255 . . . . 0.0 111.6 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.2 t -57.43 117.23 3.92 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.956 1.702 . . . . 0.0 111.641 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 20.1 p -160.09 155.59 25.44 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -74.48 169.73 17.14 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 128.78 2.832 . . . . 0.0 113.026 176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -42.17 117.0 0.9 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.344 2.258 . . . . 0.0 116.862 -146.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.254 1.316 0 C-N-CA 127.569 2.347 . . . . 0.0 111.488 174.513 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.273 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -128.97 163.59 25.01 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.741 1.216 . . . . 0.0 113.787 -173.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.1 ttm -92.4 147.47 22.88 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.578 166.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.94 155.28 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.484 1.114 . . . . 0.0 110.787 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -35.39 65.47 Favored 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.135 -0.978 . . . . 0.0 112.604 -173.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -60.77 -30.97 70.35 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.54 1.536 . . . . 0.0 114.255 173.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -60.53 -46.05 91.59 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 119.853 1.206 . . . . 0.0 110.645 176.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 15.8 mt -70.15 -43.28 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.077 1.351 . . . . 0.0 110.311 177.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.62 -43.69 92.93 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -176.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -69.87 -32.67 71.15 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.565 1.146 . . . . 0.0 111.473 172.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 97.5 m -63.03 -45.78 90.68 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.745 1.157 . . . . 0.0 110.512 171.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.2 mt -63.89 -27.67 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.625 1.102 . . . . 0.0 112.392 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -80.09 -28.42 39.09 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.443 1.497 . . . . 0.0 114.068 169.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.4 t -86.36 -26.85 24.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.193 1.397 . . . . 0.0 113.654 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.82 162.5 14.42 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.942 1.697 . . . . 0.0 112.536 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -102.08 -31.53 10.58 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.34 1.056 . . . . 0.0 111.413 173.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.28 124.81 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 C-N-CA 126.212 1.805 . . . . 0.0 110.017 178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.3 t -132.55 144.82 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.518 0.727 . . . . 0.0 110.865 176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -136.96 146.03 44.91 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 121.347 -0.846 . . . . 0.0 111.985 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.07 118.06 35.0 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.605 1.162 . . . . 0.0 108.541 172.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.1 pt -128.56 172.76 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 125.509 1.524 . . . . 0.0 111.546 -173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -95.05 80.04 3.61 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.397 1.479 . . . . 0.0 109.038 166.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.31 -170.85 25.93 Favored Glycine 0 CA--C 1.541 1.715 0 C-N-CA 125.346 1.451 . . . . 0.0 113.025 163.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.28 158.83 86.85 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 124.877 1.271 . . . . 0.0 111.176 154.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.18 -27.13 5.76 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.702 2.268 . . . . 0.0 112.61 -176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -79.41 -25.62 42.04 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 66.37 29.53 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.686 1.194 . . . . 0.0 111.278 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -71.09 153.88 62.56 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.165 1.243 . . . . 0.0 112.3 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 17.4 mtm -98.14 15.41 24.39 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.279 1.832 . . . . 0.0 111.946 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.5 t -159.01 141.25 13.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.935 1.694 . . . . 0.0 111.028 -175.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.74 -40.65 97.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.788 0.722 . . . . 0.0 112.618 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -66.93 -28.18 68.09 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.081 -1.012 . . . . 0.0 112.195 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.4 m -62.23 -48.67 78.94 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.611 -0.681 . . . . 0.0 111.419 170.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? -54.09 -47.64 71.52 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.732 0.813 . . . . 0.0 110.509 173.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -66.74 -30.63 70.9 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 117.854 -1.069 . . . . 0.0 113.346 -178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -50.14 66.27 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.66 1.184 . . . . 0.0 111.533 171.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.21 -34.18 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 123.86 0.864 . . . . 0.0 111.409 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -62.9 -28.76 70.27 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.4 -46.84 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 121.06 -1.025 . . . . 0.0 110.059 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 93.2 mt -67.52 -38.59 84.5 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.953 1.301 . . . . 0.0 111.982 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -84.45 -34.1 23.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.391 1.076 . . . . 0.0 113.27 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.67 -18.39 56.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 119.793 1.179 . . . . 0.0 113.636 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 67.9 mt -92.95 -7.46 45.93 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.888 0.875 . . . . 0.0 112.6 167.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.05 54.35 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 124.315 0.959 . . . . 0.0 114.831 173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.8 mt -85.74 161.77 19.03 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.536 1.134 . . . . 0.0 111.002 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -110.1 116.3 31.31 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.419 1.488 . . . . 0.0 109.813 166.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -132.41 177.65 7.43 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.128 1.771 . . . . 0.0 112.076 -166.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 53.4 m -127.38 124.12 37.82 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.877 0.871 . . . . 0.0 110.193 163.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.5 t -101.61 136.98 40.53 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.282 1.433 . . . . 0.0 110.156 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -119.05 138.74 52.64 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 126.284 1.834 . . . . 0.0 111.486 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -94.75 119.0 32.65 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.415 0.686 . . . . 0.0 111.53 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 m -68.77 -18.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 O-C-N 121.457 -0.777 . . . . 0.0 112.781 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.3 mt -89.28 -12.64 40.06 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 113.484 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.92 -33.3 21.23 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -154.01 128.92 4.88 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.427 1.091 . . . . 0.0 109.263 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -62.67 -30.84 79.1 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 123.068 2.512 . . . . 0.0 112.893 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 t -54.69 -32.36 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 120.933 -1.104 . . . . 0.0 112.754 171.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.5 t -70.0 -51.88 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 119.345 0.975 . . . . 0.0 111.343 175.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -67.9 -29.56 68.69 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.153 -0.967 . . . . 0.0 112.891 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.2 m -71.7 -28.66 63.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.882 1.273 . . . . 0.0 113.576 171.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -64.95 -47.18 78.57 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 120.989 -1.07 . . . . 0.0 110.304 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.7 t -60.3 -41.11 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.702 -0.624 . . . . 0.0 111.216 175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -57.36 -51.51 69.1 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.715 0.806 . . . . 0.0 111.848 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -88.91 -27.46 20.96 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -170.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.94 -36.89 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 114.104 1.15 . . . . 0.0 114.104 -163.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 96.4 p -88.59 -25.13 22.63 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.54 1.518 . . . . 0.0 112.342 165.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 59.62 -2.73 0.12 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.428 2.291 . . . . 0.0 114.639 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 61.3 t-105 -85.19 138.2 36.83 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 126.12 1.768 . . . . 0.0 112.205 -171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.97 -35.92 2.88 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.117 2.545 . . . . 0.0 114.622 -172.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 52.0 m -76.19 137.88 40.3 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.341 1.057 . . . . 0.0 112.217 -168.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.3 142.72 38.68 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 127.648 2.379 . . . . 0.0 108.637 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -65.12 166.19 51.68 Favored 'Cis proline' 0 CA--C 1.541 0.858 0 N-CA-C 117.786 2.187 . . . . 0.0 117.786 0.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -130.31 147.78 52.06 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.217 1.407 . . . . 0.0 113.252 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.61 142.23 47.0 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.267 1.827 . . . . 0.0 111.165 176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -130.23 139.01 50.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.157 2.183 . . . . 0.0 110.498 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.0 mm -126.66 130.14 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.935 1.294 . . . . 0.0 109.112 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt 41.32 57.67 2.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 126.178 1.791 . . . . 0.0 113.428 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.67 22.77 12.63 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -125.68 142.01 51.72 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.312 -1.492 . . . . 0.0 112.385 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -66.45 145.6 55.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.739 0.816 . . . . 0.0 111.407 170.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.0 t -122.82 -34.81 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.506 1.122 . . . . 0.0 113.551 -174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.04 -178.3 27.61 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.193 0.906 . . . . 0.0 114.287 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -81.71 -172.52 47.18 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 125.102 1.334 . . . . 0.0 115.308 172.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -67.57 -36.22 80.51 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.014 1.326 . . . . 0.0 112.274 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -61.34 -42.27 98.41 Favored 'General case' 0 N--CA 1.473 0.718 0 O-C-N 120.882 -1.136 . . . . 0.0 111.891 170.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.1 mm -65.35 -48.89 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 121.843 -0.536 . . . . 0.0 111.509 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.72 -34.32 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.592 1.087 . . . . 0.0 111.871 -177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 16.5 p -70.4 -37.32 74.46 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 118.664 -0.684 . . . . 0.0 112.056 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -63.44 -45.99 88.38 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.39 0.996 . . . . 0.0 111.99 170.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.4 mtp -57.17 -36.83 71.26 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.0 tt -64.38 -57.79 8.32 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.763 1.225 . . . . 0.0 110.076 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -53.21 -49.82 65.97 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.98 1.312 . . . . 0.0 111.8 176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 t -82.43 -7.89 59.63 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -172.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.19 -3.43 87.09 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 125.366 1.46 . . . . 0.0 116.364 175.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -72.39 -17.24 61.83 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 119.547 1.674 . . . . 0.0 113.872 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.52 -54.51 8.04 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 119.588 1.086 . . . . 0.0 110.527 -178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -55.17 -34.74 64.1 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.927 0.891 . . . . 0.0 112.771 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.43 ' HB2' ' HE3' ' A' ' 172' ' ' LYS . 21.9 ttmt -63.31 -35.67 81.13 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.734 0.813 . . . . 0.0 112.571 -179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.443 ' SD ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -70.74 -43.73 68.26 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.31 169.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.83 -49.23 76.05 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.977 1.262 . . . . 0.0 111.632 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -65.0 -35.02 79.84 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.2 -43.05 71.51 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.218 0.532 . . . . 0.0 111.631 174.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.443 ' HE2' ' SD ' ' A' ' 173' ' ' MET . 4.3 mptt -76.49 -15.79 59.81 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.565 1.546 . . . . 0.0 113.102 -177.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.61 34.32 31.95 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.837 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 92.6 mt -97.88 139.51 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 118.828 1.314 . . . . 0.0 110.958 -174.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.4 t -60.32 129.25 40.74 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.384 1.074 . . . . 0.0 112.234 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 31.9 p -161.33 168.68 23.5 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -63.6 163.17 11.7 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.473 1.509 . . . . 0.0 111.662 166.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -49.49 124.66 9.77 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 127.357 2.263 . . . . 0.0 115.496 -161.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.255 1.357 0 C-N-CA 129.18 2.992 . . . . 0.0 112.671 174.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -140.72 156.92 46.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 117.774 0.787 . . . . 0.0 112.86 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.2 ttp -88.02 131.35 34.67 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.568 1.147 . . . . 0.0 110.632 173.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 36.0 m -108.65 162.94 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.305 1.042 . . . . 0.0 110.778 169.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -58.74 -31.74 68.59 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 120.818 -1.177 . . . . 0.0 112.404 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -62.04 -30.09 70.73 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.308 1.443 . . . . 0.0 114.333 170.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -68.44 -37.4 80.21 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.614 1.097 . . . . 0.0 111.556 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.6 mt -64.24 -39.94 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 121.603 -0.686 . . . . 0.0 109.615 175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -65.48 -44.68 86.36 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.34 -33.26 72.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.753 0.821 . . . . 0.0 112.022 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.7 m -64.58 -47.7 77.73 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.69 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mt -63.32 -35.65 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 119.892 1.224 . . . . 0.0 111.968 176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -62.72 -37.43 86.52 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 171.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 59.8 m -98.41 -13.83 20.41 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 -167.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -88.11 162.02 16.98 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.98 1.712 . . . . 0.0 113.168 176.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -92.61 -32.46 14.78 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.67 0.788 . . . . 0.0 110.762 172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.8 t -140.36 132.82 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 126.018 1.727 . . . . 0.0 110.18 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 46.2 t -135.62 147.56 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 123.342 0.657 . . . . 0.0 111.611 173.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -141.18 155.11 46.11 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 112.387 173.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -118.6 123.64 45.5 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.544 1.538 . . . . 0.0 108.975 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 11.6 pt -137.01 179.11 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 124.683 1.193 . . . . 0.0 113.936 -174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -109.63 70.77 0.74 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.069 1.747 . . . . 0.0 110.556 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.23 -172.41 26.02 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 125.664 1.602 . . . . 0.0 112.681 171.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.17 158.57 86.25 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 121.151 -1.205 . . . . 0.0 112.217 163.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -75.42 -34.76 3.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.661 2.24 . . . . 0.0 112.038 -174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -83.26 -17.37 42.88 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 168.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -137.9 64.62 42.78 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.037 1.335 . . . . 0.0 112.319 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -72.88 149.12 47.0 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.701 1.601 . . . . 0.0 110.337 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.7 mtm -90.74 7.2 40.84 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.007 0.923 . . . . 0.0 111.642 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.9 t -150.09 141.08 22.92 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.6 1.56 . . . . 0.0 112.475 -173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -64.19 -40.97 97.21 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -65.62 -33.7 76.52 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.647 -1.283 . . . . 0.0 111.875 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.1 m -66.66 -38.65 87.29 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 119.038 -0.505 . . . . 0.0 112.111 173.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.5 tmmm? -56.66 -47.73 79.13 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.923 0.889 . . . . 0.0 111.29 167.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -60.43 -38.45 84.12 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 118.173 -0.917 . . . . 0.0 112.946 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -66.74 -43.21 84.78 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.116 0.871 . . . . 0.0 112.722 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.0 mm -61.83 -37.91 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 O-C-N 122.062 -0.399 . . . . 0.0 110.739 175.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -62.08 -36.68 82.42 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-O 117.931 -1.033 . . . . 0.0 113.324 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.2 -38.81 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 CA-C-N 120.654 1.57 . . . . 0.0 110.809 174.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 87.7 mt -79.0 -40.14 32.26 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.059 1.344 . . . . 0.0 112.423 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -74.15 -36.64 64.13 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.717 0.807 . . . . 0.0 112.024 172.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.22 -11.81 61.13 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.829 1.195 . . . . 0.0 113.922 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -106.21 -8.38 17.39 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.015 1.326 . . . . 0.0 113.419 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 76.53 36.28 38.84 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 124.971 1.272 . . . . 0.0 115.268 175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -86.64 171.3 11.1 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.976 1.388 . . . . 0.0 113.053 -171.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.07 118.85 37.73 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 126.122 1.769 . . . . 0.0 111.312 161.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -138.39 164.2 29.94 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.093 0.957 . . . . 0.0 113.188 -173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.4 m -115.67 132.88 56.5 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.54 1.136 . . . . 0.0 109.579 163.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 35.3 t -112.65 130.78 55.92 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 125.515 1.526 . . . . 0.0 110.271 174.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -114.2 131.35 56.49 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.299 1.44 . . . . 0.0 111.579 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -99.25 123.79 43.82 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.6 m -68.02 -23.18 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 125.445 1.498 . . . . 0.0 114.086 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 23.7 mt -85.21 -28.52 25.36 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.191 0.996 . . . . 0.0 113.468 -175.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -77.24 -21.54 53.61 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 177.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -158.36 123.23 2.26 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.371 0.532 . . . . 0.0 112.391 -173.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -61.99 -30.31 83.02 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.472 2.781 . . . . 0.0 111.59 174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.3 t -51.81 -33.08 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.301 1.04 . . . . 0.0 112.94 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.19 -53.5 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 O-C-N 121.216 -0.928 . . . . 0.0 111.285 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -67.72 -25.64 65.76 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 121.342 -0.849 . . . . 0.0 112.711 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 55.7 m -71.42 -33.13 69.14 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.375 1.87 . . . . 0.0 113.322 170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -69.36 -45.23 69.86 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 119.339 0.972 . . . . 0.0 110.882 168.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.1 t -57.99 -41.72 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.271 0.628 . . . . 0.0 111.84 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -62.06 -42.11 98.85 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.09 0.556 . . . . 0.0 112.17 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -102.17 -26.35 13.38 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -165.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.8 t -123.28 -41.76 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.958 1.303 . . . . 0.0 113.039 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -87.89 57.27 4.25 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.981 0.912 . . . . 0.0 110.724 170.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.1 -14.41 24.06 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 -157.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -69.58 139.64 89.12 Favored Pre-proline 0 CA--C 1.549 0.914 0 CA-C-N 119.453 1.024 . . . . 0.0 111.283 173.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -78.17 -24.81 7.76 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.894 2.396 . . . . 0.0 115.692 -168.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.2 m -64.42 132.4 49.94 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.847 1.203 . . . . 0.0 112.748 -173.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 29.9 mm -117.34 134.89 23.05 Favored Pre-proline 0 CA--C 1.541 0.61 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 158.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -78.82 154.41 91.39 Favored 'Cis proline' 0 CA--C 1.543 0.975 0 CA-C-N 119.617 0.899 . . . . 0.0 113.799 -2.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -135.12 161.25 35.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.797 1.239 . . . . 0.0 113.359 177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.11 143.2 49.68 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.795 2.038 . . . . 0.0 112.317 -168.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -130.15 139.92 50.83 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.503 2.321 . . . . 0.0 110.165 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -128.4 130.66 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.431 1.492 . . . . 0.0 108.916 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mmtt 40.84 62.08 1.51 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.895 1.678 . . . . 0.0 112.896 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.92 12.76 5.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 117.835 2.532 . . . . 0.0 117.835 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -125.56 141.35 52.08 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.841 1.257 . . . . 0.0 112.669 178.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.96 136.37 50.43 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.291 1.036 . . . . 0.0 112.377 175.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.28 -32.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.586 1.154 . . . . 0.0 113.555 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.96 -178.05 28.62 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 115.232 0.853 . . . . 0.0 115.232 174.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.73 -178.71 46.77 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.222 0.915 . . . . 0.0 113.855 168.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -51.97 -40.89 61.62 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.686 1.994 . . . . 0.0 113.441 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -58.64 -48.36 81.3 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.509 0.723 . . . . 0.0 111.324 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.3 mm -72.53 -45.02 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 O-C-N 121.187 -0.945 . . . . 0.0 111.568 -165.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.6 p -55.24 -41.94 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 118.836 0.744 . . . . 0.0 112.046 175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 22.9 p -74.52 -34.23 62.97 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 4.9 mmpt? -69.85 -45.03 68.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.184 0.902 . . . . 0.0 112.419 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 89.8 mtp -56.16 -31.51 63.46 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.026 0.93 . . . . 0.0 112.72 173.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.5 tt -61.67 -54.55 41.22 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.908 1.283 . . . . 0.0 111.491 170.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -61.61 -34.57 75.87 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.737 1.215 . . . . 0.0 112.869 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 6.5 m -75.96 -8.21 56.4 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.931 2.092 . . . . 0.0 114.394 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 74.47 -15.62 3.47 Favored Glycine 0 CA--C 1.54 1.601 0 C-N-CA 125.712 1.625 . . . . 0.0 115.602 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -57.13 -38.18 73.1 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.714 2.006 . . . . 0.0 112.971 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.83 -52.79 47.54 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.931 0.893 . . . . 0.0 110.482 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -53.65 -39.71 65.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.152 0.981 . . . . 0.0 111.235 171.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -69.03 -38.47 79.18 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.814 0.846 . . . . 0.0 112.139 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -46.42 78.66 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -55.5 -48.4 74.66 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.653 0.66 . . . . 0.0 110.789 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -68.05 -35.65 78.58 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.909 1.078 . . . . 0.0 113.909 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.34 -30.24 68.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.402 0.681 . . . . 0.0 112.655 175.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -95.6 4.02 53.5 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.41 1.484 . . . . 0.0 114.468 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.28 16.43 76.31 Favored Glycine 0 CA--C 1.537 1.427 0 N-CA-C 116.099 1.2 . . . . 0.0 116.099 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 66.2 mt -84.25 147.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 118.771 1.286 . . . . 0.0 110.981 -166.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 3.2 t -73.13 122.09 21.29 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.149 0.98 . . . . 0.0 111.561 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.9 p -160.31 169.62 22.77 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -61.53 156.0 20.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.272 1.829 . . . . 0.0 113.211 168.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.78 119.35 2.17 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.288 2.635 . . . . 0.0 115.259 -168.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.253 1.274 0 C-N-CA 127.71 2.404 . . . . 0.0 113.948 -177.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.765 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -139.92 158.8 43.49 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.837 1.255 . . . . 0.0 113.071 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 6.3 ttm -99.98 130.93 46.2 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.391 1.076 . . . . 0.0 110.421 167.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.0 m -115.94 164.07 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.894 1.278 . . . . 0.0 110.807 172.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.0 ttmt -53.93 -36.53 62.86 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 120.724 -1.235 . . . . 0.0 113.311 -178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -64.26 -23.02 67.16 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.479 1.912 . . . . 0.0 114.104 173.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.1 m-20 -70.75 -31.49 68.33 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.624 -1.298 . . . . 0.0 111.416 172.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 42.3 mt -75.45 -47.58 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.723 0.809 . . . . 0.0 110.048 173.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -61.39 -28.36 69.19 Favored 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -83.69 -30.04 27.09 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.508 1.523 . . . . 0.0 112.491 172.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 88.9 m -63.48 -41.72 98.58 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 119.024 0.829 . . . . 0.0 111.373 167.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 mm -52.59 -32.46 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.826 1.65 . . . . 0.0 111.746 172.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -87.21 -31.37 20.36 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.884 2.074 . . . . 0.0 115.448 171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 17.2 t -79.61 -16.88 55.05 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.635 1.574 . . . . 0.0 113.303 -176.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -112.8 161.51 16.84 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.08 1.752 . . . . 0.0 112.46 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -89.58 -31.5 17.56 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.72 -0.613 . . . . 0.0 111.619 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -134.67 122.26 38.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.007 1.723 . . . . 0.0 108.792 -174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 84.7 t -132.41 137.22 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.289 0.636 . . . . 0.0 110.929 176.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.9 t -138.4 151.06 47.14 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.721 -0.612 . . . . 0.0 112.316 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.13 119.75 34.22 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.488 1.515 . . . . 0.0 109.246 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.9 pt -136.59 166.12 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.24 1.016 . . . . 0.0 112.565 -168.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -84.69 75.11 10.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.08 1.352 . . . . 0.0 109.56 166.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.69 -171.58 26.65 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.389 0.995 . . . . 0.0 114.01 165.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.21 161.77 76.38 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 125.643 1.577 . . . . 0.0 112.848 157.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -81.86 -21.83 5.64 Favored 'Trans proline' 0 CA--C 1.546 1.087 0 C-N-CA 123.423 2.749 . . . . 0.0 112.312 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -85.5 -20.76 29.21 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.18 1.392 . . . . 0.0 113.792 166.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.69 64.93 13.91 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.689 1.195 . . . . 0.0 112.783 -176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.49 139.34 34.27 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.205 1.937 . . . . 0.0 109.838 177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.0 mtm -91.44 -5.81 53.73 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.611 1.165 . . . . 0.0 112.684 -171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.6 m -149.42 149.98 31.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.021 1.329 . . . . 0.0 111.66 -166.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -62.57 -54.43 39.81 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.839 1.256 . . . . 0.0 113.66 -164.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -68.5 -24.5 64.68 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.266 -0.896 . . . . 0.0 112.314 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -68.86 -41.81 77.92 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.283 0.633 . . . . 0.0 111.958 171.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -60.08 -46.16 90.49 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.676 0.79 . . . . 0.0 110.875 167.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -63.02 -36.61 84.14 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.344 1.057 . . . . 0.0 112.823 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.8 tpp -62.85 -49.58 74.33 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.425 1.012 . . . . 0.0 111.031 172.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 28.3 mm -60.65 -37.84 76.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.77 -0.582 . . . . 0.0 111.15 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -65.07 -29.05 69.9 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 73.5 t -63.76 -47.64 90.08 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 120.147 1.34 . . . . 0.0 109.924 169.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 62.0 mt -71.2 -35.86 71.71 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.734 1.214 . . . . 0.0 112.2 -174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -76.59 -42.61 41.96 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.575 1.55 . . . . 0.0 112.223 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.36 -16.61 60.9 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.423 1.01 . . . . 0.0 113.667 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 66.1 mt -95.37 -9.96 31.4 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.067 1.347 . . . . 0.0 113.053 168.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 77.76 29.93 53.65 Favored Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.115 1.206 . . . . 0.0 116.115 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -82.68 158.74 22.82 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.091 1.356 . . . . 0.0 111.526 -173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -105.63 118.77 37.44 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.576 1.55 . . . . 0.0 110.637 168.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -135.4 171.89 13.79 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.41 1.084 . . . . 0.0 113.486 -167.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 45.2 m -122.92 119.22 29.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.279 1.031 . . . . 0.0 108.632 159.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 28.1 t -92.23 158.93 15.87 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 124.724 1.21 . . . . 0.0 110.295 171.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -138.93 133.0 31.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.419 1.487 . . . . 0.0 111.014 175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -86.62 120.18 27.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.667 0.787 . . . . 0.0 111.607 175.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.61 -20.69 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 121.622 -0.674 . . . . 0.0 112.747 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.3 mt -89.11 -0.97 57.87 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.957 1.303 . . . . 0.0 113.698 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -105.48 -21.06 13.29 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -155.54 112.38 2.22 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.588 1.155 . . . . 0.0 111.286 -169.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -54.2 -33.38 74.64 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.68 2.92 . . . . 0.0 114.931 175.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.99 -32.95 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 O-C-N 119.778 -1.826 . . . . 0.0 112.68 171.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 52.7 t -70.31 -45.8 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 119.487 1.04 . . . . 0.0 111.726 176.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -66.3 -28.99 69.11 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 119.75 1.159 . . . . 0.0 112.409 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.1 m -67.54 -30.76 70.49 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -61.96 -52.11 65.36 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.582 1.083 . . . . 0.0 111.654 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.0 m -64.76 -35.42 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 O-C-N 121.597 -0.689 . . . . 0.0 112.369 173.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.36 -36.87 85.54 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.287 -0.883 . . . . 0.0 112.742 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -110.44 -18.6 13.19 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.969 1.841 . . . . 0.0 115.969 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.4 t -114.31 -38.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 64.3 p -89.0 -32.77 17.45 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-N 120.099 1.318 . . . . 0.0 111.72 161.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 57.05 18.84 4.26 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 127.033 2.133 . . . . 0.0 113.926 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 53.6 t-105 -85.59 136.57 37.02 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 124.461 1.104 . . . . 0.0 111.852 -174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.8 -19.0 16.63 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.729 2.953 . . . . 0.0 115.191 -171.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 41.5 m -90.98 140.71 29.57 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.234 1.014 . . . . 0.0 111.944 -174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.9 mm -129.57 145.85 58.66 Favored Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 126.808 2.043 . . . . 0.0 108.78 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.68 169.82 56.53 Favored 'Cis proline' 0 CA--C 1.535 0.557 0 CA-C-N 120.28 1.136 . . . . 0.0 114.09 -9.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -124.26 146.36 48.81 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.859 1.264 . . . . 0.0 112.066 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.3 tp -115.35 143.43 45.29 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.443 1.497 . . . . 0.0 111.743 172.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -124.99 142.31 51.57 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 127.293 2.237 . . . . 0.0 109.932 167.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.7 mm -127.71 126.31 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.78 1.232 . . . . 0.0 109.308 171.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 mttt 39.86 61.08 1.54 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 127.574 2.349 . . . . 0.0 113.338 -176.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.271 . . 67.55 6.84 5.21 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 118.191 2.663 . . . . 0.0 118.191 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -115.17 142.7 46.3 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.461 1.104 . . . . 0.0 112.646 176.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -69.39 144.45 53.38 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.769 0.828 . . . . 0.0 112.306 174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 23.6 t -125.38 -27.65 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 125.121 1.368 . . . . 0.0 114.356 -167.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.56 179.64 17.45 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 119.354 0.979 . . . . 0.0 114.45 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.45 -174.74 46.1 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 124.787 1.184 . . . . 0.0 114.686 169.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.13 -37.58 85.71 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.47 -41.95 95.22 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 121.003 -1.061 . . . . 0.0 111.662 174.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 34.2 mm -68.98 -50.01 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 C-N-CA 124.04 0.936 . . . . 0.0 111.098 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.44 -34.41 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 119.527 1.058 . . . . 0.0 112.026 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.5 p -72.48 -36.57 68.47 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.286 0.635 . . . . 0.0 112.072 176.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -52.09 65.69 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.305 1.042 . . . . 0.0 112.308 164.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.6 mtp -59.68 -27.45 66.42 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.828 0.74 . . . . 0.0 112.871 176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tt -74.17 -49.37 23.91 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.406 1.083 . . . . 0.0 110.862 176.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.77 -44.84 96.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.235 0.614 . . . . 0.0 111.553 175.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 34.8 m -81.18 0.49 36.25 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.73 1.612 . . . . 0.0 114.905 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.13 -15.09 2.6 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.521 1.534 . . . . 0.0 116.379 176.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.33 -24.96 47.21 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.69 -44.17 78.39 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.763 -0.585 . . . . 0.0 110.49 174.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -67.31 -33.43 75.27 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.275 1.03 . . . . 0.0 112.136 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -57.81 -53.22 60.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 119.067 0.848 . . . . 0.0 111.488 168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -42.33 98.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.348 0.976 . . . . 0.0 113.246 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.5 mt -60.22 -49.07 79.09 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.478 0.581 . . . . 0.0 111.454 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -61.76 -39.05 90.24 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -34.54 75.46 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.205 1.002 . . . . 0.0 111.928 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -85.9 -10.4 55.35 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.666 1.186 . . . . 0.0 113.598 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 88.03 22.56 41.43 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 119.597 1.089 . . . . 0.0 115.472 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.7 mt -94.09 136.9 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 118.35 1.075 . . . . 0.0 111.735 -165.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 14.3 t -58.34 117.06 4.04 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.717 1.607 . . . . 0.0 112.263 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 12.9 p -152.53 178.05 9.98 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.333 0.969 . . . . 0.0 113.284 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 90.9 mmt-85 -57.72 165.19 1.76 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.813 1.245 . . . . 0.0 112.102 168.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.28 126.13 24.88 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 125.366 1.466 . . . . 0.0 113.158 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.251 1.144 0 C-N-CA 127.0 2.12 . . . . 0.0 112.357 172.453 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.886 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.77 -168.06 1.3 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.344 1.458 . . . . 0.0 112.264 175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 44.0 ttp -131.76 134.94 46.4 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.845 0.858 . . . . 0.0 110.929 169.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.2 m -118.18 167.82 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.992 1.317 . . . . 0.0 111.523 175.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -35.16 70.62 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.623 1.169 . . . . 0.0 111.125 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -60.65 -34.5 74.38 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.603 1.961 . . . . 0.0 113.903 172.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -70.0 -36.87 75.45 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.312 0.96 . . . . 0.0 111.839 177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.9 mt -68.16 -46.6 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 0.0 109.436 173.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.55 -38.68 90.98 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.878 0.695 . . . . 0.0 112.878 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -72.0 -26.42 62.23 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 120.891 -1.131 . . . . 0.0 112.461 173.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 31.5 m -68.8 -46.75 67.84 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 118.848 0.749 . . . . 0.0 110.283 168.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.88 -37.7 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.847 1.659 . . . . 0.0 111.05 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -77.72 -36.84 50.54 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.442 1.497 . . . . 0.0 114.782 173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -82.66 -29.44 29.99 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -175.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -82.68 170.81 14.7 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.934 1.294 . . . . 0.0 110.957 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -103.23 -26.73 12.87 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.756 -1.215 . . . . 0.0 111.715 166.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.5 t -133.81 123.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.155 1.782 . . . . 0.0 110.141 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -134.32 134.9 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 123.272 0.629 . . . . 0.0 111.019 175.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -129.12 148.02 51.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.64 0.776 . . . . 0.0 112.505 178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -117.61 118.36 31.91 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.451 1.5 . . . . 0.0 109.223 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 17.5 pt -132.92 163.25 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 122.872 1.32 . . . . 0.0 114.223 -171.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -83.8 71.63 10.43 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.513 1.125 . . . . 0.0 110.289 166.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.36 -166.05 28.62 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 120.798 -1.189 . . . . 0.0 114.234 167.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.69 162.29 72.16 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 123.942 0.897 . . . . 0.0 112.066 158.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -71.79 -42.68 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 123.341 2.694 . . . . 0.0 112.01 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -78.47 -22.77 47.05 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.74 68.6 44.07 Favored Pre-proline 0 C--O 1.243 0.726 0 C-N-CA 125.33 1.452 . . . . 0.0 111.233 -176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -79.64 147.22 19.54 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 122.03 1.82 . . . . 0.0 111.885 177.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 19.0 mtm -88.7 3.93 49.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.067 1.747 . . . . 0.0 111.398 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.5 t -135.37 141.58 45.55 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.535 1.534 . . . . 0.0 113.016 -177.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.03 -53.83 53.76 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.786 1.634 . . . . 0.0 112.808 177.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -63.44 -28.22 69.83 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.957 0.903 . . . . 0.0 112.13 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -67.61 -43.91 79.33 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 121.437 -0.789 . . . . 0.0 112.345 171.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -41.75 86.99 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.275 0.943 . . . . 0.0 109.921 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -68.18 -35.6 78.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.1 tpp -63.94 -51.93 62.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.591 1.156 . . . . 0.0 111.297 171.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.3 mm -60.52 -36.24 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 122.964 0.505 . . . . 0.0 110.722 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.71 -39.36 91.24 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-O 117.193 -1.384 . . . . 0.0 113.683 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.9 t -60.89 -47.85 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 120.042 1.292 . . . . 0.0 110.296 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.3 mt -71.34 -34.39 70.47 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.588 1.155 . . . . 0.0 112.294 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -82.09 -37.56 26.15 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.637 1.175 . . . . 0.0 113.307 173.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -70.58 -31.34 68.32 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.604 1.093 . . . . 0.0 112.018 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 83.1 mt -83.72 -5.51 59.21 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 73.82 34.86 55.56 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 119.117 0.872 . . . . 0.0 115.235 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.08 175.02 9.79 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.2 1.4 . . . . 0.0 110.816 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.28 123.0 35.4 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.552 1.541 . . . . 0.0 111.883 171.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -140.95 171.52 13.96 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.613 1.565 . . . . 0.0 112.618 -165.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 74.6 m -121.63 135.53 54.98 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.885 0.874 . . . . 0.0 110.045 162.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 40.0 t -118.81 130.21 55.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.647 1.579 . . . . 0.0 111.582 -176.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -117.72 145.5 44.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.757 1.623 . . . . 0.0 112.372 -177.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.68 119.06 38.19 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.505 1.122 . . . . 0.0 113.045 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.0 m -72.06 -19.88 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.013 -1.054 . . . . 0.0 113.642 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 26.9 mt -90.19 -13.55 35.31 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.583 1.553 . . . . 0.0 114.274 -177.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -97.75 -26.11 14.84 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -174.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -151.44 108.58 2.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.401 1.08 . . . . 0.0 109.951 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.08 -36.29 35.16 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.854 3.036 . . . . 0.0 114.758 175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 43.9 t -53.25 -38.28 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 O-C-N 121.023 -1.048 . . . . 0.0 112.84 172.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 78.2 t -65.21 -46.05 91.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 119.128 0.876 . . . . 0.0 111.273 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -77.11 -26.43 53.25 Favored 'General case' 0 N--CA 1.476 0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 113.149 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 m -63.52 -40.85 98.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.24 1.016 . . . . 0.0 111.769 168.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.26 -48.33 79.13 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.766 0.712 . . . . 0.0 111.393 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 79.4 t -57.85 -48.46 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 121.525 -0.734 . . . . 0.0 111.797 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.5 tmtt? -62.79 -29.26 70.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -108.08 -20.24 13.23 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 -171.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.7 t -108.35 -42.15 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.276 1.03 . . . . 0.0 112.159 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.6 m -73.44 -34.12 65.26 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 118.935 0.789 . . . . 0.0 111.4 168.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 53.78 35.59 21.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.852 1.261 . . . . 0.0 111.699 -174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 43.8 t-105 -139.9 139.46 21.7 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.55 1.54 . . . . 0.0 111.833 -165.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -82.42 -33.77 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.002 2.468 . . . . 0.0 114.44 -170.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 25.2 m -65.19 134.71 54.29 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.188 0.995 . . . . 0.0 112.805 -165.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.9 mm -122.96 142.42 38.04 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 125.433 1.493 . . . . 0.0 109.336 172.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -78.19 170.83 69.12 Favored 'Cis proline' 0 CA--C 1.538 0.69 0 CA-C-N 119.652 0.912 . . . . 0.0 113.234 -7.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -127.57 155.17 44.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.592 1.157 . . . . 0.0 113.847 -175.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 44.1 tp -123.21 139.47 54.02 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.092 1.757 . . . . 0.0 111.885 171.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -117.51 143.21 46.3 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.51 2.324 . . . . 0.0 109.658 166.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.3 mm -126.19 135.03 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.994 1.317 . . . . 0.0 108.107 170.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 43.47 52.09 6.03 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.304 1.842 . . . . 0.0 113.852 177.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.63 20.17 11.83 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -132.25 153.41 50.67 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.855 1.262 . . . . 0.0 112.989 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -75.24 132.37 41.03 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.337 1.055 . . . . 0.0 111.766 -174.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.3 t -105.65 -43.28 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.783 1.233 . . . . 0.0 112.726 -175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 151.66 -178.21 29.1 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 119.182 0.901 . . . . 0.0 114.426 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.96 -173.66 49.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.584 1.087 . . . . 0.0 114.969 170.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.47 -39.67 94.19 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.05 0.94 . . . . 0.0 113.061 -176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.38 -39.66 80.23 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.329 -0.857 . . . . 0.0 111.96 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.5 mm -68.07 -50.78 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.485 -0.759 . . . . 0.0 111.738 -177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.03 -34.94 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 O-C-N 121.429 -0.794 . . . . 0.0 112.104 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -73.81 -39.83 63.8 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.743 0.817 . . . . 0.0 111.639 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.451 ' HE3' ' N ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -60.88 -44.22 97.38 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.375 0.988 . . . . 0.0 111.703 173.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.1 mtp -66.78 -29.94 70.02 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.636 1.174 . . . . 0.0 112.948 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -67.98 -47.02 69.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 120.551 -1.343 . . . . 0.0 111.131 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -63.41 -34.76 78.45 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 76.1 p -82.86 -16.67 46.72 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 175.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 88.3 -13.3 62.2 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 125.77 1.652 . . . . 0.0 115.019 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.15 -29.04 69.55 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 119.436 1.618 . . . . 0.0 113.451 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -66.39 -49.77 65.72 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.607 1.163 . . . . 0.0 110.9 175.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 33.8 mttm -62.17 -34.63 76.79 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.853 0.861 . . . . 0.0 110.772 172.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 tttp -65.82 -47.48 74.9 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.664 0.666 . . . . 0.0 111.835 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -37.56 84.06 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 119.234 0.925 . . . . 0.0 113.412 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 64.6 mt -61.21 -50.18 74.15 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.103 0.865 . . . . 0.0 111.092 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -64.89 -34.52 78.59 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -64.31 -44.25 92.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.031 1.332 . . . . 0.0 112.842 174.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -81.39 -11.92 59.13 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.79 21.62 59.3 Favored Glycine 0 CA--C 1.538 1.477 0 N-CA-C 115.279 0.872 . . . . 0.0 115.279 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.3 mt -84.22 142.5 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.522 1.661 . . . . 0.0 111.405 -171.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.3 t -59.13 126.87 29.47 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.551 1.94 . . . . 0.0 111.653 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 8.0 p -164.91 161.87 20.38 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -67.23 158.52 31.19 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.996 1.319 . . . . 0.0 112.194 167.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -49.65 124.8 10.24 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 126.668 1.987 . . . . 0.0 113.831 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.25 1.098 0 C-N-CA 127.714 2.406 . . . . 0.0 112.717 -170.804 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.58 152.35 30.8 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.909 1.077 . . . . 0.0 113.909 -176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 9.2 ttm -66.0 147.58 53.14 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.278 1.431 . . . . 0.0 110.507 163.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.87 162.69 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 124.982 1.313 . . . . 0.0 111.547 172.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -57.79 -33.99 69.14 Favored 'General case' 0 N--CA 1.479 1.017 0 O-C-N 121.074 -1.016 . . . . 0.0 112.486 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -55.97 -32.7 64.12 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.703 2.001 . . . . 0.0 113.961 169.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -71.62 -38.68 70.76 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.097 0.959 . . . . 0.0 112.088 176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 20.6 mt -67.37 -46.39 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.308 0.643 . . . . 0.0 109.763 176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -65.5 -36.8 84.93 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 118.671 0.668 . . . . 0.0 112.439 -177.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -58.93 -39.53 81.87 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.13 0.972 . . . . 0.0 112.072 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.0 m -66.8 -45.81 77.2 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.416 0.686 . . . . 0.0 111.52 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -56.0 -36.38 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 126.159 1.784 . . . . 0.0 111.019 174.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -79.43 -23.19 43.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.411 1.884 . . . . 0.0 115.177 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -97.44 -35.87 10.53 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 120.079 1.309 . . . . 0.0 114.468 -175.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.7 157.05 22.32 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.424 1.089 . . . . 0.0 110.126 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -91.38 -26.42 18.9 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.359 -1.463 . . . . 0.0 111.572 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -132.72 127.36 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.525 1.93 . . . . 0.0 109.382 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.21 137.64 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 122.962 0.505 . . . . 0.0 111.412 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -134.12 150.48 51.14 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.929 0.891 . . . . 0.0 112.149 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.53 119.61 36.11 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.341 1.457 . . . . 0.0 109.714 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 10.8 pt -136.35 159.55 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -84.78 74.83 10.41 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.074 1.749 . . . . 0.0 110.693 171.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 148.1 -173.9 27.98 Favored Glycine 0 CA--C 1.538 1.531 0 C-N-CA 127.516 2.484 . . . . 0.0 111.31 164.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.21 158.01 67.0 Favored Pre-proline 0 CA--C 1.546 0.792 0 O-C-N 121.005 -1.291 . . . . 0.0 110.72 155.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.42 -35.46 2.18 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.782 2.322 . . . . 0.0 111.341 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -75.9 -21.2 57.38 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.339 1.456 . . . . 0.0 113.74 171.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.04 67.9 34.29 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.783 1.633 . . . . 0.0 112.339 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.45 152.98 49.8 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.263 1.976 . . . . 0.0 111.329 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.4 mtm -103.31 7.25 38.32 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.824 1.649 . . . . 0.0 112.439 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -152.73 140.38 19.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.14 0.976 . . . . 0.0 110.864 -166.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.37 -44.8 78.06 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -66.3 -26.54 67.37 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.337 -0.852 . . . . 0.0 112.195 176.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.4 m -73.08 -43.46 61.79 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.15 -0.969 . . . . 0.0 111.741 175.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -53.44 -46.72 69.93 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.324 1.049 . . . . 0.0 111.707 165.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -66.22 -36.89 84.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.102 0.961 . . . . 0.0 113.504 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 53.9 tpp -61.14 -48.76 80.15 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 119.873 1.215 . . . . 0.0 110.864 172.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 40.9 mm -63.58 -34.18 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 121.83 -0.544 . . . . 0.0 111.415 176.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -62.69 -41.22 99.0 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 117.727 -1.13 . . . . 0.0 113.115 174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.48 -46.44 92.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 CA-C-N 119.986 1.267 . . . . 0.0 110.614 173.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.1 mt -72.12 -37.15 69.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.479 1.111 . . . . 0.0 112.328 -175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -77.62 -38.98 46.85 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.184 0.994 . . . . 0.0 112.184 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.29 -13.85 60.82 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.414 1.006 . . . . 0.0 113.627 -176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 87.7 mt -102.22 -4.45 25.73 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.235 1.414 . . . . 0.0 113.106 168.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.19 33.98 38.54 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.913 1.125 . . . . 0.0 115.913 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.38 162.26 16.63 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.757 1.278 . . . . 0.0 112.531 -173.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.73 122.97 46.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 127.017 2.127 . . . . 0.0 110.046 166.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -139.35 173.11 11.89 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.681 1.593 . . . . 0.0 113.322 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.6 m -116.32 133.83 55.58 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.116 0.966 . . . . 0.0 109.162 155.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.2 t -108.56 132.32 53.97 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.765 1.226 . . . . 0.0 110.975 174.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -110.0 129.51 55.66 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 126.128 1.771 . . . . 0.0 111.409 -178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -96.96 117.69 31.71 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.19 0.596 . . . . 0.0 110.341 -174.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.65 -28.64 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.1 mt -82.91 -8.41 59.57 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.146 0.978 . . . . 0.0 113.289 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -101.92 -10.79 19.5 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -160.73 114.69 1.35 Allowed Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 119.112 0.869 . . . . 0.0 111.98 -175.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.28 -34.44 93.75 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.407 2.738 . . . . 0.0 114.989 177.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 t -62.01 -31.44 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 120.158 -1.589 . . . . 0.0 112.397 171.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 97.0 t -72.09 -44.21 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 O-C-N 120.802 -1.186 . . . . 0.0 111.537 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -70.05 -20.46 63.24 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.368 0.986 . . . . 0.0 113.071 173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -77.0 -35.99 56.71 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.514 1.526 . . . . 0.0 112.475 171.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -56.8 -44.88 82.38 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 120.731 1.605 . . . . 0.0 111.784 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 m -68.4 -21.6 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 174.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -39.75 19.95 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 118.91 0.777 . . . . 0.0 111.836 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.34 -27.11 14.64 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 -171.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.1 -39.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.007 0.923 . . . . 0.0 112.484 -170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.5 m -75.04 -41.04 60.0 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 121.409 -0.807 . . . . 0.0 111.404 164.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 56.57 -2.3 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.866 2.466 . . . . 0.0 115.513 -171.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -79.66 141.93 56.63 Favored Pre-proline 0 CA--C 1.545 0.76 0 C-N-CA 127.739 2.416 . . . . 0.0 111.529 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.08 -30.34 4.45 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 122.87 2.38 . . . . 0.0 114.425 -170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 6.2 m -74.43 139.68 44.14 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.631 1.172 . . . . 0.0 112.572 -170.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.6 mm -134.86 140.22 34.52 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 126.118 1.767 . . . . 0.0 109.51 176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -78.17 171.26 67.38 Favored 'Cis proline' 0 C--N 1.35 0.625 0 CA-C-N 120.629 1.26 . . . . 0.0 113.388 -0.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -126.68 152.42 46.79 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.809 1.244 . . . . 0.0 113.596 -171.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 47.4 tp -122.89 141.88 51.4 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.186 1.794 . . . . 0.0 112.195 174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -125.63 143.37 51.06 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.736 2.414 . . . . 0.0 110.069 169.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 24.8 mm -125.95 130.57 72.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.787 1.235 . . . . 0.0 108.875 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 46.98 39.38 7.57 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.916 1.686 . . . . 0.0 114.253 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.265 . . 71.76 25.0 3.29 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 117.661 2.467 . . . . 0.0 117.661 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -130.52 145.22 51.82 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.4 1.48 . . . . 0.0 112.135 167.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -69.28 144.61 53.54 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.556 1.143 . . . . 0.0 112.639 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 26.8 t -121.36 -29.87 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 124.97 1.308 . . . . 0.0 113.663 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.31 19.11 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 118.88 0.764 . . . . 0.0 113.592 177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.92 -179.67 49.99 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.453 1.025 . . . . 0.0 113.88 167.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.21 -41.35 88.39 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.818 0.847 . . . . 0.0 112.723 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -54.83 -34.03 62.36 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 175.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.7 mm -91.51 -33.69 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.712 1.205 . . . . 0.0 113.531 -173.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.0 m -59.94 -33.74 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 CA-C-N 120.019 1.281 . . . . 0.0 111.336 175.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 33.8 p -69.96 -41.98 73.79 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 118.395 -0.812 . . . . 0.0 112.611 171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -55.2 -47.46 75.23 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 120.021 1.282 . . . . 0.0 111.177 172.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.0 mtp -69.28 -29.79 67.75 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.709 0.803 . . . . 0.0 112.909 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 tt -66.71 -55.36 15.45 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.786 1.175 . . . . 0.0 110.939 172.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -58.09 -45.81 86.55 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.634 1.173 . . . . 0.0 111.819 -178.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.6 m -83.62 9.28 11.92 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.477 1.511 . . . . 0.0 114.992 175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.21 -22.34 2.52 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.825 1.49 . . . . 0.0 116.825 171.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.27 -33.35 41.48 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.645 1.722 . . . . 0.0 115.131 -177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.47 -48.88 65.89 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.578 1.151 . . . . 0.0 110.487 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -62.81 -35.25 79.28 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.929 1.292 . . . . 0.0 111.132 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -63.39 -47.84 80.36 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.656 0.783 . . . . 0.0 111.77 173.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.02 -34.45 74.86 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.965 0.802 . . . . 0.0 113.074 -176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 33.0 mt -65.82 -50.81 63.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 118.578 0.626 . . . . 0.0 111.718 179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -64.83 -31.12 72.21 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -70.28 -38.22 75.0 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.603 1.561 . . . . 0.0 112.789 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.56 -5.72 53.59 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.138 0.975 . . . . 0.0 113.397 -178.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 24.94 62.74 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 118.799 0.727 . . . . 0.0 114.489 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 97.2 mt -86.84 139.5 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 O-C-N 120.934 -1.333 . . . . 0.0 109.484 -174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.6 t -61.26 121.83 13.55 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.628 0.771 . . . . 0.0 110.978 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.9 p -156.69 154.21 29.7 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.52 0.6 . . . . 0.0 112.461 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.69 153.94 22.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.98 1.712 . . . . 0.0 112.744 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -44.35 109.11 0.14 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 127.181 2.192 . . . . 0.0 112.832 -162.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.092 1.757 . . . . 0.0 112.515 -168.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.65 160.04 0.09 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.41 1.884 . . . . 0.0 115.531 -170.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 10.1 ttm -63.59 129.66 41.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.356 1.462 . . . . 0.0 110.276 166.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.14 164.9 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.556 1.142 . . . . 0.0 111.152 175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -56.86 -34.83 68.2 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 121.013 -1.054 . . . . 0.0 112.875 -172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.4 tttm -62.56 -31.8 72.67 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.455 1.502 . . . . 0.0 113.804 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -65.35 -36.18 83.24 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.681 1.128 . . . . 0.0 111.899 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.9 mt -72.34 -49.91 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 119.15 -0.452 . . . . 0.0 109.875 173.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -64.12 -38.35 90.75 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -174.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -68.13 -34.26 76.02 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 121.072 -1.017 . . . . 0.0 111.855 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 86.4 m -67.63 -42.08 82.88 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.51 0.595 . . . . 0.0 110.847 172.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 mm -55.98 -40.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.555 1.542 . . . . 0.0 111.222 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -78.16 -19.37 54.12 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.699 2.0 . . . . 0.0 115.337 175.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.5 t -93.2 -39.52 10.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.387 1.475 . . . . 0.0 113.833 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.19 168.17 18.82 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.675 1.59 . . . . 0.0 111.481 -175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -94.46 -30.49 14.41 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.17 -0.956 . . . . 0.0 110.998 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.5 t -138.25 126.82 31.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 125.351 1.46 . . . . 0.0 109.845 -176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 42.9 t -132.94 142.78 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.622 0.769 . . . . 0.0 110.252 174.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -136.47 148.58 47.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.375 0.67 . . . . 0.0 111.575 175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.84 117.06 30.39 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.805 1.242 . . . . 0.0 108.329 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 12.8 pt -130.77 179.28 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.616 1.166 . . . . 0.0 112.769 -170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -106.9 69.35 0.76 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.702 1.201 . . . . 0.0 109.794 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.98 -167.81 27.7 Favored Glycine 0 CA--C 1.539 1.589 0 C-N-CA 125.617 1.579 . . . . 0.0 112.187 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.8 161.04 64.98 Favored Pre-proline 0 CA--C 1.546 0.795 0 O-C-N 120.94 -1.33 . . . . 0.0 111.924 156.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -78.03 -35.95 1.21 Allowed 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.824 2.349 . . . . 0.0 111.287 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -76.69 -17.71 58.95 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.783 1.233 . . . . 0.0 114.001 170.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.52 68.97 15.22 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.474 1.509 . . . . 0.0 112.452 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.72 149.13 54.11 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.725 1.617 . . . . 0.0 110.332 174.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 20.9 mtm -90.79 13.54 16.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.999 1.72 . . . . 0.0 111.153 175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 11.8 t -154.57 141.51 19.21 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.59 79.87 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.814 1.646 . . . . 0.0 113.242 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -65.5 -34.65 78.75 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 121.514 -0.741 . . . . 0.0 111.875 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.5 m -68.69 -39.36 80.58 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.769 -0.582 . . . . 0.0 111.519 174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 tmmm? -56.97 -48.01 79.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.023 0.929 . . . . 0.0 111.426 168.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.5 tpt85 -64.01 -36.12 82.95 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.548 1.139 . . . . 0.0 112.902 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.18 -50.38 72.05 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.797 1.239 . . . . 0.0 111.471 173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.7 mm -63.86 -34.47 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 123.467 0.707 . . . . 0.0 110.911 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.83 -29.45 70.41 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 120.656 -1.277 . . . . 0.0 114.275 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.5 t -64.75 -46.35 92.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 120.953 -1.092 . . . . 0.0 109.782 169.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 78.9 mt -71.58 -35.31 70.5 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.095 1.358 . . . . 0.0 112.644 -175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -84.95 -37.1 20.91 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.763 1.225 . . . . 0.0 113.45 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.56 81.31 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.802 1.183 . . . . 0.0 111.707 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.1 mt -75.87 -5.76 47.57 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.359 1.064 . . . . 0.0 113.617 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 72.09 35.23 61.07 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 124.306 0.955 . . . . 0.0 115.28 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.8 mt -84.69 175.51 9.16 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.336 1.454 . . . . 0.0 111.417 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.23 131.24 53.6 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.652 1.981 . . . . 0.0 110.997 165.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -147.75 166.42 27.56 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.703 1.201 . . . . 0.0 113.877 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m -110.56 139.12 46.1 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.98 1.312 . . . . 0.0 109.606 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 44.2 t -124.09 123.47 40.39 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.459 1.104 . . . . 0.0 110.338 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -109.15 145.75 35.25 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.167 1.787 . . . . 0.0 111.429 -177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -114.8 118.32 33.23 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.674 1.19 . . . . 0.0 114.156 -176.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.9 m -72.22 -11.7 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 14.2 mt -89.58 -12.25 40.35 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.891 1.277 . . . . 0.0 113.223 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -103.83 -18.35 14.68 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 -173.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -158.26 134.35 6.2 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-N 119.137 0.881 . . . . 0.0 111.712 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -63.87 -28.96 67.49 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 124.054 3.169 . . . . 0.0 113.001 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.01 -32.93 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 120.915 -1.116 . . . . 0.0 111.646 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 59.6 t -72.16 -45.73 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 119.194 0.906 . . . . 0.0 111.443 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -67.83 -27.34 66.63 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.792 0.724 . . . . 0.0 112.654 175.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.1 t -73.5 -42.23 62.09 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.275 1.03 . . . . 0.0 112.825 172.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -58.21 -42.87 87.18 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 120.06 1.3 . . . . 0.0 112.883 -174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 m -65.35 -25.53 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -75.23 -19.29 59.84 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.013 0.824 . . . . 0.0 111.49 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -111.36 -34.78 6.03 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 -176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.3 -37.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 120.627 1.558 . . . . 0.0 114.361 -170.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 11.4 p -87.29 -27.96 22.58 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 119.316 0.962 . . . . 0.0 111.482 156.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 57.92 20.73 6.96 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.428 1.891 . . . . 0.0 113.148 -170.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 47.7 t-105 -101.5 133.82 20.62 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.421 1.089 . . . . 0.0 112.774 -168.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -78.59 -31.25 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.244 2.629 . . . . 0.0 114.539 -172.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 22.5 m -66.75 137.54 56.72 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -170.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -117.22 141.29 28.33 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.588 1.555 . . . . 0.0 108.615 163.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -74.86 160.3 96.69 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.242 0.765 . . . . 0.0 111.712 -10.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -135.14 157.53 46.69 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.64 141.32 51.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.116 1.767 . . . . 0.0 112.26 -167.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -128.11 136.41 51.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.081 2.152 . . . . 0.0 110.485 171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 35.4 mm -123.45 125.2 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.902 1.281 . . . . 0.0 109.065 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.2 mmtt 42.89 55.93 4.2 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.675 1.59 . . . . 0.0 112.198 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 63.7 6.46 2.66 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -177.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -105.09 145.95 29.81 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 120.142 1.337 . . . . 0.0 111.444 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -83.95 134.15 34.67 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.434 1.094 . . . . 0.0 111.159 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.7 t -105.83 -56.3 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.305 1.042 . . . . 0.0 111.636 -174.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 157.59 -167.55 34.12 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 123.542 0.591 . . . . 0.0 114.091 -175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.41 -168.68 45.09 Favored Glycine 0 CA--C 1.539 1.534 0 C-N-CA 125.018 1.294 . . . . 0.0 115.011 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -66.36 -35.96 81.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.904 1.282 . . . . 0.0 112.301 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -56.48 -42.2 77.87 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.453 1.101 . . . . 0.0 112.422 168.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 51.7 mm -71.49 -49.74 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 123.903 0.881 . . . . 0.0 112.199 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.16 -34.67 61.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 CA-C-N 119.435 1.016 . . . . 0.0 111.925 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.4 p -72.54 -44.05 62.68 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.37 -0.824 . . . . 0.0 111.676 175.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.98 -44.22 63.95 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.929 1.241 . . . . 0.0 112.411 169.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.9 mtp -74.93 -26.31 59.53 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.094 1.358 . . . . 0.0 113.581 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.8 tt -69.1 -46.57 67.41 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 120.48 -1.387 . . . . 0.0 110.506 170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -69.01 -27.65 65.88 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 93.5 p -84.06 -15.58 46.94 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.916 1.286 . . . . 0.0 113.729 166.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.08 2.48 82.84 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 126.232 1.873 . . . . 0.0 115.223 -175.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -64.53 -32.93 74.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.189 1.494 . . . . 0.0 113.081 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -61.34 -46.73 89.05 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.427 1.491 . . . . 0.0 110.52 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -67.29 -36.07 80.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.208 1.003 . . . . 0.0 111.514 173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -64.02 -43.21 96.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.569 0.622 . . . . 0.0 111.877 178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -38.61 87.61 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.151 0.887 . . . . 0.0 113.16 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 46.2 mt -64.14 -50.37 68.48 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.31 0.644 . . . . 0.0 111.395 178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -61.46 -36.12 79.52 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.41 -43.91 89.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.306 0.642 . . . . 0.0 111.591 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.8 mptt -77.98 -10.62 59.68 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.72 21.29 59.98 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.223 0.916 . . . . 0.0 115.115 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 25.7 mm -80.12 148.14 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 118.79 1.295 . . . . 0.0 111.706 -172.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.1 t -57.96 112.72 1.59 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.169 1.387 . . . . 0.0 111.293 175.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.5 p -154.62 154.35 32.84 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -80.11 168.68 18.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 128.128 2.571 . . . . 0.0 113.361 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -40.95 119.38 1.13 Allowed 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 118.488 2.773 . . . . 0.0 118.488 -144.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 C--O 1.254 1.334 0 C-N-CA 129.685 3.194 . . . . 0.0 112.242 173.74 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.845 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.82 160.82 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.429 2.292 . . . . 0.0 114.343 -167.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 21.5 ttm -81.13 140.61 34.92 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.012 -1.055 . . . . 0.0 110.01 165.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.8 m -114.35 153.96 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.142 0.977 . . . . 0.0 110.547 170.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -56.01 -33.87 65.29 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 121.22 -0.925 . . . . 0.0 112.476 -174.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -61.62 -30.12 70.49 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.272 1.429 . . . . 0.0 114.378 173.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -60.77 -42.62 97.83 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.861 1.21 . . . . 0.0 111.143 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.2 mt -72.98 -41.35 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.704 1.202 . . . . 0.0 110.483 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -67.27 -29.04 68.54 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -77.89 -35.51 50.69 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.453 -0.779 . . . . 0.0 112.136 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.3 m -60.37 -46.22 90.71 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 119.991 1.268 . . . . 0.0 111.472 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.7 mt -64.48 -30.55 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 O-C-N 121.033 -1.042 . . . . 0.0 112.59 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.95 -16.77 54.56 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.924 1.29 . . . . 0.0 114.023 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 t -103.75 -39.4 6.68 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.073 1.349 . . . . 0.0 113.907 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -86.73 150.5 24.13 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.557 1.543 . . . . 0.0 112.413 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.51 ' HB3' HD12 ' A' ' 179' ' ' ILE . 75.5 m-20 -84.6 -23.84 29.42 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.904 -1.123 . . . . 0.0 112.004 -175.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.5 t -141.67 125.48 16.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 125.606 1.563 . . . . 0.0 108.469 -177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 45.2 t -134.79 139.16 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.658 0.783 . . . . 0.0 110.593 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.1 t -135.87 145.78 46.73 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.599 0.759 . . . . 0.0 111.937 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -111.96 122.73 48.58 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.021 1.328 . . . . 0.0 109.341 175.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 13.4 pt -133.27 161.29 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 124.741 1.217 . . . . 0.0 112.894 -176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.7 mttt -78.9 76.06 5.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.13 1.372 . . . . 0.0 108.59 164.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.04 -172.51 24.53 Favored Glycine 0 CA--C 1.539 1.551 0 O-C-N 120.761 -1.212 . . . . 0.0 113.321 166.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.1 160.11 80.02 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 125.211 1.404 . . . . 0.0 111.399 158.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.29 -30.68 3.22 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.639 2.226 . . . . 0.0 111.946 -178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -82.36 -25.14 34.09 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.662 1.185 . . . . 0.0 113.963 172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.26 66.8 45.81 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 124.933 1.293 . . . . 0.0 110.074 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.12 151.45 44.25 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 121.227 1.285 . . . . 0.0 110.795 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 14.9 mtm -91.75 4.06 53.66 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.996 1.318 . . . . 0.0 111.4 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 38.1 t -140.53 141.03 35.33 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.88 1.672 . . . . 0.0 113.076 -174.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.3 98.57 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.144 1.378 . . . . 0.0 113.345 176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -68.41 -26.81 65.73 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.392 -0.818 . . . . 0.0 112.288 178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 t -66.78 -46.05 76.51 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 118.5 -0.762 . . . . 0.0 112.122 172.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.76 -50.59 33.27 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 119.207 0.912 . . . . 0.0 109.971 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -63.86 -37.59 87.95 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 117.614 -1.184 . . . . 0.0 113.728 -177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.6 tpp -59.65 -48.24 82.46 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.004 1.274 . . . . 0.0 110.866 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 39.4 mm -65.03 -35.43 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.409 0.684 . . . . 0.0 111.694 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -66.31 -29.79 70.07 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 121.083 -1.011 . . . . 0.0 110.032 170.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 45.4 mt -78.41 -35.41 47.11 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.639 1.176 . . . . 0.0 112.488 -175.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -79.24 -39.36 33.31 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.151 1.38 . . . . 0.0 112.441 173.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -65.23 -24.74 67.43 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.416 1.007 . . . . 0.0 112.118 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 61.9 mt -96.87 -3.89 41.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 172.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.98 39.66 74.15 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.287 0.946 . . . . 0.0 114.628 173.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.98 151.91 22.01 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.1 1.36 . . . . 0.0 111.496 -175.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.57 124.41 36.58 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.899 1.68 . . . . 0.0 109.858 165.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -149.74 166.44 29.4 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.362 1.065 . . . . 0.0 112.516 -176.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.2 m -109.07 133.55 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.824 1.249 . . . . 0.0 110.271 168.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 45.0 t -120.02 127.42 52.59 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.017 1.327 . . . . 0.0 110.863 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -107.99 128.2 54.44 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.254 1.422 . . . . 0.0 110.939 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -84.54 121.09 27.12 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.842 0.857 . . . . 0.0 109.723 168.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.16 -19.43 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.4 mt -90.81 -5.75 55.2 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.244 1.417 . . . . 0.0 113.353 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.75 -19.14 22.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -161.86 123.6 1.66 Allowed Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.053 . . . . 0.0 109.923 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -51.08 -38.77 60.59 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 124.041 3.161 . . . . 0.0 114.241 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.9 t -53.21 -34.29 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 84.2 t -65.02 -47.3 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 120.277 1.399 . . . . 0.0 111.368 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -78.04 -19.77 53.69 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 121.155 -0.965 . . . . 0.0 113.258 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.5 t -63.29 -46.97 84.26 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.632 0.773 . . . . 0.0 111.3 163.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -59.5 -42.72 92.8 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.704 -0.623 . . . . 0.0 111.579 174.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 97.7 t -61.45 -46.1 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 O-C-N 121.345 -0.847 . . . . 0.0 111.865 174.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -64.14 -44.78 91.11 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.395 0.678 . . . . 0.0 112.443 -178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.87 -16.17 15.45 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -165.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.4 t -124.26 -50.37 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.901 1.28 . . . . 0.0 111.801 -178.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.5 m -85.78 52.97 2.61 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.465 1.106 . . . . 0.0 111.724 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.53 -1.43 0.81 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.932 2.493 . . . . 0.0 115.879 -164.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . 0.401 ' CD2' ' HD2' ' A' ' 143' ' ' PRO . 72.0 t-105 -58.18 136.71 84.63 Favored Pre-proline 0 CA--C 1.546 0.816 0 CA-C-N 118.94 0.791 . . . . 0.0 110.357 167.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.401 ' HD2' ' CD2' ' A' ' 142' ' ' TRP . 56.9 Cg_endo -69.61 -34.7 14.54 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 114.432 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 4.8 m -76.49 142.41 40.93 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.514 0.726 . . . . 0.0 112.759 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mm -125.59 147.55 58.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 126.655 1.982 . . . . 0.0 109.505 163.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.57 164.99 85.89 Favored 'Cis proline' 0 CA--C 1.541 0.837 0 CA-C-N 120.576 1.241 . . . . 0.0 114.604 -5.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -126.99 156.98 40.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.294 1.438 . . . . 0.0 113.497 -174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 41.6 tp -124.44 143.24 50.74 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.488 1.915 . . . . 0.0 112.161 173.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -128.32 140.84 51.65 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.957 2.503 . . . . 0.0 110.245 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 4.3 mt -134.16 130.83 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.246 1.419 . . . . 0.0 110.58 172.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt 44.03 49.85 7.34 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 126.73 2.012 . . . . 0.0 112.95 -175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 62.13 20.7 11.86 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.53 1.932 . . . . 0.0 115.857 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -111.57 140.58 46.06 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 125.156 1.382 . . . . 0.0 111.557 167.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.76 136.5 52.89 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 169.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 54.6 t -108.44 -46.82 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.213 1.405 . . . . 0.0 111.72 -171.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.2 178.9 33.62 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 123.949 0.785 . . . . 0.0 113.21 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.11 -176.94 47.65 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 123.927 0.775 . . . . 0.0 113.376 164.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -61.39 -38.01 85.52 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 113.861 1.06 . . . . 0.0 113.861 -170.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -60.12 -41.94 93.7 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.304 -0.873 . . . . 0.0 111.792 173.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 43.8 mm -73.29 -46.33 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.9 m -61.68 -36.69 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 CA-C-N 119.423 1.01 . . . . 0.0 111.972 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 56.6 p -73.99 -39.45 63.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.358 0.663 . . . . 0.0 111.709 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -44.13 90.1 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 119.462 1.028 . . . . 0.0 112.717 170.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.16 -30.13 69.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.544 1.138 . . . . 0.0 112.913 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.9 tt -69.34 -52.11 30.36 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.637 1.108 . . . . 0.0 110.892 171.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -51.34 -38.24 52.04 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.758 1.623 . . . . 0.0 112.727 174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.4 m -98.24 12.33 35.01 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.429 2.292 . . . . 0.0 114.764 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.09 -23.13 0.9 Allowed Glycine 0 CA--C 1.537 1.444 0 C-N-CA 126.66 2.076 . . . . 0.0 117.117 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -61.05 -28.66 69.23 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 120.612 -1.522 . . . . 0.0 114.085 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -66.63 -49.36 66.49 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.974 1.31 . . . . 0.0 110.837 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -62.49 -34.01 76.0 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.093 0.957 . . . . 0.0 111.178 173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 49.7 tttm -68.11 -40.18 82.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 118.733 -0.651 . . . . 0.0 111.967 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.63 -40.74 72.54 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.593 1.088 . . . . 0.0 112.914 177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.8 mt -58.56 -50.2 74.65 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.256 0.622 . . . . 0.0 111.508 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -69.39 -31.17 69.38 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.53 -34.58 65.29 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.462 0.705 . . . . 0.0 112.869 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 -9.51 46.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 177.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 80.37 31.39 37.83 Favored Glycine 0 CA--C 1.537 1.445 0 N-CA-C 115.482 0.953 . . . . 0.0 115.482 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 90' ' ' ASP . 15.7 mm -85.39 148.96 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-N 118.697 1.248 . . . . 0.0 112.3 -175.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 7.6 t -64.39 126.52 28.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.59 0.756 . . . . 0.0 111.786 174.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 29.6 p -160.5 169.62 22.61 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 57.4 mtt-85 -64.64 161.29 17.99 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.586 1.154 . . . . 0.0 111.752 160.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -53.81 136.77 39.7 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 117.377 2.362 . . . . 0.0 117.377 -166.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.252 1.23 0 C-N-CA 127.395 2.278 . . . . 0.0 113.122 -175.559 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.984 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -150.4 158.25 43.94 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.173 0.986 . . . . 0.0 112.825 -175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 27.4 ttm -74.94 137.68 41.81 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.723 0.809 . . . . 0.0 110.954 169.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.1 m -113.66 161.05 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.822 1.249 . . . . 0.0 110.935 172.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -57.15 -34.46 68.44 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 120.783 -1.198 . . . . 0.0 112.272 -175.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -56.95 -31.88 65.45 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -64.75 -29.51 70.49 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.987 0.812 . . . . 0.0 112.091 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -87.72 -43.55 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.105 0.962 . . . . 0.0 110.532 173.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -57.36 -45.2 84.61 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.057 1.743 . . . . 0.0 112.584 -176.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -72.13 -25.04 61.57 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.964 1.306 . . . . 0.0 113.389 174.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 76.1 m -75.43 -45.74 36.94 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.233 0.613 . . . . 0.0 110.385 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 49.0 mt -59.29 -29.15 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-N 118.979 0.809 . . . . 0.0 111.87 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -78.07 -22.56 48.9 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.7 m -122.03 -19.84 6.5 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 115.519 1.674 . . . . 0.0 115.519 -174.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -84.32 148.57 26.58 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 120.32 -1.488 . . . . 0.0 110.685 167.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -82.11 -26.77 33.29 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.785 -0.572 . . . . 0.0 111.123 -177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 62.0 t -140.95 129.37 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 126.524 1.93 . . . . 0.0 109.51 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.6 t -135.83 140.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.494 1.118 . . . . 0.0 110.862 177.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -134.8 142.02 46.57 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.865 0.866 . . . . 0.0 112.708 -177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.69 115.23 29.48 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.176 1.39 . . . . 0.0 109.859 176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.8 pt -131.79 168.63 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -170.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -94.36 73.08 3.86 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.246 1.418 . . . . 0.0 109.824 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.07 -169.64 26.71 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.827 1.203 . . . . 0.0 112.975 166.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.39 159.87 46.59 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 124.269 1.028 . . . . 0.0 111.629 158.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.84 -39.39 0.66 Allowed 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.885 2.39 . . . . 0.0 111.249 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.48 -27.35 61.34 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.373 -0.83 . . . . 0.0 113.162 170.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -134.23 63.68 62.23 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.717 1.207 . . . . 0.0 113.228 -173.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.13 153.64 71.5 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 121.365 1.377 . . . . 0.0 111.135 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.5 mtm -96.36 8.04 44.98 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.775 2.03 . . . . 0.0 111.083 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 48.8 t -147.33 141.32 25.94 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.205 1.802 . . . . 0.0 111.687 -173.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -59.12 -52.77 64.28 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.639 1.576 . . . . 0.0 112.979 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -64.85 -23.55 67.27 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 120.915 -1.116 . . . . 0.0 112.619 179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -71.77 -40.19 69.44 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 118.735 -0.65 . . . . 0.0 112.409 171.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -57.81 -45.66 85.8 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.268 0.94 . . . . 0.0 110.864 166.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -64.19 -35.17 79.94 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.168 1.387 . . . . 0.0 113.63 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.5 mmt -62.79 -53.67 50.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.292 0.951 . . . . 0.0 112.065 169.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 36.6 mm -60.31 -33.66 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-O 119.382 -0.342 . . . . 0.0 110.718 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -57.66 -42.19 83.0 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 117.574 -1.203 . . . . 0.0 113.131 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.0 t -60.67 -43.01 94.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-N 120.01 1.277 . . . . 0.0 110.843 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 43.7 mt -76.69 -32.17 57.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.019 0.927 . . . . 0.0 111.914 -175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -83.31 -31.02 27.09 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.138 1.375 . . . . 0.0 113.626 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -74.85 -18.15 60.49 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 119.509 1.05 . . . . 0.0 112.383 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 89.3 mt -107.81 -5.48 17.27 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.752 1.621 . . . . 0.0 113.296 173.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.67 45.29 53.81 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.359 0.981 . . . . 0.0 115.251 172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.2 mt -94.16 162.03 14.03 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.388 1.475 . . . . 0.0 111.897 -174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -103.95 117.27 33.92 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.018 1.727 . . . . 0.0 111.02 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -138.89 163.51 32.11 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.202 1.001 . . . . 0.0 113.023 -168.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m -115.02 125.03 53.11 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.204 0.602 . . . . 0.0 110.183 163.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.0 t -98.42 137.59 36.89 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.155 1.382 . . . . 0.0 110.621 173.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -125.63 143.47 51.01 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.706 1.602 . . . . 0.0 110.9 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.6 117.15 32.15 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.458 1.103 . . . . 0.0 112.331 -171.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -70.9 -21.99 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.788 -1.195 . . . . 0.0 113.064 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.6 mt -86.14 -9.02 57.4 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.89 1.276 . . . . 0.0 113.36 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -111.99 -9.3 14.01 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -169.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -161.23 132.85 4.03 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 123.812 0.845 . . . . 0.0 111.556 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -62.39 -26.55 76.87 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.433 2.755 . . . . 0.0 113.768 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.36 -37.12 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 O-C-N 121.258 -0.902 . . . . 0.0 112.076 171.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.0 t -68.63 -46.29 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-N 119.775 1.17 . . . . 0.0 111.197 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ptt85 -67.65 -31.58 71.67 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 121.8 -0.562 . . . . 0.0 112.024 174.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 71.0 m -67.79 -36.71 80.92 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.593 -0.692 . . . . 0.0 112.569 174.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -58.0 -48.35 80.29 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.645 1.111 . . . . 0.0 111.501 178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.1 m -67.63 -27.87 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 O-C-N 120.473 -1.392 . . . . 0.0 113.164 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -81.13 -35.03 32.08 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.29 -0.881 . . . . 0.0 112.769 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -101.39 -26.46 13.59 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.0 t -112.99 -45.54 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.158 0.983 . . . . 0.0 112.642 -167.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 56.8 p -91.85 -32.29 15.38 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.587 1.085 . . . . 0.0 113.259 173.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 56.8 4.11 0.15 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 127.065 2.146 . . . . 0.0 115.349 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.0 t-105 -76.23 131.61 74.95 Favored Pre-proline 0 CA--C 1.541 0.631 0 O-C-N 120.862 -1.149 . . . . 0.0 111.006 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.0 -31.17 6.43 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 123.627 2.885 . . . . 0.0 114.778 -167.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 74.4 m -77.74 135.73 38.06 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.762 1.225 . . . . 0.0 111.629 -170.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.0 mm -127.55 139.65 35.83 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 125.103 1.361 . . . . 0.0 108.896 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.79 163.08 90.75 Favored 'Cis proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.4 0.822 . . . . 0.0 114.213 -7.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -138.31 150.88 47.05 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.71 1.204 . . . . 0.0 113.959 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.28 144.17 46.94 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.781 2.032 . . . . 0.0 112.894 -164.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -128.59 138.37 52.18 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.109 2.164 . . . . 0.0 110.757 172.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 3.1 mt -131.14 133.95 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.956 1.303 . . . . 0.0 109.696 173.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 41.6 mmtt 39.85 53.96 2.59 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.391 1.876 . . . . 0.0 112.662 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.26 . . 67.85 2.55 3.13 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 118.175 2.657 . . . . 0.0 118.175 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -105.65 144.02 32.99 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 120.224 1.374 . . . . 0.0 112.953 173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -69.54 139.64 53.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.751 0.82 . . . . 0.0 110.739 169.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 99.4 t -117.05 -44.79 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.235 1.014 . . . . 0.0 113.124 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.72 -177.36 30.47 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.12 0.867 . . . . 0.0 113.84 -176.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.61 -172.57 46.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.981 1.277 . . . . 0.0 114.732 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -61.11 -40.1 92.47 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.731 1.212 . . . . 0.0 113.115 -174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.36 -39.23 92.46 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.747 -1.22 . . . . 0.0 112.513 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 41.3 mm -68.54 -48.37 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.729 0.812 . . . . 0.0 111.907 179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.5 m -61.83 -35.3 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 CA-C-N 119.583 1.083 . . . . 0.0 111.774 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 24.2 p -73.65 -40.4 63.75 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.901 0.88 . . . . 0.0 112.465 176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -45.78 89.71 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 119.468 1.031 . . . . 0.0 112.125 170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 90.2 mtp -63.93 -34.46 78.01 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.34 1.056 . . . . 0.0 112.46 175.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -62.82 -52.13 64.34 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.697 1.135 . . . . 0.0 111.505 173.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -61.43 -30.86 70.84 Favored 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 4.0 t -76.39 -10.39 59.36 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.73 -24.6 1.52 Allowed Glycine 0 CA--C 1.537 1.45 0 C-N-CA 125.881 1.705 . . . . 0.0 114.2 -168.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -49.56 -32.08 11.81 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 127.043 2.137 . . . . 0.0 115.875 -178.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.45 -51.86 46.41 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.796 0.839 . . . . 0.0 110.946 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -63.71 -32.76 74.35 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.212 1.005 . . . . 0.0 111.703 174.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -59.3 -47.05 86.86 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.987 0.915 . . . . 0.0 110.611 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.1 -38.08 78.68 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 69.7 mt -62.71 -52.45 63.23 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.328 0.513 . . . . 0.0 110.912 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -65.94 -30.94 71.6 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.12 -43.79 90.83 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 125.107 1.363 . . . . 0.0 112.716 173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -87.96 -7.51 57.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.371 1.068 . . . . 0.0 113.616 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 83.24 18.68 64.13 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 116.24 1.256 . . . . 0.0 116.24 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.9 mm -78.52 147.16 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-N 119.088 1.444 . . . . 0.0 112.762 -168.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 t -59.81 123.16 16.12 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.643 0.777 . . . . 0.0 110.985 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 11.1 p -164.28 159.56 20.08 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 175.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.81 165.92 7.92 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.725 1.61 . . . . 0.0 111.717 169.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -46.8 119.58 2.56 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.583 2.353 . . . . 0.0 116.306 -163.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.1 mm? . . . . . 0 C--O 1.254 1.312 0 C-N-CA 127.195 2.198 . . . . 0.0 111.273 173.024 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.04 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -131.86 11.56 4.74 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.3 1.44 . . . . 0.0 113.814 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 24.7 ttp 59.53 95.41 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.32 2.248 . . . . 0.0 113.468 -169.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -93.69 169.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.205 1.402 . . . . 0.0 110.479 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -59.56 -31.93 69.88 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 120.388 -1.445 . . . . 0.0 112.716 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HE3' ' HA ' ' A' ' 80' ' ' LYS . 0.5 OUTLIER -63.27 -29.73 71.0 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.115 1.366 . . . . 0.0 113.791 172.562 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.07 -33.57 72.09 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 120.176 1.353 . . . . 0.0 112.025 176.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.43 -42.74 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 O-C-N 121.384 -0.822 . . . . 0.0 110.103 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 80' ' ' LYS . 5.4 t70 -60.89 -43.01 99.09 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.429 0.692 . . . . 0.0 112.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -60.98 -39.89 91.35 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.775 0.83 . . . . 0.0 111.997 173.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -43.03 99.29 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.01 0.524 . . . . 0.0 110.969 175.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.6 mt -65.1 -30.17 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.144 0.978 . . . . 0.0 112.244 175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -77.66 -12.81 60.01 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.284 1.834 . . . . 0.0 115.453 172.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.7 m -118.02 -22.98 7.6 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 115.554 1.686 . . . . 0.0 115.554 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -85.14 157.67 20.6 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 120.753 -1.217 . . . . 0.0 111.881 174.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.417 ' HB3' HD12 ' A' ' 179' ' ' ILE . 63.5 m-20 -87.85 -31.74 19.37 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.378 -0.827 . . . . 0.0 111.311 172.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -136.96 125.09 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 125.997 1.719 . . . . 0.0 109.392 -174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.6 t -132.47 139.02 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 123.29 0.636 . . . . 0.0 110.841 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.8 t -131.74 142.17 49.71 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.201 1.001 . . . . 0.0 111.973 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -111.48 122.04 46.78 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.379 1.472 . . . . 0.0 108.262 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 19.1 pt -139.07 168.88 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.248 1.019 . . . . 0.0 113.387 -170.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.64 76.22 7.34 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.271 1.028 . . . . 0.0 110.455 167.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.88 -166.8 28.33 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 120.539 -1.351 . . . . 0.0 113.836 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.39 159.86 84.27 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.861 1.265 . . . . 0.0 111.217 154.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.13 -29.91 1.83 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.246 2.63 . . . . 0.0 111.739 178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -83.38 -7.97 59.48 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.284 1.434 . . . . 0.0 114.529 170.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -151.0 61.91 4.81 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 125.913 1.685 . . . . 0.0 113.777 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.28 140.93 38.09 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.706 2.271 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.98 -10.56 50.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.246 1.019 . . . . 0.0 112.712 -173.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 83.7 m -141.39 146.82 37.08 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.602 1.161 . . . . 0.0 111.024 -169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.5 -53.79 51.9 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 -169.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -70.61 -27.24 63.93 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 120.562 -1.337 . . . . 0.0 112.034 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -62.7 -36.91 84.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.196 0.598 . . . . 0.0 111.584 171.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.9 tmmm? -65.81 -51.1 61.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.572 1.149 . . . . 0.0 111.967 167.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.4 tpt85 -57.85 -32.17 67.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.595 1.158 . . . . 0.0 113.327 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.0 tpt -65.92 -48.21 72.16 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.192 1.397 . . . . 0.0 112.025 173.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -64.33 -33.95 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.011 0.525 . . . . 0.0 110.918 178.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -60.92 -38.04 84.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 85.2 t -60.48 -45.54 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.659 1.118 . . . . 0.0 109.922 173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.29 -41.75 69.57 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.768 1.227 . . . . 0.0 111.814 -176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -75.26 -34.74 61.4 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.991 0.916 . . . . 0.0 112.986 174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.54 -24.78 62.01 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.717 1.144 . . . . 0.0 112.545 -177.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.6 mt -94.92 -9.23 34.76 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.86 1.264 . . . . 0.0 113.305 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 81.83 20.01 64.36 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.051 1.31 . . . . 0.0 116.259 173.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.2 mt -73.69 162.27 29.36 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.127 1.371 . . . . 0.0 111.161 -172.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -116.63 129.92 56.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.778 1.275 . . . . 0.0 112.524 171.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -144.55 170.9 15.16 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.361 -163.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 98.9 m -118.2 132.43 56.32 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.012 0.925 . . . . 0.0 109.901 161.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.1 t -111.39 134.64 52.83 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.274 1.83 . . . . 0.0 110.452 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -122.1 140.1 52.93 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.336 1.454 . . . . 0.0 111.565 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -105.87 118.11 35.75 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.586 1.154 . . . . 0.0 112.29 -172.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.7 m -75.31 -18.0 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.8 mt -89.63 -11.67 41.91 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.999 1.32 . . . . 0.0 112.097 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.24 -32.59 12.95 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 177.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -148.13 112.27 3.82 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 123.721 0.808 . . . . 0.0 112.526 -163.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 -34.38 30.12 Favored 'Trans proline' 0 CA--C 1.54 0.797 1 C-N-CA 125.46 4.107 . . . . 0.0 116.054 173.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.34 -38.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 O-C-N 121.272 -0.892 . . . . 0.0 112.268 172.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 91.8 t -67.91 -44.55 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.015 -1.053 . . . . 0.0 111.095 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -73.04 -19.5 61.17 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.7 t -70.0 -43.15 72.0 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.041 0.936 . . . . 0.0 111.886 168.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -53.87 -49.51 68.36 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.3 m -61.65 -33.02 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -73.42 -42.07 62.51 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.403 1.081 . . . . 0.0 111.263 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -82.93 -23.25 33.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.467 1.107 . . . . 0.0 113.982 -175.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.13 -60.5 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -171.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 p -82.74 -15.88 50.14 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -173.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 54.13 43.52 30.54 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.446 1.117 . . . . 0.0 112.31 175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -131.93 138.45 32.48 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 125.339 1.456 . . . . 0.0 110.961 -177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.7 -18.75 9.08 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 123.609 2.873 . . . . 0.0 115.152 -170.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 64.7 m -95.62 138.09 33.77 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -159.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.8 mm -118.83 135.47 23.77 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 125.406 1.482 . . . . 0.0 108.052 162.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -79.72 156.09 88.84 Favored 'Cis proline' 0 CA--C 1.535 0.57 0 CA-C-N 119.743 0.944 . . . . 0.0 113.91 1.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -141.65 154.17 45.2 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.755 1.021 . . . . 0.0 113.755 175.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.26 145.94 46.56 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.447 1.899 . . . . 0.0 112.132 -164.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -129.77 138.98 51.37 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 127.753 2.421 . . . . 0.0 110.328 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 26.1 mm -128.65 128.24 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.949 1.3 . . . . 0.0 110.323 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt 40.12 63.67 1.03 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 126.464 1.905 . . . . 0.0 112.052 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.268 . . 62.41 8.85 3.01 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 118.483 2.772 . . . . 0.0 118.483 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -123.73 140.54 52.88 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 121.008 1.731 . . . . 0.0 113.522 173.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -61.66 146.66 48.4 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 112.786 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 75.1 t -115.86 -55.94 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 125.741 1.617 . . . . 0.0 112.787 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.3 -176.44 32.14 Favored Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.771 1.176 . . . . 0.0 113.31 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.06 -165.48 40.1 Favored Glycine 0 CA--C 1.538 1.506 0 C-N-CA 124.772 1.177 . . . . 0.0 115.06 174.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -64.55 -36.81 85.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.247 1.019 . . . . 0.0 112.871 -173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -58.74 -38.04 77.52 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.717 0.807 . . . . 0.0 111.361 172.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 22.9 mm -77.2 -49.24 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 124.547 1.139 . . . . 0.0 112.222 -174.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.1 m -58.85 -34.9 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 CA-C-N 119.251 0.932 . . . . 0.0 111.762 178.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.9 p -76.92 -41.82 41.9 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.576 0.75 . . . . 0.0 112.018 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -45.26 72.64 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 119.835 1.198 . . . . 0.0 112.213 170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 82.5 mtp -64.36 -39.59 94.18 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.884 1.274 . . . . 0.0 112.952 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.7 tt -57.5 -49.58 75.84 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 119.466 1.03 . . . . 0.0 111.047 173.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -70.21 -23.34 62.92 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.9 t -77.2 -19.64 56.43 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.598 1.159 . . . . 0.0 113.023 169.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.72 -14.34 56.28 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 125.627 1.584 . . . . 0.0 114.605 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -61.91 -30.49 70.92 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.769 1.227 . . . . 0.0 113.734 -175.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -68.92 -49.57 56.91 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.57 0.748 . . . . 0.0 110.68 -178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -56.24 -39.61 72.83 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 119.108 -0.473 . . . . 0.0 111.916 166.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.12 -51.99 66.78 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.652 -176.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.96 -36.4 81.34 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.02 0.827 . . . . 0.0 113.115 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.5 -53.01 62.64 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.109 0.868 . . . . 0.0 111.229 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.6 ptt85 -68.83 -30.99 69.65 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -67.21 -41.85 85.1 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -86.73 -7.56 58.17 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.729 1.212 . . . . 0.0 113.764 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 84.43 25.35 43.52 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 115.547 0.979 . . . . 0.0 115.547 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.417 HD12 ' HB3' ' A' ' 90' ' ' ASP . 16.3 mm -79.8 147.07 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.481 1.112 . . . . 0.0 111.75 -170.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 12.7 t -62.61 117.02 5.68 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.292 0.637 . . . . 0.0 111.163 177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 16.4 p -158.0 164.96 36.26 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 11.4 mmp_? -51.66 164.52 0.23 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.475 1.91 . . . . 0.0 113.543 167.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -50.12 135.82 20.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.217 1.807 . . . . 0.0 112.935 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--O 1.251 1.14 0 C-N-CA 127.703 2.401 . . . . 0.0 114.148 -166.433 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -87.12 155.08 20.27 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.61 1.164 . . . . 0.0 113.516 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 22.2 ttm -72.62 137.05 45.86 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.824 0.849 . . . . 0.0 110.497 167.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.8 m -111.21 156.91 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 123.864 0.866 . . . . 0.0 110.14 167.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 tmmm? -58.08 -29.92 65.82 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.298 -0.876 . . . . 0.0 112.498 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -63.74 -30.97 72.0 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.651 1.581 . . . . 0.0 114.826 171.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -65.89 -39.73 90.9 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.796 1.18 . . . . 0.0 110.864 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.7 mt -64.65 -48.3 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.299 0.64 . . . . 0.0 109.673 170.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -62.41 -37.9 87.58 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -175.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -70.9 -31.5 68.16 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.906 1.282 . . . . 0.0 112.171 174.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.6 m -69.18 -43.31 74.48 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.976 1.311 . . . . 0.0 111.325 171.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -55.74 -31.22 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.619 1.567 . . . . 0.0 111.258 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 -19.68 31.0 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 115.891 174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 70.2 m -114.36 -20.19 10.94 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.915 1.286 . . . . 0.0 113.983 -168.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -85.1 168.04 15.22 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.713 1.205 . . . . 0.0 110.397 164.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 -92.84 -27.33 17.21 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.434 -0.791 . . . . 0.0 111.358 165.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 t -138.13 127.75 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 126.053 1.741 . . . . 0.0 110.046 -173.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -136.21 143.54 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.583 0.753 . . . . 0.0 111.055 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.7 t -141.56 153.76 45.04 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -119.89 116.13 25.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.509 1.924 . . . . 0.0 109.039 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.8 pt -134.29 171.04 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.305 1.042 . . . . 0.0 113.177 -170.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -96.04 72.8 2.96 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.865 1.266 . . . . 0.0 111.045 172.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.73 -172.33 26.45 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.757 1.17 . . . . 0.0 112.231 167.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.36 154.81 77.46 Favored Pre-proline 0 CA--C 1.542 0.645 0 O-C-N 121.264 -1.139 . . . . 0.0 111.287 157.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.63 -33.06 5.45 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.753 2.302 . . . . 0.0 111.242 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.17 -18.98 54.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.059 1.744 . . . . 0.0 114.735 169.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -144.77 65.75 12.67 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.77 1.228 . . . . 0.0 112.785 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.24 150.72 42.58 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.798 2.332 . . . . 0.0 111.856 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.2 mtm -100.31 15.45 27.63 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.596 1.958 . . . . 0.0 111.813 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.46 137.35 14.47 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.03 1.732 . . . . 0.0 110.681 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -63.95 -44.07 93.91 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.486 1.114 . . . . 0.0 113.376 -174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -64.06 -29.28 70.43 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 120.568 -1.333 . . . . 0.0 111.996 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.7 m -69.69 -38.79 77.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.736 172.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.6 ttpt -53.72 -49.41 68.18 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.768 0.827 . . . . 0.0 111.756 164.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -69.42 -30.51 68.47 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 -172.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttm -67.12 -41.28 86.45 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.561 1.073 . . . . 0.0 112.017 171.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 46.3 mm -65.62 -34.32 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.845 -0.534 . . . . 0.0 111.631 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.22 -36.96 83.57 Favored 'General case' 0 C--O 1.214 -0.763 0 CA-C-N 119.398 0.999 . . . . 0.0 113.2 173.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.17 -42.34 92.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.063 1.301 . . . . 0.0 110.843 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 84.0 mt -77.26 -38.16 51.56 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.539 1.136 . . . . 0.0 112.46 -174.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -76.91 -38.97 52.47 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.965 1.306 . . . . 0.0 112.324 173.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -71.31 -21.02 62.12 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.558 1.072 . . . . 0.0 112.755 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 85.7 mt -97.46 -8.62 28.9 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.388 1.075 . . . . 0.0 113.623 169.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 71.71 47.64 32.43 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 124.657 1.122 . . . . 0.0 114.591 172.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.8 mt -94.98 154.48 17.16 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.008 1.323 . . . . 0.0 111.19 -176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -90.54 121.59 32.62 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.721 0.808 . . . . 0.0 111.589 162.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -134.48 172.24 13.18 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.14 1.376 . . . . 0.0 112.187 -178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.3 m -123.95 128.78 49.92 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.082 0.953 . . . . 0.0 109.013 158.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.2 t -106.42 136.26 46.48 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.335 1.454 . . . . 0.0 110.993 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -118.3 136.28 53.79 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.377 1.471 . . . . 0.0 111.731 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -94.86 118.74 32.28 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.144 0.978 . . . . 0.0 113.241 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.7 m -71.61 -16.36 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 C-N-CA 124.612 1.165 . . . . 0.0 113.501 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -87.31 -18.44 30.14 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 124.122 0.969 . . . . 0.0 112.993 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.64 5.37 22.91 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -167.45 120.21 0.76 Allowed Pre-proline 0 CA--C 1.547 0.849 0 CA-C-N 119.625 1.102 . . . . 0.0 111.117 173.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.95 -33.63 89.65 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 123.405 2.736 . . . . 0.0 114.955 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.4 t -52.71 -38.07 26.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 120.483 -1.386 . . . . 0.0 112.798 170.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 92.8 t -71.56 -44.41 70.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 O-C-N 121.294 -0.879 . . . . 0.0 111.125 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 -71.81 -24.9 61.8 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 121.663 -0.648 . . . . 0.0 112.552 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 32.0 t -70.9 -37.76 72.99 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.97 1.308 . . . . 0.0 112.766 171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -58.09 -50.32 73.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 119.155 0.889 . . . . 0.0 111.659 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 11.9 m -67.5 -21.29 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 O-C-N 120.694 -1.254 . . . . 0.0 113.668 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -72.39 -44.87 61.9 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.294 -0.879 . . . . 0.0 110.406 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -104.13 -24.72 13.15 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 -169.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 16.0 t -104.16 -32.97 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -166.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -99.23 -30.91 11.99 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 119.386 0.994 . . . . 0.0 112.744 166.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 55.64 22.98 5.72 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.918 1.687 . . . . 0.0 113.113 -171.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -94.6 136.79 22.84 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 125.396 1.478 . . . . 0.0 111.46 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.74 -32.76 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.63 2.22 . . . . 0.0 114.512 -168.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 24.4 m -70.94 140.56 50.97 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.428 1.269 . . . . 0.0 114.428 -165.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.5 mm -118.17 140.11 27.56 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.636 1.174 . . . . 0.0 108.935 160.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.34 162.94 91.43 Favored 'Cis proline' 0 CA--C 1.54 0.818 0 CA-C-N 119.29 0.782 . . . . 0.0 112.063 -12.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -136.02 158.67 43.84 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.6 141.71 51.41 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.577 1.951 . . . . 0.0 112.484 -165.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -127.03 137.66 53.1 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.106 2.162 . . . . 0.0 110.517 171.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -125.26 124.16 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.186 1.394 . . . . 0.0 110.021 174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.9 mttt 38.66 63.59 0.87 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 127.515 2.326 . . . . 0.0 113.866 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 60.96 27.51 17.37 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -135.36 140.77 45.29 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.407 1.483 . . . . 0.0 111.962 172.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -73.6 144.16 46.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.585 1.154 . . . . 0.0 111.894 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.76 -52.05 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.609 1.164 . . . . 0.0 113.8 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 164.73 178.85 38.41 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 119.202 0.91 . . . . 0.0 114.901 -174.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.35 -170.14 45.53 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 124.967 1.27 . . . . 0.0 114.52 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.71 -41.41 96.02 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 121.541 -0.976 . . . . 0.0 113.443 -175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -57.41 -40.39 78.22 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.399 -0.813 . . . . 0.0 111.962 170.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 39.8 mm -69.41 -50.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 123.452 0.701 . . . . 0.0 111.87 -178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 30.0 m -61.29 -35.09 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.625 1.102 . . . . 0.0 111.967 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 37.7 p -73.94 -40.8 62.81 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.524 0.729 . . . . 0.0 111.937 176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.41 -44.94 96.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.628 1.104 . . . . 0.0 112.091 173.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.9 mtp -63.09 -33.68 75.96 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.03 1.332 . . . . 0.0 113.007 172.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.5 -52.14 54.92 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 120.375 1.443 . . . . 0.0 110.996 171.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -59.83 -27.87 66.99 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.294 1.038 . . . . 0.0 112.999 178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.2 t -89.58 -7.62 54.42 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.366 2.266 . . . . 0.0 113.874 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.72 -16.03 5.55 Favored Glycine 0 CA--C 1.533 1.2 0 C-N-CA 126.934 2.207 . . . . 0.0 115.822 -176.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -53.9 -34.63 60.06 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.247 2.219 . . . . 0.0 114.838 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -64.31 -50.46 67.75 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.857 0.863 . . . . 0.0 110.432 175.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt -67.32 -26.38 66.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.264 1.426 . . . . 0.0 112.096 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -41.68 88.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.557 1.143 . . . . 0.0 112.076 170.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -38.47 91.2 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 119.559 1.072 . . . . 0.0 112.487 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.2 mt -59.67 -52.54 65.06 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 118.671 0.668 . . . . 0.0 112.441 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.0 ptp180 -66.97 -27.33 67.37 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.33 -40.26 74.24 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.072 0.949 . . . . 0.0 112.811 171.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -93.87 0.36 56.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.204 1.402 . . . . 0.0 114.309 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 70.47 27.61 72.37 Favored Glycine 0 CA--C 1.538 1.477 0 O-C-N 121.242 -0.911 . . . . 0.0 114.959 -179.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 73.2 mt -87.53 128.22 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 CA-C-N 118.822 1.311 . . . . 0.0 109.758 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.0 t -51.11 121.57 6.32 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.745 1.218 . . . . 0.0 111.814 -175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -156.33 166.64 32.85 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -61.38 166.74 3.71 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.114 1.765 . . . . 0.0 113.206 168.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -57.82 126.85 29.19 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.936 1.694 . . . . 0.0 114.225 -167.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 C--O 1.253 1.284 0 C-N-CA 129.175 2.99 . . . . 0.0 115.12 -161.266 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.044 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.6 150.29 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.637 0.775 . . . . 0.0 112.253 169.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 20.3 ttp -85.11 153.35 22.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.778 0.831 . . . . 0.0 110.331 167.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 m -124.21 159.63 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.372 1.069 . . . . 0.0 110.823 171.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 26.2 ttmt -56.01 -36.6 68.11 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 121.43 -0.794 . . . . 0.0 112.47 -175.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -58.73 -30.72 67.69 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.03 -42.26 89.86 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.708 1.14 . . . . 0.0 111.259 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.92 -41.85 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.581 0.752 . . . . 0.0 110.022 174.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.38 -42.8 98.85 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.13 -28.06 62.04 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.2 173.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 87.8 m -62.58 -45.76 91.43 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.832 1.196 . . . . 0.0 110.27 169.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 54.5 mt -64.5 -27.71 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.437 0.695 . . . . 0.0 112.294 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 31.2 mttm -82.96 -22.76 33.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.074 1.35 . . . . 0.0 114.431 171.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 46.4 t -88.93 -51.6 5.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.702 1.201 . . . . 0.0 113.86 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -89.35 152.75 21.35 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 126.098 1.759 . . . . 0.0 111.946 -170.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -89.78 -24.91 21.35 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.611 -0.681 . . . . 0.0 111.222 -168.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.2 t -134.84 123.11 40.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 126.442 1.897 . . . . 0.0 109.766 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -132.81 133.37 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.771 0.829 . . . . 0.0 110.124 176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -131.77 145.62 51.7 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.612 -0.68 . . . . 0.0 112.556 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -110.14 116.15 31.01 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.796 1.638 . . . . 0.0 108.637 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 25.1 pt -128.96 -177.1 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.456 1.102 . . . . 0.0 112.224 -178.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 71.8 tttt -115.76 72.32 0.8 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.677 1.991 . . . . 0.0 109.252 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.51 -169.92 26.32 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 125.376 1.465 . . . . 0.0 111.98 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 159.34 83.4 Favored Pre-proline 0 CA--C 1.544 0.734 0 O-C-N 120.881 -1.364 . . . . 0.0 111.71 158.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.15 -30.71 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.806 2.337 . . . . 0.0 111.865 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.88 -11.03 58.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.687 1.595 . . . . 0.0 114.676 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -149.53 66.38 8.3 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 125.403 1.481 . . . . 0.0 112.498 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.11 139.57 24.16 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.255 1.97 . . . . 0.0 110.473 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.46 ' CE ' HD12 ' A' ' 127' ' ' LEU . 23.6 mtm -82.65 17.48 1.8 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.61 1.564 . . . . 0.0 111.508 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.69 144.28 13.5 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.392 1.077 . . . . 0.0 113.436 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.31 -48.39 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.861 1.664 . . . . 0.0 113.002 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -69.79 -29.77 67.16 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 120.796 -1.19 . . . . 0.0 111.956 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 29.5 m -68.45 -43.53 76.88 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.432 0.693 . . . . 0.0 111.548 173.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -50.35 -51.12 48.53 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.464 1.105 . . . . 0.0 111.895 164.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.56 -33.0 74.69 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.025 1.33 . . . . 0.0 113.076 -173.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 59.0 tpp -63.25 -50.39 70.35 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.928 0.891 . . . . 0.0 111.573 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 32.6 mm -60.45 -35.11 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 121.897 -0.502 . . . . 0.0 111.289 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -61.75 -36.33 80.68 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 93.2 t -63.85 -37.97 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 119.787 1.176 . . . . 0.0 110.832 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 57.6 mt -80.36 -32.75 37.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.355 1.462 . . . . 0.0 112.551 -176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -86.35 -31.07 21.72 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.178 1.791 . . . . 0.0 114.035 174.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.03 -11.81 60.01 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.187 0.903 . . . . 0.0 113.151 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.69 -9.42 14.85 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.751 1.62 . . . . 0.0 114.076 173.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 78.37 28.41 55.7 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 116.485 1.354 . . . . 0.0 116.485 171.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 8.0 mt -77.17 160.95 28.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.832 1.653 . . . . 0.0 111.627 -176.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -95.61 125.1 39.97 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.106 1.362 . . . . 0.0 109.719 162.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -144.14 159.17 43.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.522 1.129 . . . . 0.0 113.749 -177.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.6 m -105.74 135.55 46.95 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.71 1.204 . . . . 0.0 109.969 165.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.0 t -116.65 137.28 52.3 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.697 1.199 . . . . 0.0 111.078 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -115.36 155.66 26.95 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.417 1.487 . . . . 0.0 111.301 175.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -119.63 120.5 36.86 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.517 1.127 . . . . 0.0 111.456 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -65.21 -21.06 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.46 HD12 ' CE ' ' A' ' 103' ' ' MET . 23.0 mt -88.83 -13.36 39.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.6 1.16 . . . . 0.0 112.958 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -92.17 -21.39 20.41 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -162.47 128.1 2.24 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.815 0.846 . . . . 0.0 111.15 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -58.94 -30.76 94.08 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.706 2.27 . . . . 0.0 113.763 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 1.9 t -49.84 -34.72 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 120.498 -1.376 . . . . 0.0 112.474 170.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.6 t -70.53 -49.09 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 119.013 0.824 . . . . 0.0 111.402 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -71.46 -31.32 67.04 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 119.282 0.946 . . . . 0.0 112.597 177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.4 t -60.39 -41.59 94.15 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.839 1.256 . . . . 0.0 111.804 170.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -61.06 -45.84 93.09 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.352 -0.843 . . . . 0.0 111.663 173.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 80.8 t -60.74 -49.88 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 O-C-N 121.003 -1.06 . . . . 0.0 110.959 177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -42.5 76.04 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.668 0.667 . . . . 0.0 112.784 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -98.13 -16.44 19.53 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -170.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.0 t -122.93 -36.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 t -83.71 -40.21 19.16 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 119.465 1.03 . . . . 0.0 112.456 173.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 58.31 27.84 15.85 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.932 1.693 . . . . 0.0 114.214 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -113.62 143.99 30.53 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 127.038 2.135 . . . . 0.0 111.385 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -82.69 -14.11 9.15 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.479 2.786 . . . . 0.0 116.044 -166.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 43.6 p -84.25 154.96 22.7 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.913 1.233 . . . . 0.0 113.645 -170.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 22.7 mm -128.97 137.0 30.06 Favored Pre-proline 0 N--CA 1.469 0.485 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 154.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -73.89 178.49 33.12 Favored 'Cis proline' 0 CA--C 1.544 0.977 0 CA-C-N 119.965 1.023 . . . . 0.0 114.149 -5.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -136.85 154.11 50.6 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.446 1.499 . . . . 0.0 112.345 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.4 tp -122.72 142.88 50.22 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.301 1.84 . . . . 0.0 111.725 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.66 142.11 51.68 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 127.752 2.421 . . . . 0.0 109.649 167.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.7 mm -129.25 131.85 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.07 1.348 . . . . 0.0 108.785 173.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt 47.99 41.82 15.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.529 1.531 . . . . 0.0 114.4 172.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.266 . . 70.88 24.0 4.23 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -178.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -126.57 147.22 49.9 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.555 1.542 . . . . 0.0 111.857 167.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -67.55 145.17 55.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.56 0.744 . . . . 0.0 111.089 170.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 37.1 t -117.99 -49.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.193 0.997 . . . . 0.0 113.102 -173.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 159.97 176.5 32.12 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-N 118.692 0.678 . . . . 0.0 114.219 -178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.73 -172.91 46.71 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.703 1.144 . . . . 0.0 113.521 165.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.65 -39.91 91.89 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -167.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -60.95 -38.33 85.52 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.07 -1.019 . . . . 0.0 112.246 174.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.8 mm -71.58 -49.7 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.663 1.185 . . . . 0.0 112.092 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 23.3 m -61.99 -35.55 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 121.247 -0.908 . . . . 0.0 111.77 -178.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 32.9 p -74.31 -40.25 62.34 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.877 0.871 . . . . 0.0 112.358 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.58 -48.45 69.18 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.712 1.142 . . . . 0.0 111.77 167.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 85.5 mtp -66.92 -31.35 71.87 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.27 1.028 . . . . 0.0 112.741 178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.2 tt -65.07 -53.27 48.21 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 120.085 1.311 . . . . 0.0 111.429 174.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -59.19 -37.4 77.34 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.237 0.542 . . . . 0.0 111.739 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 5.0 t -76.61 -2.55 33.17 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.139 1.376 . . . . 0.0 114.389 176.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.37 -24.96 0.58 Allowed Glycine 0 CA--C 1.538 1.469 0 O-C-N 120.301 -1.499 . . . . 0.0 114.981 -173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -46.34 -36.78 6.67 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 126.999 2.12 . . . . 0.0 114.997 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.38 -45.96 71.32 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.911 0.884 . . . . 0.0 111.138 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -64.88 -37.62 88.25 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.653 1.181 . . . . 0.0 110.583 173.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -62.63 -38.62 90.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.69 1.196 . . . . 0.0 112.152 -178.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.21 -32.99 72.76 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 177.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.1 mt -65.35 -48.05 74.33 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.817 0.847 . . . . 0.0 111.601 -178.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -67.88 -28.1 67.24 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.843 0.857 . . . . 0.0 112.692 177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -72.22 -44.25 63.22 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.597 0.759 . . . . 0.0 111.491 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.72 -6.93 57.97 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 77.21 35.18 38.85 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 115.876 1.11 . . . . 0.0 115.876 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.0 mt -95.4 143.0 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-N 118.968 1.384 . . . . 0.0 112.209 -173.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.0 t -57.97 124.52 19.57 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.41 1.484 . . . . 0.0 112.129 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 23.2 p -164.46 168.18 18.71 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.685 0.794 . . . . 0.0 112.632 174.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -51.16 167.48 0.08 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.806 2.043 . . . . 0.0 113.058 163.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.84 118.85 3.1 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.544 1.937 . . . . 0.0 112.542 177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.249 1.063 0 C-N-CA 126.927 2.091 . . . . 0.0 113.609 169.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.073 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 62.25 154.57 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.466 2.306 . . . . 0.0 116.975 -175.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 31.7 ttp -83.7 149.13 26.68 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.3 1.04 . . . . 0.0 110.119 164.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.6 m -122.15 159.46 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.044 1.338 . . . . 0.0 110.11 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -65.05 -25.57 67.88 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.959 -1.088 . . . . 0.0 113.522 -170.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -55.9 -37.73 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.196 1.398 . . . . 0.0 113.223 168.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -62.03 -23.9 66.74 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.563 0.745 . . . . 0.0 111.868 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 mt -89.91 -54.13 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.686 1.194 . . . . 0.0 111.034 168.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.39 -28.17 68.43 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -167.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -84.95 -28.11 26.08 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.248 -0.908 . . . . 0.0 112.48 171.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -68.43 -35.82 78.16 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.615 -0.678 . . . . 0.0 111.417 170.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 3.4 mm -54.85 -41.88 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.692 1.197 . . . . 0.0 110.874 168.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.8 mmtt -74.62 -30.54 61.69 Favored 'General case' 0 C--N 1.342 0.263 0 C-N-CA 125.124 1.369 . . . . 0.0 114.598 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.1 t -78.65 -47.35 17.21 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.456 1.025 . . . . 0.0 113.324 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -82.64 151.04 26.47 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.939 0.895 . . . . 0.0 110.58 -172.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -81.42 -26.9 35.0 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.111 -0.993 . . . . 0.0 111.605 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.4 t -137.52 130.77 43.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 126.966 2.107 . . . . 0.0 109.64 177.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.6 t -134.73 142.65 39.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.458 0.703 . . . . 0.0 110.949 173.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -138.32 149.6 45.8 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 121.321 -0.862 . . . . 0.0 111.841 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -113.59 118.38 34.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 125.428 1.491 . . . . 0.0 108.58 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.0 pt -127.1 -177.16 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.631 1.173 . . . . 0.0 111.816 -177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -115.28 71.87 0.78 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.71 1.604 . . . . 0.0 108.505 -178.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.84 -167.04 27.29 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 125.959 1.742 . . . . 0.0 112.427 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.5 mp -70.41 162.24 71.47 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.236 -1.155 . . . . 0.0 112.836 159.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.96 -42.87 3.81 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 123.178 2.585 . . . . 0.0 112.232 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -78.5 -23.81 46.16 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 176.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.47 70.12 67.24 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 125.592 1.557 . . . . 0.0 111.901 -177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.6 154.04 64.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 121.642 1.561 . . . . 0.0 110.584 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.409 ' CE ' HD12 ' A' ' 127' ' ' LEU . 17.7 mtm -94.88 17.3 13.99 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.304 1.842 . . . . 0.0 111.216 176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 13.1 t -159.57 140.15 12.22 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.764 1.225 . . . . 0.0 113.368 -177.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -52.78 -48.03 67.11 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.539 1.535 . . . . 0.0 114.0 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.28 -29.28 69.47 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.026 -1.046 . . . . 0.0 112.389 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.9 m -69.55 -42.0 75.16 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.652 -0.655 . . . . 0.0 111.894 173.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.7 tmmm? -55.55 -45.83 77.22 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.674 0.79 . . . . 0.0 110.697 168.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.1 tpt85 -64.72 -34.24 77.84 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 117.673 -1.156 . . . . 0.0 112.838 -178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.4 tpp -64.65 -52.84 55.24 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.657 1.117 . . . . 0.0 111.519 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.5 mm -58.89 -37.18 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.163 0.585 . . . . 0.0 111.127 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.32 -39.91 84.61 Favored 'General case' 0 C--O 1.22 -0.466 0 CA-C-O 117.617 -1.182 . . . . 0.0 114.006 175.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.14 -40.84 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 CA-C-N 120.067 1.303 . . . . 0.0 110.162 175.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.1 mt -78.54 -38.95 39.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.893 1.277 . . . . 0.0 111.403 -173.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -74.35 -38.32 63.27 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.111 1.364 . . . . 0.0 112.382 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.37 -24.99 60.39 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 120.909 -1.119 . . . . 0.0 112.446 -176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.97 -13.02 31.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 0.0 112.769 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 83.88 29.2 32.42 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.178 1.371 . . . . 0.0 115.632 171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mt -87.21 146.2 26.09 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.365 1.466 . . . . 0.0 110.778 -172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.3 127.88 35.48 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 121.579 -0.701 . . . . 0.0 111.258 165.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -139.54 165.28 27.67 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.957 1.703 . . . . 0.0 113.025 -176.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.9 m -112.39 133.74 54.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.122 0.969 . . . . 0.0 109.667 160.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.9 t -114.66 137.93 51.3 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.256 1.422 . . . . 0.0 111.675 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -121.38 141.25 51.15 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.745 1.618 . . . . 0.0 111.481 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -102.74 119.66 39.22 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.126 0.97 . . . . 0.0 112.611 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.7 m -71.55 -9.75 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.8 -1.188 . . . . 0.0 113.665 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.409 HD12 ' CE ' ' A' ' 103' ' ' MET . 16.3 mt -91.36 -14.12 31.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.856 1.262 . . . . 0.0 113.017 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.16 -34.81 20.44 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -155.64 132.44 6.15 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 124.647 1.179 . . . . 0.0 109.69 -173.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -55.36 -34.46 88.93 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.588 2.859 . . . . 0.0 114.403 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.2 -38.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.648 -1.283 . . . . 0.0 112.926 168.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.37 -47.69 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 119.6 1.091 . . . . 0.0 111.499 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 27.2 ptt180 -70.37 -35.95 73.84 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.564 -0.71 . . . . 0.0 111.845 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.46 -27.61 68.7 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.339 -0.85 . . . . 0.0 112.645 169.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.8 t80 -65.07 -49.59 69.47 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 120.6 1.546 . . . . 0.0 111.941 175.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 8.0 m -68.4 -32.64 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 O-C-N 121.017 -1.052 . . . . 0.0 112.646 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -75.57 -42.44 52.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -110.39 -17.53 13.45 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -166.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.3 t -111.87 -51.46 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.467 1.107 . . . . 0.0 111.289 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.2 t -67.39 -35.55 79.54 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 118.589 0.631 . . . . 0.0 111.17 169.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 56.06 34.15 23.23 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.399 1.88 . . . . 0.0 114.117 -177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -117.68 135.72 23.4 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.714 1.205 . . . . 0.0 111.708 -174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.02 -27.17 10.21 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.707 2.938 . . . . 0.0 114.797 -168.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 95.1 m -77.33 152.94 34.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.461 1.504 . . . . 0.0 113.582 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.4 mm -129.95 142.79 46.59 Favored Pre-proline 0 N--CA 1.475 0.793 0 C-N-CA 127.155 2.182 . . . . 0.0 108.588 163.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.51 177.99 34.84 Favored 'Cis proline' 0 CA--C 1.543 0.955 0 CA-C-N 120.152 1.09 . . . . 0.0 112.886 -10.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -133.7 155.77 49.13 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 113.354 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.6 tp -130.27 140.09 50.7 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.494 1.917 . . . . 0.0 112.07 -178.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -129.46 143.03 50.67 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 127.829 2.452 . . . . 0.0 110.458 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.69 126.72 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.303 1.441 . . . . 0.0 109.716 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt 46.82 42.63 12.22 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.087 1.755 . . . . 0.0 113.398 176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 61.59 40.39 13.52 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 115.98 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -135.53 141.15 45.19 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.939 1.695 . . . . 0.0 110.83 163.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -69.69 145.23 52.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.606 1.163 . . . . 0.0 112.08 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 74.0 t -112.54 -49.83 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.832 1.653 . . . . 0.0 112.367 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 152.83 -177.22 30.64 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.687 0.661 . . . . 0.0 113.384 -173.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -88.16 -165.92 41.8 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.187 0.898 . . . . 0.0 114.208 165.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -70.54 -37.74 74.09 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -169.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.35 -41.83 94.47 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.206 -0.934 . . . . 0.0 111.075 170.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 50.1 mm -68.71 -53.11 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.028 -177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 7.5 p -51.23 -42.34 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-N 119.943 1.247 . . . . 0.0 112.162 175.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.6 p -75.56 -40.09 57.28 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.71 -46.94 74.26 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.51 1.05 . . . . 0.0 112.294 168.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 93.2 mtp -64.75 -35.77 82.15 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.431 1.492 . . . . 0.0 112.651 175.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tt -65.56 -49.01 70.46 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.096 1.317 . . . . 0.0 111.63 173.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -61.79 -38.75 89.24 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.514 -0.741 . . . . 0.0 111.186 174.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -70.18 -15.05 62.89 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 173.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.24 -23.78 3.19 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.873 1.225 . . . . 0.0 114.401 -170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -49.06 -29.4 5.03 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.533 1.933 . . . . 0.0 115.481 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -69.13 -50.73 45.35 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.088 -1.008 . . . . 0.0 111.214 174.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -62.45 -34.94 77.8 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.985 1.314 . . . . 0.0 110.738 174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -63.8 -39.48 94.36 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.786 1.234 . . . . 0.0 112.669 178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.9 -43.92 86.77 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 50.3 mt -63.22 -44.87 94.05 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.951 0.796 . . . . 0.0 111.327 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 51.9 ptt85 -64.93 -35.32 80.77 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.31 -46.57 73.14 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 173.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -74.43 -13.97 60.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.826 1.25 . . . . 0.0 113.149 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 74.62 37.59 45.6 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 118.929 0.786 . . . . 0.0 113.504 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 82.5 mt -87.84 144.73 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-N 118.224 1.012 . . . . 0.0 110.165 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 6.0 t -57.43 113.18 1.66 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.156 1.382 . . . . 0.0 110.242 177.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 24.4 p -149.98 167.04 27.85 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.018 0.913 . . . . 0.0 113.263 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -68.22 168.69 11.8 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.867 1.667 . . . . 0.0 112.347 169.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -47.57 128.12 12.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 128.359 2.663 . . . . 0.0 113.623 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--O 1.251 1.162 0 C-N-CA 126.56 1.944 . . . . 0.0 110.355 175.538 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.01 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.03 148.1 45.11 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 117.646 0.723 . . . . 0.0 112.133 176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 14.7 ttm -73.27 135.57 44.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.722 0.809 . . . . 0.0 110.137 173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 16.8 m -121.43 167.39 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.727 1.611 . . . . 0.0 109.505 164.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -54.91 -36.72 65.51 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 120.66 -1.275 . . . . 0.0 112.043 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -56.49 -32.09 64.69 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.104 1.361 . . . . 0.0 114.065 172.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -71.83 -32.9 68.01 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.101 1.319 . . . . 0.0 113.098 177.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.1 mt -70.64 -47.49 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 170.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -60.82 -40.26 92.1 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -70.72 -36.92 73.45 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.94 1.296 . . . . 0.0 112.054 175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 90.3 m -70.95 -36.03 72.43 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.396 -0.815 . . . . 0.0 111.346 176.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 mm -58.53 -32.13 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.501 1.121 . . . . 0.0 111.256 170.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 27.6 mmtt -84.16 -21.79 31.22 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.454 1.901 . . . . 0.0 115.223 177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 4.3 m -106.03 -22.8 12.79 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.303 1.441 . . . . 0.0 114.283 -175.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -95.04 149.3 21.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.699 1.599 . . . . 0.0 110.007 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -92.45 -24.99 18.65 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.506 -1.371 . . . . 0.0 111.98 -175.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -132.37 120.84 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 127.199 2.2 . . . . 0.0 108.849 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 63.8 t -135.15 139.76 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.554 0.742 . . . . 0.0 110.699 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.4 t -136.38 144.73 44.71 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.717 -0.615 . . . . 0.0 112.311 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -111.6 118.4 35.58 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.279 1.432 . . . . 0.0 109.373 176.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.38 172.31 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -167.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.7 mttt -94.62 74.19 3.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.364 1.465 . . . . 0.0 110.793 169.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.85 26.33 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 124.638 1.113 . . . . 0.0 112.439 164.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.45 154.96 92.11 Favored Pre-proline 0 CA--C 1.541 0.626 0 O-C-N 121.106 -1.232 . . . . 0.0 110.87 158.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.67 -16.91 14.54 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 123.203 2.602 . . . . 0.0 112.323 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -87.29 -20.53 26.69 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.012 1.325 . . . . 0.0 114.164 170.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.01 65.95 11.21 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.377 1.471 . . . . 0.0 112.66 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.7 135.92 31.85 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.847 2.364 . . . . 0.0 110.73 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.412 ' CE ' HD12 ' A' ' 127' ' ' LEU . 22.6 mtm -82.01 -12.64 58.21 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.372 1.069 . . . . 0.0 113.155 -170.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 90.3 m -142.78 144.54 32.64 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.764 1.226 . . . . 0.0 111.774 -162.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.13 61.61 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -165.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -69.15 -24.75 64.12 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 120.933 -1.104 . . . . 0.0 112.127 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.3 m -70.27 -35.75 73.96 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.466 0.706 . . . . 0.0 111.867 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -62.63 -51.79 65.9 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 118.796 0.725 . . . . 0.0 110.807 165.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -61.07 -30.39 70.31 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 2.6 mmt -63.93 -52.68 58.68 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.928 1.291 . . . . 0.0 112.356 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.2 mm -61.47 -32.77 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 121.776 -0.577 . . . . 0.0 110.851 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -69.07 -13.19 62.29 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.174 1.789 . . . . 0.0 115.579 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.4 t -78.33 -46.79 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.727 -1.233 . . . . 0.0 110.493 161.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.8 mt -76.59 -37.62 56.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.975 0.91 . . . . 0.0 113.058 -170.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -72.46 -43.19 64.07 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.025 1.33 . . . . 0.0 111.924 171.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.3 -17.75 63.76 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.61 0.71 39.77 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.429 1.492 . . . . 0.0 113.617 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.47 23.94 74.18 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 119.775 1.171 . . . . 0.0 115.892 174.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 11.5 mt -80.06 159.38 26.18 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 122.584 1.183 . . . . 0.0 112.349 -170.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -97.52 124.51 41.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 126.114 1.766 . . . . 0.0 110.245 165.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -145.87 163.25 35.67 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.919 1.287 . . . . 0.0 112.522 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.1 m -116.47 131.95 56.81 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.111 0.964 . . . . 0.0 110.19 163.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.0 t -109.05 135.32 50.41 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.97 1.308 . . . . 0.0 111.925 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -118.61 127.91 54.05 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.062 1.745 . . . . 0.0 111.677 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.59 120.14 38.52 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.6 -18.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 113.669 0.988 . . . . 0.0 113.669 178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.412 HD12 ' CE ' ' A' ' 103' ' ' MET . 18.0 mt -87.33 -5.13 59.02 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.41 1.484 . . . . 0.0 113.251 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.94 -15.26 12.37 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 -169.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -160.86 131.13 3.51 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 119.188 0.904 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -58.62 -36.65 96.97 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 123.41 2.74 . . . . 0.0 112.574 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -56.45 -36.18 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.023 0.929 . . . . 0.0 112.371 175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.24 -47.85 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 119.387 0.994 . . . . 0.0 111.533 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -75.86 -25.72 56.44 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.316 -0.865 . . . . 0.0 113.235 179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.6 m -65.25 -42.74 93.0 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.323 1.049 . . . . 0.0 112.203 167.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.18 -43.27 92.17 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.037 0.835 . . . . 0.0 111.268 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.19 -50.97 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 O-C-N 121.508 -0.745 . . . . 0.0 111.039 174.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -66.07 -35.19 79.87 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.525 -0.735 . . . . 0.0 112.619 -175.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -96.42 -24.44 16.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.5 t -116.67 -37.62 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-N 120.277 1.399 . . . . 0.0 112.979 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 8.0 m -75.66 -46.96 28.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.398 0.999 . . . . 0.0 110.743 166.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 59.6 -8.66 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.42 2.688 . . . . 0.0 116.162 -174.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 62.4 t-105 -72.66 139.0 80.35 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.313 1.845 . . . . 0.0 111.024 168.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.07 -38.33 2.24 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.272 2.648 . . . . 0.0 114.788 -173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 40.5 m -66.63 130.85 44.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.512 0.725 . . . . 0.0 112.237 -165.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.6 mm -114.14 142.61 28.24 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.139 1.776 . . . . 0.0 109.558 165.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -76.18 168.9 75.92 Favored 'Cis proline' 0 CA--C 1.537 0.646 0 CA-C-N 120.052 1.054 . . . . 0.0 114.066 -3.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -130.05 153.71 48.17 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.857 1.663 . . . . 0.0 112.781 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 40.7 tp -125.32 139.73 53.44 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 126.427 1.891 . . . . 0.0 111.341 175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -123.43 143.58 50.05 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.79 2.436 . . . . 0.0 110.054 170.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.5 mm -130.4 131.14 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.904 1.281 . . . . 0.0 108.934 172.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 61.8 mmtt 41.05 55.94 3.08 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 126.246 1.818 . . . . 0.0 111.907 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 59.05 20.02 7.86 Favored 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -118.9 141.42 48.67 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 121.33 1.877 . . . . 0.0 111.813 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -64.2 134.84 55.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.486 0.715 . . . . 0.0 111.134 172.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.43 -39.86 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 125.667 1.587 . . . . 0.0 112.287 -173.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 148.53 -174.42 28.2 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.032 0.825 . . . . 0.0 114.055 176.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.7 -174.83 50.62 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.207 1.384 . . . . 0.0 114.452 168.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -62.29 -34.6 76.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.758 2.423 . . . . 0.0 112.918 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -63.21 -51.16 67.4 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.977 -1.077 . . . . 0.0 111.248 169.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.8 mm -65.45 -46.79 89.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 O-C-N 121.454 -0.778 . . . . 0.0 112.372 -174.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.7 p -54.39 -40.69 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 CA-C-N 119.454 1.025 . . . . 0.0 112.01 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 25.2 p -75.43 -40.05 58.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 118.544 -0.741 . . . . 0.0 112.95 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -61.56 -41.73 97.8 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 120.04 1.291 . . . . 0.0 112.189 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 92.6 mtp -61.84 -33.17 73.68 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.83 0.852 . . . . 0.0 112.945 171.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.61 -49.89 64.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 119.875 1.216 . . . . 0.0 111.446 172.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -56.47 -38.61 71.95 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.165 0.586 . . . . 0.0 111.556 174.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 16.4 m -77.05 -3.79 40.96 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.652 1.981 . . . . 0.0 114.708 175.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.77 -30.75 0.89 Allowed Glycine 0 CA--C 1.539 1.535 0 C-N-CA 125.282 1.42 . . . . 0.0 114.793 -173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -45.1 -36.29 3.57 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.996 2.518 . . . . 0.0 114.42 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.45 -55.03 20.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.47 1.108 . . . . 0.0 111.509 174.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -64.84 -24.97 67.71 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.886 1.275 . . . . 0.0 111.364 176.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -72.42 -42.66 64.84 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.587 1.155 . . . . 0.0 111.441 173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -36.57 78.45 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.307 0.958 . . . . 0.0 112.98 -179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 47.1 mt -61.37 -52.58 64.05 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.345 0.658 . . . . 0.0 111.735 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.14 -35.93 81.79 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.727 0.64 . . . . 0.0 112.727 176.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.33 -45.72 91.95 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.51 1.124 . . . . 0.0 112.783 177.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -85.14 -8.6 58.55 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.286 1.434 . . . . 0.0 114.701 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.09 47.66 10.89 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 114.668 0.627 . . . . 0.0 114.668 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 85.7 mt -106.7 145.74 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.568 1.547 . . . . 0.0 110.418 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -63.62 135.18 56.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.938 1.295 . . . . 0.0 112.737 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 26.3 p -161.69 171.79 17.32 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 122.302 1.049 . . . . 0.0 113.727 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -66.29 167.47 10.32 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.664 1.986 . . . . 0.0 111.533 161.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.98 138.78 14.9 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.462 1.905 . . . . 0.0 115.216 -164.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 7.0 mt . . . . . 0 C--O 1.253 1.277 0 CA-C-N 112.356 -2.202 . . . . 0.0 112.95 -171.207 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.908 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -155.69 149.13 24.88 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 19.1 ttm -58.71 145.22 40.97 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.011 0.925 . . . . 0.0 110.826 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.9 m -127.91 161.47 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 124.828 1.251 . . . . 0.0 110.794 175.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.35 -30.76 68.62 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.169 -0.957 . . . . 0.0 112.923 -177.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -62.84 -30.38 71.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.563 1.945 . . . . 0.0 113.88 170.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -62.75 -45.05 94.49 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 119.965 1.257 . . . . 0.0 110.756 176.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 14.0 mt -68.05 -43.01 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 123.144 0.578 . . . . 0.0 110.111 177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -64.74 -37.08 86.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -75.75 -34.3 60.27 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.865 0.866 . . . . 0.0 113.018 174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.3 m -62.66 -42.94 99.89 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.025 -0.422 . . . . 0.0 110.654 172.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.0 mt -63.1 -28.63 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 CA-C-N 118.863 0.756 . . . . 0.0 112.794 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -79.76 -25.12 41.12 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.6 m -115.77 -19.94 10.27 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 116.081 1.882 . . . . 0.0 116.081 -169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -82.02 166.09 20.09 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.536 1.062 . . . . 0.0 109.217 163.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 179' ' ' ILE . 85.5 m-20 -92.31 -26.49 18.08 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 120.403 -1.436 . . . . 0.0 111.137 172.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.1 t -138.35 124.02 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 C-N-CA 125.35 1.46 . . . . 0.0 109.458 -173.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 65.8 t -134.4 137.52 51.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.493 0.717 . . . . 0.0 110.35 176.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.5 t -134.9 151.49 50.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.411 0.684 . . . . 0.0 112.436 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -112.99 123.02 49.37 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.961 1.704 . . . . 0.0 108.834 175.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 pt -133.48 179.49 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.958 1.303 . . . . 0.0 112.937 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.6 tttt -110.44 71.08 0.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.586 1.954 . . . . 0.0 110.05 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.6 -168.01 26.91 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.208 1.385 . . . . 0.0 112.575 173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.25 158.62 81.12 Favored Pre-proline 0 CA--C 1.542 0.644 0 O-C-N 121.35 -1.089 . . . . 0.0 111.259 158.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.99 -31.64 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.911 2.407 . . . . 0.0 111.811 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -87.58 -13.86 41.74 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 172.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.55 62.88 11.66 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 125.117 1.367 . . . . 0.0 113.546 175.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.27 147.98 67.25 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.771 2.314 . . . . 0.0 110.368 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.0 mtm -84.53 6.09 25.03 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.371 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 5.9 t -154.27 143.6 21.36 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.938 1.295 . . . . 0.0 113.67 -170.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.05 -47.33 74.97 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.519 1.928 . . . . 0.0 113.739 178.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -66.42 -36.41 82.75 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.229 -0.919 . . . . 0.0 111.991 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.5 m -65.02 -42.16 94.65 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.302 0.641 . . . . 0.0 111.339 176.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -55.65 -49.68 72.23 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 124.041 0.936 . . . . 0.0 111.486 167.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.4 tpt85 -64.81 -31.48 72.73 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 117.846 -1.073 . . . . 0.0 113.756 -174.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 40.0 ttm -72.13 -45.32 61.0 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.526 1.057 . . . . 0.0 111.915 171.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.5 mm -57.64 -38.77 66.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.668 0.667 . . . . 0.0 110.748 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -59.34 -33.08 70.71 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 173.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 90.2 t -65.29 -47.2 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 120.795 -1.19 . . . . 0.0 110.093 173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.1 mt -71.56 -32.81 68.51 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.726 1.21 . . . . 0.0 111.932 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.8 -32.66 21.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.026 1.731 . . . . 0.0 113.605 177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -75.45 -41.55 55.49 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.856 0.753 . . . . 0.0 111.534 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 50.9 mt -73.76 -16.55 61.17 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 121.713 -0.617 . . . . 0.0 111.983 169.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 70.78 58.29 5.88 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 124.789 1.185 . . . . 0.0 113.032 171.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.6 mt -99.55 153.12 19.3 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.143 1.777 . . . . 0.0 110.753 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -83.77 118.64 24.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.112 0.965 . . . . 0.0 109.451 165.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -142.6 164.51 29.91 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 114.195 1.183 . . . . 0.0 114.195 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.0 m -114.65 133.82 55.55 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.908 1.283 . . . . 0.0 109.864 164.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 29.8 t -113.89 131.48 56.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.449 1.5 . . . . 0.0 110.41 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -110.21 141.98 42.41 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.521 1.528 . . . . 0.0 110.966 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -103.25 121.62 43.08 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.908 1.283 . . . . 0.0 111.054 177.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.4 m -66.26 -23.4 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.486 0.714 . . . . 0.0 112.917 176.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.4 mt -86.12 -7.71 58.39 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.183 0.993 . . . . 0.0 113.054 -178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.63 -17.51 17.77 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -162.44 122.35 1.45 Allowed Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.447 1.099 . . . . 0.0 110.943 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.2 -41.23 50.61 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.552 3.502 . . . . 0.0 114.743 175.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.21 -38.8 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 O-C-N 121.142 -0.974 . . . . 0.0 113.04 173.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 98.8 t -67.56 -47.03 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 CA-C-N 119.454 1.025 . . . . 0.0 111.453 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -73.18 -21.09 60.75 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 7.1 t -70.07 -46.21 65.42 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.86 1.264 . . . . 0.0 111.758 169.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -57.2 -44.79 83.95 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.75 0.82 . . . . 0.0 111.973 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.73 -35.85 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 120.574 -1.329 . . . . 0.0 113.143 175.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.15 -46.11 57.79 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.843 0.857 . . . . 0.0 111.994 -177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -93.94 -34.63 13.0 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -173.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.0 t -108.82 -40.92 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.496 1.119 . . . . 0.0 113.254 -169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.0 t -76.05 -42.28 48.1 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 119.529 1.059 . . . . 0.0 110.918 168.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 67.94 -8.39 0.55 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.603 2.761 . . . . 0.0 115.168 -177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 32.6 t-105 -76.51 133.08 71.29 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.175 -0.953 . . . . 0.0 112.05 176.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.73 -27.32 7.42 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.542 2.828 . . . . 0.0 114.107 -169.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 29.1 m -81.84 131.14 35.25 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.904 0.881 . . . . 0.0 112.917 -166.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.6 mm -108.45 140.61 21.93 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 125.78 1.632 . . . . 0.0 108.309 162.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.34 155.72 96.44 Favored 'Cis proline' 0 CA--C 1.537 0.669 0 CA-C-N 119.81 0.968 . . . . 0.0 112.862 -7.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -135.08 156.17 49.48 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.321 1.048 . . . . 0.0 112.769 177.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -122.36 143.17 49.81 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.652 1.581 . . . . 0.0 112.87 -170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -124.31 141.1 52.34 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 127.161 2.185 . . . . 0.0 110.688 168.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.4 mm -130.46 129.27 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.538 1.535 . . . . 0.0 110.061 175.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HE2' HD11 ' A' ' 179' ' ' ILE . 29.3 mmtt 39.55 54.91 2.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.278 1.831 . . . . 0.0 112.357 -177.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 65.09 14.66 9.52 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 118.305 2.705 . . . . 0.0 118.305 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -113.65 143.68 44.19 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.983 1.265 . . . . 0.0 113.1 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.11 139.71 58.73 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.85 0.86 . . . . 0.0 111.57 166.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 3.4 t -122.77 -31.63 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.099 1.36 . . . . 0.0 113.856 -170.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 146.77 176.52 20.62 Favored Glycine 0 CA--C 1.531 1.068 0 CA-C-N 119.435 1.016 . . . . 0.0 114.803 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.48 -173.72 49.36 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 125.455 1.502 . . . . 0.0 114.083 167.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -67.08 -29.58 69.39 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.205 1.402 . . . . 0.0 113.755 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -68.59 -32.2 71.92 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 120.972 -1.08 . . . . 0.0 113.229 172.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 44.1 mm -78.78 -43.09 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 123.865 0.866 . . . . 0.0 112.371 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 28.7 m -62.04 -34.52 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-N 119.1 0.864 . . . . 0.0 112.712 -173.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 48.2 p -72.69 -38.4 67.55 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.29 0.636 . . . . 0.0 111.897 173.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.46 -43.87 79.98 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.429 1.092 . . . . 0.0 111.879 172.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 81.9 mtp -64.87 -33.51 76.19 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.062 0.945 . . . . 0.0 113.232 172.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.0 tt -71.51 -48.96 45.47 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.44 1.096 . . . . 0.0 110.676 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -60.28 -41.17 92.79 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.632 1.573 . . . . 0.0 112.482 174.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 22.7 t -70.64 -23.08 62.46 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 113.235 174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 81.05 -6.34 63.28 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 125.218 1.39 . . . . 0.0 114.687 -170.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -55.9 -34.88 65.95 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.553 1.541 . . . . 0.0 113.209 177.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.86 -46.03 76.28 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.458 -0.776 . . . . 0.0 110.534 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -60.72 -38.68 85.91 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.288 1.035 . . . . 0.0 111.661 172.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -58.96 -53.46 58.15 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 118.446 -0.788 . . . . 0.0 111.28 173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -40.87 93.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.645 1.111 . . . . 0.0 113.263 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.3 mt -60.22 -50.15 74.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.923 0.783 . . . . 0.0 111.271 178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 28.1 ptt-85 -64.52 -39.9 94.62 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.25 -45.41 87.84 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.829 0.852 . . . . 0.0 111.608 177.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -82.68 -9.46 59.36 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.301 1.44 . . . . 0.0 113.95 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 81.78 27.98 44.32 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 115.774 1.07 . . . . 0.0 115.774 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.472 HD11 ' HE2' ' A' ' 151' ' ' LYS . 11.8 mm -85.69 152.85 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.004 1.402 . . . . 0.0 111.679 -175.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 11.8 t -68.04 134.05 50.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 169.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 27.6 p -163.31 174.76 11.62 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.221 1.408 . . . . 0.0 111.467 170.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -67.47 168.81 10.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.177 1.391 . . . . 0.0 112.144 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -47.15 142.18 3.93 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.292 2.237 . . . . 0.0 116.308 -154.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 C--O 1.258 1.505 0 CA-C-N 112.689 -2.051 . . . . 0.0 113.779 -161.143 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.77 152.76 43.58 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.179 0.991 . . . . 0.0 113.338 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 56.8 ttp -119.47 130.99 55.52 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.894 1.278 . . . . 0.0 110.612 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 27.8 m -106.95 163.92 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.893 1.277 . . . . 0.0 111.329 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -59.69 -33.61 71.81 Favored 'General case' 0 N--CA 1.476 0.852 0 O-C-N 121.146 -0.971 . . . . 0.0 112.809 -176.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.461 1.504 . . . . 0.0 113.614 170.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -61.51 -37.72 84.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.63 1.105 . . . . 0.0 111.22 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.8 mt -73.65 -41.72 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.204 1.402 . . . . 0.0 110.509 175.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -62.48 -45.96 90.64 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -70.94 -25.99 62.99 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.595 0.758 . . . . 0.0 112.196 173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 95.2 m -63.3 -47.72 81.12 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.74 1.155 . . . . 0.0 110.757 170.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.2 mt -61.56 -27.14 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-N 119.348 0.976 . . . . 0.0 112.389 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.6 mttt -80.61 -30.93 36.77 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 73.8 m -99.29 -29.16 12.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -167.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -82.85 165.65 19.63 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.925 1.29 . . . . 0.0 110.408 169.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -99.09 -24.45 14.89 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 120.662 -1.274 . . . . 0.0 111.884 173.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.59 126.28 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 126.165 1.786 . . . . 0.0 110.113 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.92 144.93 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.543 0.737 . . . . 0.0 111.358 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.3 t -138.95 150.32 45.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.705 0.802 . . . . 0.0 112.881 175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.06 123.9 49.08 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.413 1.485 . . . . 0.0 108.896 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.0 pt -138.63 167.12 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 124.632 1.173 . . . . 0.0 112.872 -172.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -88.04 76.05 8.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.283 1.433 . . . . 0.0 109.859 169.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 143.93 -176.34 23.3 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.622 1.106 . . . . 0.0 112.076 166.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.86 157.28 88.96 Favored Pre-proline 0 CA--C 1.541 0.625 0 O-C-N 120.724 -1.457 . . . . 0.0 111.772 159.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.74 -18.44 13.42 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.336 2.691 . . . . 0.0 112.72 -175.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -86.32 -26.57 24.82 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.08 171.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -143.72 66.39 15.18 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.675 0.79 . . . . 0.0 111.212 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -67.45 147.82 77.97 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 121.946 1.764 . . . . 0.0 110.876 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 10.4 mtm -91.36 6.5 45.11 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.717 1.207 . . . . 0.0 111.832 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 1.6 t -155.34 140.68 17.67 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.137 -0.977 . . . . 0.0 111.721 -166.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -61.72 -49.19 77.43 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -170.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -67.2 -27.38 67.21 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.042 -1.036 . . . . 0.0 112.028 179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.1 m -70.05 -34.31 73.06 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.521 0.728 . . . . 0.0 111.664 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.14 -48.05 74.93 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 121.624 -0.672 . . . . 0.0 111.627 166.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -62.97 -33.83 76.23 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.807 1.243 . . . . 0.0 113.391 -175.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.1 mmt -58.4 -54.17 50.07 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.728 1.211 . . . . 0.0 112.216 169.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.54 -35.94 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 123.402 0.681 . . . . 0.0 111.286 -175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.71 -29.51 70.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.8 t -66.91 -43.89 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.587 -1.321 . . . . 0.0 110.206 173.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.7 mt -75.16 -38.44 60.91 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.481 1.112 . . . . 0.0 111.621 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -79.24 -31.73 43.63 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 125.17 1.388 . . . . 0.0 112.719 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -80.24 -23.84 40.56 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 119.492 1.042 . . . . 0.0 113.619 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.2 mt -90.83 -7.44 52.29 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 170.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.92 43.53 27.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.493 1.044 . . . . 0.0 114.246 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.5 mt -96.65 146.62 24.69 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.748 1.619 . . . . 0.0 110.62 -176.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.29 133.55 34.15 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.558 -0.714 . . . . 0.0 110.656 160.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -148.11 168.9 21.2 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.2 1.4 . . . . 0.0 111.734 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 54.9 m -116.76 134.87 54.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.254 1.022 . . . . 0.0 109.948 162.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.2 t -116.51 129.13 56.02 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.667 1.587 . . . . 0.0 110.495 178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -109.01 134.77 51.21 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.411 1.485 . . . . 0.0 111.737 179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -96.64 119.98 36.13 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.955 0.902 . . . . 0.0 111.247 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 19.2 m -68.53 -21.28 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.351 -0.843 . . . . 0.0 113.128 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.6 mt -89.11 -20.6 24.1 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.53 1.132 . . . . 0.0 112.979 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.56 -22.2 32.44 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -156.89 110.62 1.95 Allowed Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.742 0.817 . . . . 0.0 111.896 -166.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -48.21 -41.62 34.33 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 124.017 3.145 . . . . 0.0 114.903 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.8 t -56.57 -34.01 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 O-C-N 120.968 -1.082 . . . . 0.0 113.038 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.4 t -65.37 -49.39 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.046 -1.033 . . . . 0.0 110.877 178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -72.41 -29.09 63.41 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 121.468 -0.77 . . . . 0.0 112.616 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 m -67.77 -31.97 72.24 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.282 1.033 . . . . 0.0 113.469 170.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -61.52 -45.65 93.3 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.748 1.158 . . . . 0.0 110.296 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.1 t -65.02 -38.45 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 O-C-N 121.179 -0.951 . . . . 0.0 111.707 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -60.73 -44.7 96.32 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.863 -1.148 . . . . 0.0 112.344 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.51 -33.84 10.5 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.13 -23.9 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.912 1.285 . . . . 0.0 113.621 -164.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -126.5 69.47 1.24 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.25 1.42 . . . . 0.0 110.212 171.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -65.43 0.87 1.32 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -58.75 135.46 86.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.159 0.984 . . . . 0.0 111.637 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.53 -37.64 28.67 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.237 2.625 . . . . 0.0 113.625 -172.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 20.6 m -77.64 130.24 36.6 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -168.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 7.7 mm -105.32 142.39 24.6 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.566 1.546 . . . . 0.0 108.085 152.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.68 161.29 93.91 Favored 'Cis proline' 0 CA--C 1.539 0.738 0 CA-C-N 119.946 1.016 . . . . 0.0 113.416 -6.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -142.68 158.7 43.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -122.41 143.28 49.76 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.581 1.952 . . . . 0.0 112.723 -170.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -128.77 139.03 52.39 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.557 2.343 . . . . 0.0 111.101 173.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 29.5 mm -129.58 129.19 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.227 1.411 . . . . 0.0 109.68 173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt 42.63 58.85 2.98 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 126.267 1.827 . . . . 0.0 112.328 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . 56.58 28.68 14.31 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -132.17 141.45 49.11 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.265 -1.522 . . . . 0.0 112.461 173.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -72.72 140.42 47.8 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 112.026 175.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 62.1 t -116.86 -43.86 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 124.449 1.1 . . . . 0.0 113.495 -173.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 154.09 -176.08 32.1 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.158 0.885 . . . . 0.0 114.251 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.49 -173.83 49.78 Favored Glycine 0 CA--C 1.539 1.582 0 C-N-CA 125.516 1.531 . . . . 0.0 114.523 171.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.98 -39.2 88.73 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.908 0.883 . . . . 0.0 111.612 177.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -51.78 -33.44 35.31 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.578 1.151 . . . . 0.0 113.41 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 mm -86.41 -48.48 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 124.525 1.13 . . . . 0.0 112.071 -174.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.7 m -59.93 -36.29 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 CA-C-N 118.939 0.79 . . . . 0.0 112.678 -174.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 65.1 p -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.417 1.087 . . . . 0.0 112.727 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -43.87 74.06 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.913 1.285 . . . . 0.0 111.874 172.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 91.5 mtp -66.13 -26.16 67.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.83 1.252 . . . . 0.0 112.928 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.1 tt -65.01 -50.72 65.18 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.562 -1.336 . . . . 0.0 111.072 171.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -71.88 -20.79 61.74 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 97.0 p -85.07 -16.91 39.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.167 0.987 . . . . 0.0 113.258 168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 87.63 -9.42 73.83 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 126.578 2.037 . . . . 0.0 114.503 -173.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.05 -26.45 68.84 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 120.282 2.041 . . . . 0.0 114.416 -173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -68.21 -51.09 49.41 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.313 1.445 . . . . 0.0 110.383 172.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -60.33 -35.62 76.06 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.241 1.016 . . . . 0.0 111.22 172.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -63.45 -49.51 73.38 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.682 0.793 . . . . 0.0 111.23 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.54 -40.1 93.46 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 119.317 0.962 . . . . 0.0 113.298 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 63.4 mt -60.91 -48.8 80.17 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 119.146 0.885 . . . . 0.0 111.479 178.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -68.43 -35.27 77.37 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.28 -45.5 93.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.443 1.097 . . . . 0.0 112.631 173.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 7.8 mptt -86.17 -5.47 59.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.748 1.219 . . . . 0.0 113.809 -178.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 86.66 29.16 24.73 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 116.875 1.51 . . . . 0.0 116.875 171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 90.0 mt -91.99 151.52 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 119.097 1.448 . . . . 0.0 111.198 -170.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 4.3 t -62.08 127.32 30.83 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.59 1.156 . . . . 0.0 111.731 174.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 7.8 p -163.17 172.93 14.09 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.099 1.359 . . . . 0.0 111.976 178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -67.83 157.92 33.73 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.005 1.322 . . . . 0.0 112.135 167.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -48.58 139.18 9.65 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 126.939 2.096 . . . . 0.0 115.606 -166.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 62.4 mt . . . . . 0 C--O 1.256 1.437 0 CA-C-N 112.542 -2.117 . . . . 0.0 114.781 -161.228 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.931 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.23 139.34 58.16 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -164.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 48.1 ttp -114.54 136.07 53.43 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.256 1.822 . . . . 0.0 110.366 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.6 m -114.68 165.31 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.788 1.235 . . . . 0.0 111.379 176.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -55.21 -37.52 67.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 121.359 -0.838 . . . . 0.0 112.459 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.9 -33.38 64.57 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.752 1.621 . . . . 0.0 113.746 172.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -67.24 -31.07 71.17 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 120.176 1.353 . . . . 0.0 112.174 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 25.2 mt -78.57 -44.05 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.903 0.881 . . . . 0.0 110.244 176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -59.48 -39.31 83.33 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.989 0.916 . . . . 0.0 111.71 175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -68.83 -45.09 72.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.87 2.068 . . . . 0.0 112.288 173.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 73.9 m -59.93 -47.9 83.9 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.301 0.64 . . . . 0.0 111.283 176.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.5 mt -61.25 -31.45 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-N 119.401 1.0 . . . . 0.0 112.567 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.54 -16.23 59.67 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -122.46 -13.01 8.1 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 114.89 1.441 . . . . 0.0 114.89 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -94.07 165.1 12.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.501 1.92 . . . . 0.0 112.697 169.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -89.48 -32.18 17.33 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.958 0.903 . . . . 0.0 111.301 170.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.51 122.43 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.485 1.514 . . . . 0.0 109.893 -171.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 55.8 t -131.6 142.49 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.37 0.668 . . . . 0.0 112.023 177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 148' ' ' LEU . 15.1 t -141.91 153.12 44.16 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -120.08 123.19 42.79 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.816 1.646 . . . . 0.0 109.355 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.0 pt -139.95 166.29 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.397 1.079 . . . . 0.0 113.798 -167.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -82.83 73.34 9.87 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 120.784 -1.197 . . . . 0.0 110.597 166.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.64 -166.67 27.75 Favored Glycine 0 CA--C 1.538 1.485 0 O-C-N 120.541 -1.349 . . . . 0.0 113.394 164.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.99 156.9 86.47 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 110.693 155.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.6 -36.33 2.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.793 2.329 . . . . 0.0 111.199 -178.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.06 -21.41 50.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.953 1.301 . . . . 0.0 114.107 173.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.05 69.36 35.19 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.495 1.518 . . . . 0.0 112.113 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.34 143.45 31.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.43 2.087 . . . . 0.0 111.471 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 15.1 mtm -84.26 8.3 16.38 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 125.326 1.45 . . . . 0.0 112.498 177.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 4.0 t -154.09 145.05 22.66 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.126 -0.984 . . . . 0.0 112.866 -173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.17 -52.86 62.85 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -66.44 -29.17 69.25 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.835 -1.165 . . . . 0.0 112.191 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.1 m -67.74 -37.8 82.65 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 119.045 -0.502 . . . . 0.0 111.939 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.51 -48.56 81.18 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.739 0.7 . . . . 0.0 110.799 165.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -59.99 -37.66 80.32 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -177.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.484 ' SD ' HD23 ' A' ' 148' ' ' LEU . 31.5 tpp -61.47 -46.08 91.54 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.734 0.697 . . . . 0.0 111.29 173.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.0 mm -66.0 -38.6 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 O-C-N 121.753 -0.592 . . . . 0.0 111.417 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -60.21 -41.37 92.87 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-O 117.637 -1.173 . . . . 0.0 112.818 175.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.79 -49.56 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-N 120.061 1.3 . . . . 0.0 110.905 172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.429 HD21 HD21 ' A' ' 148' ' ' LEU . 73.3 mt -69.43 -35.91 76.15 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.962 0.905 . . . . 0.0 111.743 -174.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -79.04 -30.32 44.05 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.39 1.076 . . . . 0.0 113.271 173.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.52 58.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.329 1.051 . . . . 0.0 111.7 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.4 mt -83.85 -13.18 54.31 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.304 -0.872 . . . . 0.0 111.92 164.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 69.97 39.56 74.36 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.463 1.506 . . . . 0.0 113.775 173.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.1 mt -82.73 167.31 18.31 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.867 1.267 . . . . 0.0 110.496 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.42 119.59 35.55 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.0 1.72 . . . . 0.0 109.613 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -137.59 174.57 10.45 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.359 1.064 . . . . 0.0 113.366 -160.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 90.7 m -126.49 122.71 35.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.302 1.041 . . . . 0.0 110.271 164.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.7 t -108.46 142.1 39.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 126.037 1.735 . . . . 0.0 111.241 178.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -121.38 128.38 52.16 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.046 1.338 . . . . 0.0 112.231 178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -74.41 122.45 23.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 0.0 110.896 165.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -69.61 -34.15 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 166.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.82 -25.01 59.87 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 112.884 -173.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.6 -8.3 35.33 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -152.76 123.91 3.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.574 1.079 . . . . 0.0 113.092 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -61.47 -36.97 74.58 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 124.067 3.178 . . . . 0.0 112.323 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -55.84 -34.98 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 121.338 -0.851 . . . . 0.0 112.361 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 80.8 t -68.31 -53.55 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.324 0.965 . . . . 0.0 111.116 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -68.75 -26.94 65.49 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.431 -0.793 . . . . 0.0 112.616 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.9 t -66.29 -42.29 88.59 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.312 1.445 . . . . 0.0 112.501 169.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -60.78 -41.62 95.93 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 120.782 -1.198 . . . . 0.0 111.612 171.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.76 -34.73 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 O-C-N 120.902 -1.124 . . . . 0.0 111.429 174.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -76.68 -50.06 14.6 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.726 0.811 . . . . 0.0 112.945 -178.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -88.57 -25.11 22.66 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.576 1.324 . . . . 0.0 114.576 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -119.09 -47.68 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.705 0.802 . . . . 0.0 112.786 -166.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.5 t -71.44 -44.46 64.78 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 119.551 1.069 . . . . 0.0 111.515 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 66.81 -16.14 0.14 Allowed 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 127.35 2.26 . . . . 0.0 115.32 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -77.18 136.05 65.83 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 119.616 1.098 . . . . 0.0 110.972 171.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -84.82 -29.27 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.59 0 C-N-CA 123.037 2.492 . . . . 0.0 113.829 -171.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 17.7 m -65.71 131.06 45.41 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.879 0.763 . . . . 0.0 112.201 -169.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.1 135.87 22.56 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 165.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -80.2 156.32 87.02 Favored 'Cis proline' 0 CA--C 1.541 0.849 0 CA-C-N 120.272 1.133 . . . . 0.0 114.192 -4.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -136.23 158.91 43.29 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.641 1.576 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.484 HD23 ' SD ' ' A' ' 110' ' ' MET . 0.1 OUTLIER -129.34 143.56 50.89 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.529 1.532 . . . . 0.0 112.288 -168.068 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.423 ' H ' HD13 ' A' ' 148' ' ' LEU . 35.4 m-85 -129.79 137.67 50.63 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.9 2.48 . . . . 0.0 110.597 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -122.94 128.56 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.58 1.152 . . . . 0.0 110.228 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 35.8 mttt 36.02 53.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.316 2.247 . . . . 0.0 113.492 -176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.278 . . 76.4 13.5 2.47 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 118.524 2.787 . . . . 0.0 118.524 178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -132.54 142.25 49.09 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 121.246 1.839 . . . . 0.0 114.423 170.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -63.7 136.49 57.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.542 1.937 . . . . 0.0 113.236 -176.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.9 t -102.92 -43.65 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 125.502 1.521 . . . . 0.0 112.636 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 143.84 -174.47 24.22 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.083 1.325 . . . . 0.0 114.216 -171.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.72 -173.68 49.89 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 125.17 1.367 . . . . 0.0 114.636 171.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.41 -36.29 77.79 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.24 1.416 . . . . 0.0 113.354 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.11 -28.34 65.31 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 120.91 -1.119 . . . . 0.0 113.002 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 46.3 mm -74.19 -48.06 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 O-C-N 121.533 -0.73 . . . . 0.0 110.74 177.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 26.2 m -62.35 -35.66 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 118.796 0.725 . . . . 0.0 111.775 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 23.0 p -68.94 -36.23 77.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.58 0.752 . . . . 0.0 112.248 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.459 ' HE3' ' N ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -65.72 -37.4 86.3 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.274 1.03 . . . . 0.0 112.967 173.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 87.5 mtp -68.99 -26.61 65.11 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.157 0.983 . . . . 0.0 113.34 169.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.51 -49.24 56.47 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.347 1.059 . . . . 0.0 109.873 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -59.18 -50.17 75.05 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.048 0.939 . . . . 0.0 113.367 173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 80.9 p -74.27 -7.51 53.01 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.35 -0.98 45.29 Favored Glycine 0 CA--C 1.54 1.602 0 O-C-N 120.995 -1.065 . . . . 0.0 114.738 -172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -61.96 -28.28 69.44 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.179 1.489 . . . . 0.0 113.019 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.66 -50.51 29.85 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 120.99 -1.069 . . . . 0.0 110.647 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -60.53 -31.71 70.78 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.497 -0.752 . . . . 0.0 112.72 169.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 35.8 ttmt -63.69 -45.57 89.43 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.1 -0.952 . . . . 0.0 112.422 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -64.48 -46.93 80.91 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.757 1.162 . . . . 0.0 113.288 171.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 31.4 mt -61.12 -42.34 98.34 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.673 -0.642 . . . . 0.0 111.874 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -67.49 -33.77 75.78 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 175.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.48 -43.47 98.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.701 0.801 . . . . 0.0 112.007 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -76.14 -14.73 60.16 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 126.021 1.728 . . . . 0.0 114.159 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.14 20.13 73.35 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 124.522 1.058 . . . . 0.0 115.462 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.63 154.04 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-N 119.035 1.417 . . . . 0.0 112.018 -170.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 13.9 t -67.24 111.61 4.06 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.417 0.687 . . . . 0.0 111.023 176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 9.5 p -154.02 161.3 42.05 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -76.62 168.48 20.01 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 126.512 1.925 . . . . 0.0 113.608 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -50.27 110.58 0.42 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 117.018 2.229 . . . . 0.0 117.018 -152.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.7 mt . . . . . 0 C--O 1.252 1.236 0 C-N-CA 127.211 2.205 . . . . 0.0 114.667 -168.049 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.172 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -145.58 141.58 28.33 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.79 1.236 . . . . 0.0 114.042 -170.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 29.1 ttp -72.43 160.61 32.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.5 1.12 . . . . 0.0 110.707 165.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -127.93 155.6 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.866 0.866 . . . . 0.0 111.653 175.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -59.7 -30.61 68.91 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 120.826 -1.171 . . . . 0.0 113.564 -171.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.76 -34.9 70.04 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.995 1.718 . . . . 0.0 113.327 168.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -61.83 -41.43 97.78 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 120.019 1.281 . . . . 0.0 111.704 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.61 -45.51 73.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 118.661 -0.685 . . . . 0.0 109.795 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -62.79 -38.8 92.09 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 119.261 0.937 . . . . 0.0 112.403 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.08 -40.88 97.21 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.133 1.773 . . . . 0.0 111.946 173.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.9 m -68.46 -41.39 80.28 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.041 0.936 . . . . 0.0 111.392 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.1 mm -57.07 -38.09 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.648 1.579 . . . . 0.0 110.745 173.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.16 -25.25 47.15 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.479 1.912 . . . . 0.0 114.529 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 43.8 t -89.83 -45.74 9.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.029 1.332 . . . . 0.0 113.443 -178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 63.9 mm-40 -86.75 152.0 22.9 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.81 1.244 . . . . 0.0 111.674 -172.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -86.32 -24.98 25.67 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.248 -0.908 . . . . 0.0 111.119 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.0 t -135.1 122.36 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 127.27 2.228 . . . . 0.0 109.994 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 59.2 t -133.35 135.5 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 123.64 0.776 . . . . 0.0 111.163 176.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -133.95 151.2 51.39 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 121.346 -0.846 . . . . 0.0 112.605 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -120.89 117.55 27.65 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.02 1.728 . . . . 0.0 109.273 -177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 18.2 pt -136.0 172.63 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.968 1.307 . . . . 0.0 114.267 -165.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -97.3 74.2 2.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.308 1.443 . . . . 0.0 110.454 170.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 145.57 -167.38 27.57 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.983 -1.073 . . . . 0.0 113.205 165.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.75 153.08 73.35 Favored Pre-proline 0 CA--C 1.539 0.539 0 O-C-N 121.732 -0.864 . . . . 0.0 112.055 155.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.03 -18.69 12.79 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.844 3.029 . . . . 0.0 111.312 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -96.38 -16.31 21.33 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.773 1.629 . . . . 0.0 114.163 173.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -145.91 67.47 12.34 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.413 1.485 . . . . 0.0 112.943 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.0 139.75 30.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.088 1.858 . . . . 0.0 112.1 -177.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 18.8 mtm -81.52 17.05 1.49 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 127.331 2.252 . . . . 0.0 112.893 179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 25.3 t -155.18 133.12 11.48 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.648 1.579 . . . . 0.0 111.736 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.79 -43.68 73.07 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.991 1.316 . . . . 0.0 113.776 174.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -69.15 -28.31 66.32 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.063 -1.023 . . . . 0.0 111.915 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 72.6 m -73.54 -40.22 64.14 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 121.394 -0.816 . . . . 0.0 112.269 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.0 tmmm? -53.16 -49.04 67.45 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.66 0.664 . . . . 0.0 110.753 163.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.1 tpt180 -65.83 -29.93 70.47 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.457 -1.258 . . . . 0.0 113.247 -175.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.2 tpp -67.7 -53.98 23.18 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 119.914 1.234 . . . . 0.0 111.071 169.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.1 mm -61.3 -34.71 62.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 122.928 0.491 . . . . 0.0 111.378 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -56.27 -37.69 70.16 Favored 'General case' 0 C--O 1.215 -0.713 0 C-N-CA 123.905 0.882 . . . . 0.0 113.329 172.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.6 -37.09 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 120.152 1.342 . . . . 0.0 110.94 174.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 50.2 mt -80.52 -36.43 33.2 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.155 1.382 . . . . 0.0 111.584 -175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -76.56 -43.36 39.29 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.211 1.405 . . . . 0.0 112.1 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.14 -11.64 60.61 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.6 mt -103.27 -2.68 26.78 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.974 1.31 . . . . 0.0 113.036 169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 74.87 28.44 62.75 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.664 1.126 . . . . 0.0 115.545 173.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.57 153.87 27.8 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.837 1.255 . . . . 0.0 110.931 -173.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -98.82 114.8 27.53 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.792 1.637 . . . . 0.0 109.11 166.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -139.67 167.26 22.51 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.17 1.388 . . . . 0.0 112.906 -169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 77.3 m -121.91 133.32 54.85 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.261 1.025 . . . . 0.0 110.592 170.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 30.9 t -119.58 136.14 54.49 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 125.469 1.507 . . . . 0.0 111.117 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -122.29 144.47 48.98 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.08 1.752 . . . . 0.0 111.854 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -107.39 119.74 40.25 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -69.99 -15.6 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -85.25 -20.7 29.69 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.693 1.197 . . . . 0.0 112.954 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -98.64 -20.2 17.12 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -169.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -157.35 120.24 2.16 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 119.285 0.948 . . . . 0.0 110.48 -173.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -47.5 -42.27 28.93 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 124.834 3.689 . . . . 0.0 114.298 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 3.4 t -50.71 -39.01 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 124.881 1.272 . . . . 0.0 113.156 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -66.45 -45.88 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 119.769 1.168 . . . . 0.0 111.146 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -76.87 -31.95 57.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -31.21 65.05 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 171.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -58.91 -43.29 91.05 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.982 1.265 . . . . 0.0 111.307 171.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.0 t -57.62 -55.03 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 121.674 -0.641 . . . . 0.0 110.333 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -60.29 -26.7 66.71 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -105.78 -15.22 15.0 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.015 1.326 . . . . 0.0 114.48 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 17.9 t -126.11 -29.8 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -177.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.6 p -94.8 -30.44 14.23 Favored 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 121.051 1.75 . . . . 0.0 112.013 162.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 58.98 26.69 15.36 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.009 1.724 . . . . 0.0 113.394 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TRP . . . . . . . . . . . . . 40.5 t-105 -114.72 144.17 31.41 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.037 1.735 . . . . 0.0 112.699 -172.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -78.27 -30.66 3.24 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.817 3.011 . . . . 0.0 115.689 -174.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 3.0 m -66.51 140.31 57.99 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.144 0.578 . . . . 0.0 112.326 -168.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 27.1 mm -129.21 138.15 32.53 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-N 119.436 1.016 . . . . 0.0 109.637 169.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.19 170.53 68.37 Favored 'Cis proline' 0 CA--C 1.541 0.848 0 CA-C-N 120.453 1.197 . . . . 0.0 114.174 -3.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -128.29 158.18 38.88 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.983 1.313 . . . . 0.0 113.868 -177.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 45.9 tp -124.71 142.35 51.46 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.409 1.884 . . . . 0.0 112.46 176.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -122.63 143.72 49.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 127.812 2.445 . . . . 0.0 109.924 165.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.7 mm -129.35 130.02 67.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 125.262 1.425 . . . . 0.0 108.97 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt 45.79 54.65 7.63 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.677 1.591 . . . . 0.0 112.878 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . 0.252 . . 67.22 4.86 3.87 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -120.04 143.05 48.3 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 120.082 1.31 . . . . 0.0 113.169 178.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -67.07 140.74 57.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.881 1.672 . . . . 0.0 112.551 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.66 -38.92 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.051 1.741 . . . . 0.0 112.863 -170.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 150.67 -179.3 27.5 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 123.84 0.733 . . . . 0.0 113.526 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.81 -172.36 48.3 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.151 0.881 . . . . 0.0 114.225 167.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.35 -44.24 95.39 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.641 1.176 . . . . 0.0 112.766 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -64.94 -25.08 67.73 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 45.6 mm -74.19 -49.64 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.262 1.025 . . . . 0.0 111.058 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.13 -36.28 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 118.855 0.752 . . . . 0.0 112.332 -175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 40.7 p -66.52 -35.48 80.34 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.921 0.488 . . . . 0.0 112.088 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -45.85 77.89 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.038 0.935 . . . . 0.0 112.083 173.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 84.5 mtp -62.23 -23.3 66.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.326 1.05 . . . . 0.0 113.589 173.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.55 -45.17 39.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.011 0.925 . . . . 0.0 110.855 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -69.27 -35.71 76.34 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 99.0 p -76.36 -11.7 59.94 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.84 1.256 . . . . 0.0 113.708 170.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 68.21 3.54 31.59 Favored Glycine 0 CA--C 1.535 1.304 0 CA-C-O 117.681 -1.621 . . . . 0.0 115.108 -171.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -62.25 -29.7 70.59 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 121.23 2.515 . . . . 0.0 112.533 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -48.99 66.1 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.142 0.977 . . . . 0.0 110.402 175.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -62.92 -32.75 74.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.866 1.266 . . . . 0.0 111.12 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -65.87 -39.07 90.36 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.312 1.045 . . . . 0.0 110.957 174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -41.85 95.79 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 119.175 0.898 . . . . 0.0 113.22 173.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.5 mt -61.13 -48.7 80.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 119.764 1.166 . . . . 0.0 111.911 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -66.31 -34.63 78.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -65.89 -39.69 90.88 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 111.717 170.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -87.37 -6.69 58.37 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.475 1.51 . . . . 0.0 113.753 -177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 78.41 19.05 74.88 Favored Glycine 0 CA--C 1.536 1.402 0 N-CA-C 116.263 1.265 . . . . 0.0 116.263 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 98.1 mt -84.03 143.62 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 CA-C-N 119.57 1.685 . . . . 0.0 111.254 -169.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 15.3 t -54.39 118.92 4.52 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.518 1.127 . . . . 0.0 111.893 176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 22.6 p -159.43 161.7 35.59 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 176.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -70.61 166.96 19.57 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 128.156 2.582 . . . . 0.0 112.252 167.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -48.19 133.37 15.45 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 126.699 2.0 . . . . 0.0 115.151 -165.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 56.4 mt . . . . . 0 C--O 1.249 1.037 0 C-N-CA 128.19 2.596 . . . . 0.0 115.401 -157.348 . . . . . . . . 0 0 . 1 stop_ save_